nivolumab/adverse effects	carcinoma non-small-cell lung/drug therapy	0.240219629375429	35124713
nivolumab/adverse effects	neoplasms/drug therapy	0.8265108416969653	33096100
interleukin-17/genetics	APC	0.02127659574468085	33462141
interleukin-17/genetics	CD274	0.1595744680851064	33462141
nivolumab/adverse effects	diarrhea/chemically induced	0.892764266875473	31595568
interleukin-17/genetics	CD8A	0.05319148936170214	33462141
nivolumab/adverse effects	ipilimumab/adverse effects	2.5111394794997657e-06	34159488
nivolumab/adverse effects	ipilimumab/adverse effects	2.5111394794997657e-06	33096100
nivolumab/adverse effects	ipilimumab/adverse effects	2.5111394794997657e-06	33882697
nivolumab/adverse effects	ipilimumab/adverse effects	2.5111394794997657e-06	34332139
nivolumab/adverse effects	ipilimumab/adverse effects	2.5111394794997657e-06	31595568
nivolumab/adverse effects	ipilimumab/adverse effects	2.5111394794997657e-06	32931028
nivolumab/adverse effects	ipilimumab/adverse effects	2.5111394794997657e-06	35191192
neoplasms	LTF	0.0425531914893617	32584703
adrenal gland diseases/diagnostic imaging	myocarditis/diagnostic imaging	0.010638297872340427	33375984
interleukin-17/genetics	IL17A	0.02127659574468085	33462141
nivolumab/adverse effects	colitis/chemically induced	0.36030611328699463	34159488
nivolumab/adverse effects	colitis/chemically induced	0.36030611328699463	34716545
nivolumab/adverse effects	colitis/chemically induced	0.36030611328699463	33096100
nivolumab/adverse effects	colitis/chemically induced	0.36030611328699463	35124713
nivolumab/adverse effects	colitis/chemically induced	0.36030611328699463	33906378
nivolumab/adverse effects	colitis/chemically induced	0.36030611328699463	34332139
nivolumab/adverse effects	colitis/chemically induced	0.36030611328699463	33882697
nivolumab/adverse effects	colitis/chemically induced	0.36030611328699463	31595568
nivolumab/adverse effects	colitis/chemically induced	0.36030611328699463	32931028
nivolumab/adverse effects	colitis/chemically induced	0.36030611328699463	35191192
adrenal gland diseases/diagnostic imaging	immune checkpoint inhibitors/adverse effects	0.5638297872340425	33375984
interleukin-17/genetics	MIR15B	0.010638297872340427	33462141
interleukin-17/genetics	NRF1	0.010638297872340427	33462141
nivolumab/adverse effects	paclitaxel/therapeutic use	0.1276595744680851	33476895
interleukin-17/genetics	PDCD1	0.2659574468085107	33462141
adrenal gland diseases/diagnostic imaging	pancreatitis/diagnostic imaging	0.010638297872340427	33375984
adrenal gland diseases/diagnostic imaging	neoplasms/diagnostic imaging	0.02127659574468085	33375984
colitis ulcerative	immune checkpoint inhibitors	0.31914893617021284	33146440
nephritis/chemically induced	nivolumab/therapeutic use	0.02127659574468085	32130969
nivolumab/adverse effects	oropharyngeal neoplasms/drug therapy	0.1276595744680851	33906378
nivolumab/adverse effects	disease susceptibility	0.1276595744680851	32028372
nivolumab/adverse effects	colitis ulcerative/chemically induced	0.1276595744680851	33476895
nivolumab/adverse effects	melanoma/drug therapy	0.5029180183905498	33882697
nephritis/chemically induced	diabetes mellitus type 1/chemically induced	0.010638297872340427	32130969
adrenal gland diseases/diagnostic imaging	sarcoidosis/diagnostic imaging	0.010638297872340427	33375984
nivolumab/adverse effects	piperidines/therapeutic use	0.240219629375429	33096100
nivolumab/therapeutic use	diabetes mellitus type 1/chemically induced	0.02127659574468085	32130969
nivolumab/adverse effects	drug-related side effects and adverse reactions/diagnosis	0.1276595744680851	35191192
adrenal gland diseases/diagnostic imaging	hepatitis/diagnostic imaging	0.010638297872340427	33375984
diarrhea	neoplasms	0.0837336993822924	35842365
nephritis/chemically induced	exanthema/chemically induced	0.010638297872340427	32130969
nephritis/chemically induced	bevacizumab/administration & dosage	0.010638297872340427	32130969
nivolumab/therapeutic use	exanthema/chemically induced	0.02127659574468085	32130969
nivolumab/therapeutic use	bevacizumab/administration & dosage	0.02127659574468085	32130969
nivolumab/adverse effects	programmed cell death 1 receptor/antagonists & inhibitors	0.6798144926672951	33476895
nivolumab/therapeutic use	arthritis/chemically induced	0.02127659574468085	36096534
nephritis/chemically induced	pneumonia/chemically induced	0.031914893617021274	32130969
nivolumab/adverse effects	postoperative complications	0.1276595744680851	32028372
nephritis/chemically induced	fatigue/chemically induced	0.010638297872340427	32130969
adrenal gland diseases/diagnostic imaging	pericarditis/diagnostic imaging	0.010638297872340427	33375984
nivolumab/therapeutic use	pneumonia/chemically induced	0.06314344543582705	32130969
adrenal gland diseases/diagnostic imaging	encephalitis/diagnostic imaging	0.010638297872340427	33375984
nivolumab/therapeutic use	fatigue/chemically induced	0.02127659574468085	32130969
nephritis/chemically induced	pruritus/chemically induced	0.010638297872340427	32130969
nivolumab/therapeutic use	immune checkpoint inhibitors	0.5387783115991764	36096534
nivolumab/therapeutic use	glucocorticoids	0.02127659574468085	36096534
nephritis/chemically induced	adrenal insufficiency/chemically induced	0.010638297872340427	32130969
nivolumab/therapeutic use	pruritus/chemically induced	0.02127659574468085	32130969
nivolumab/adverse effects	antineoplastic agents immunological/adverse effects	0.6285848114940625	33476895
nephritis/chemically induced	axitinib/administration & dosage	0.010638297872340427	32130969
nivolumab/adverse effects	ipilimumab/therapeutic use	0.33932141684819905	35124713
adrenal gland diseases/diagnostic imaging	colitis/diagnostic imaging	0.010638297872340427	33375984
nivolumab/therapeutic use	adrenal insufficiency/chemically induced	0.02127659574468085	32130969
nephritis/chemically induced	colitis/chemically induced	0.7446808510638299	32130969
nephritis/chemically induced	hypophysitis/chemically induced	0.010638297872340427	32130969
nivolumab/therapeutic use	axitinib/administration & dosage	0.02127659574468085	32130969
diarrhea	immune checkpoint inhibitors	0.09951956074124915	35842365
diarrhea	immune checkpoint inhibitors	0.09951956074124915	32780983
nephritis/chemically induced	angiogenesis inhibitors/therapeutic use	0.010638297872340427	32130969
nephritis/chemically induced	myocarditis/chemically induced	0.010638297872340427	32130969
nivolumab/therapeutic use	diarrhea/chemically induced	0.2951269732326699	36096534
nivolumab/adverse effects	CTLA4	0.8265108416969653	35191192
diarrhea	colitis	0.0013726835964310228	35842365
diarrhea	colitis	0.0013726835964310228	32780983
nephritis/chemically induced	hepatitis autoimmune/etiology	0.010638297872340427	32130969
nivolumab/therapeutic use	colitis/chemically induced	0.5525051475634867	32130969
nivolumab/therapeutic use	colitis/chemically induced	0.5525051475634867	36096534
nivolumab/therapeutic use	hypophysitis/chemically induced	0.02127659574468085	32130969
nivolumab/adverse effects	PDCD1	0.8860618360204824	35191192
nivolumab/adverse effects	PDCD1	0.8860618360204824	33906378
nephritis/chemically induced	myasthenia gravis/chemically induced	0.010638297872340427	32130969
nivolumab/adverse effects	SNCA	0.33932141684819905	33476895
nephritis/chemically induced	immune checkpoint inhibitors/therapeutic use	0.02127659574468085	32130969
nivolumab/therapeutic use	angiogenesis inhibitors/therapeutic use	0.02127659574468085	32130969
diarrhea	recurrence	0.04232441088995653	35842365
adrenal gland diseases/diagnostic imaging	pneumonia/diagnostic imaging	0.010638297872340427	33375984
nivolumab/therapeutic use	myocarditis/chemically induced	0.02127659574468085	32130969
gene expression regulation/genetics	receptors cxcr3/genetics	0.010638297872340427	32603654
nephritis/chemically induced	ipilimumab/therapeutic use	0.031914893617021274	32130969
gene expression regulation/genetics	cd8-positive t-lymphocytes/cytology	0.010638297872340427	32603654
nivolumab/therapeutic use	hepatitis autoimmune/etiology	0.02127659574468085	32130969
gene expression regulation/genetics	inflammation/drug therapy	0.02127659574468085	32603654
gene expression regulation/genetics	immune checkpoint inhibitors/adverse effects	0.5638297872340425	32603654
nivolumab/therapeutic use	myasthenia gravis/chemically induced	0.02127659574468085	32130969
gene expression regulation/genetics	myeloid cells/cytology	0.010638297872340427	32603654
nivolumab/therapeutic use	immune checkpoint inhibitors/therapeutic use	0.04232441088995653	32130969
gene expression regulation/genetics	ctla-4 antigen/immunology	0.010638297872340427	32603654
diarrhea	inflammatory bowel diseases	0.04232441088995653	35842365
nivolumab/therapeutic use	ipilimumab/therapeutic use	0.06314344543582705	32130969
hashimoto disease/chemically induced	nivolumab/adverse effects	0.1276595744680851	33476895
hashimoto disease/chemically induced	immune checkpoint inhibitors/adverse effects	0.5638297872340425	33476895
nivolumab/therapeutic use	CHI3L1	0.02127659574468085	36096534
gene expression regulation/genetics	colitis/drug therapy	0.031914893617021274	32603654
intestinal mucosa/diagnostic imaging	colon/diagnostic imaging	0.010638297872340427	32414860
intestinal mucosa/diagnostic imaging	drug resistance/immunology	0.010638297872340427	32414860
nivolumab/therapeutic use	CXCL8	0.02127659574468085	36096534
nivolumab/therapeutic use	IL17A	0.04232441088995653	36096534
intestinal mucosa/diagnostic imaging	immune checkpoint inhibitors/adverse effects	0.5638297872340425	32414860
nivolumab/therapeutic use	IL6	0.04232441088995653	36096534
hashimoto disease/chemically induced	squamous cell carcinoma of head and neck/drug therapy	0.010638297872340427	33476895
hashimoto disease/chemically induced	tongue neoplasms/drug therapy	0.010638297872340427	33476895
gene expression regulation/genetics	receptors antigen t-cell/genetics	0.010638297872340427	32603654
myeloid-derived suppressor cells/metabolism	azoxymethane/adverse effects	0.010638297872340427	33495297
intestinal mucosa/diagnostic imaging	skin neoplasms/drug therapy	0.02127659574468085	32414860
intestinal mucosa/diagnostic imaging	infliximab/adverse effects	0.0425531914893617	32414860
gene expression regulation/genetics	t-lymphocytes regulatory/cytology	0.010638297872340427	32603654
sirolimus/therapeutic use	drug-related side effects and adverse reactions/prevention & control	0.010638297872340427	34987517
myeloid-derived suppressor cells/metabolism	immune checkpoint inhibitors/administration & dosage	0.0425531914893617	33495297
hashimoto disease/chemically induced	paclitaxel/therapeutic use	0.010638297872340427	33476895
myeloid-derived suppressor cells/metabolism	colitis/chemically induced	0.7446808510638299	33495297
myeloid-derived suppressor cells/metabolism	phthalazines/administration & dosage	0.010638297872340427	33495297
myeloid-derived suppressor cells/metabolism	dextran sulfate/adverse effects	0.010638297872340427	33495297
carcinoma renal cell/drug therapy	nephritis/chemically induced	0.02127659574468085	32130969
gene expression regulation/genetics	chemokines/metabolism	0.010638297872340427	32603654
hashimoto disease/chemically induced	colitis ulcerative/chemically induced	0.010638297872340427	33476895
carcinoma renal cell/drug therapy	nivolumab/therapeutic use	0.04232441088995653	32130969
gene expression regulation/genetics	multigene family	0.010638297872340427	32603654
intestinal mucosa/diagnostic imaging	colitis/chemically induced	0.7446808510638299	32414860
myeloid-derived suppressor cells/metabolism	colonic neoplasms/drug therapy	0.010638297872340427	33495297
intestinal mucosa/diagnostic imaging	glucocorticoids/pharmacology	0.010638297872340427	32414860
carcinoma renal cell/drug therapy	diabetes mellitus type 1/chemically induced	0.02127659574468085	32130969
hashimoto disease/chemically induced	programmed cell death 1 receptor/antagonists & inhibitors	0.08510638297872342	33476895
carcinoma renal cell/drug therapy	immune checkpoint inhibitors/adverse effects	0.8123999084877602	35277350
carcinoma renal cell/drug therapy	exanthema/chemically induced	0.02127659574468085	32130969
carcinoma renal cell/drug therapy	bevacizumab/administration & dosage	0.02127659574468085	32130969
intestinal mucosa/diagnostic imaging	melanoma/drug therapy	0.05319148936170214	32414860
myeloid-derived suppressor cells/metabolism	cell line tumor	0.02127659574468085	33495297
carcinoma renal cell/drug therapy	pneumonia/chemically induced	0.06314344543582705	32130969
hashimoto disease/chemically induced	antineoplastic agents immunological/adverse effects	0.07446808510638298	33476895
gene expression regulation/genetics	CTLA4	0.1276595744680851	32603654
myeloid-derived suppressor cells/metabolism	poly(adp-ribose) polymerase inhibitors/administration & dosage	0.010638297872340427	33495297
carcinoma renal cell/drug therapy	fatigue/chemically induced	0.02127659574468085	32130969
intestinal mucosa/diagnostic imaging	immunosuppressive agents/pharmacology	0.010638297872340427	32414860
sirolimus/therapeutic use	growth inhibitors/therapeutic use	0.010638297872340427	34987517
gene expression regulation/genetics	PDCD1	0.2659574468085107	32603654
carcinoma renal cell/drug therapy	pruritus/chemically induced	0.02127659574468085	32130969
intestinal mucosa/diagnostic imaging	mucositis/chemically induced	0.010638297872340427	32414860
myeloid-derived suppressor cells/metabolism	piperazines/administration & dosage	0.010638297872340427	33495297
carcinoma renal cell/drug therapy	adrenal insufficiency/chemically induced	0.02127659574468085	32130969
myeloid-derived suppressor cells/metabolism	APC	0.02127659574468085	33495297
myeloid-derived suppressor cells/metabolism	ARG1	0.010638297872340427	33495297
carcinoma renal cell/drug therapy	axitinib/administration & dosage	0.02127659574468085	32130969
sirolimus/therapeutic use	phosphatidylinositol 3-kinases/metabolism	0.010638297872340427	34987517
carcinoma renal cell/drug therapy	inflammatory bowel diseases/drug therapy	0.06314344543582705	35277350
sirolimus/therapeutic use	antineoplastic agents immunological/therapeutic use	0.031914893617021274	34987517
hashimoto disease/chemically induced	SNCA	0.031914893617021274	33476895
sirolimus/therapeutic use	lymphocytes tumor-infiltrating/immunology	0.010638297872340427	34987517
carcinoma renal cell/drug therapy	proton pump inhibitors/adverse effects	0.02127659574468085	35277350
sirolimus/therapeutic use	colitis/etiology	0.02127659574468085	34987517
myeloid-derived suppressor cells/metabolism	PARP1	0.010638297872340427	33495297
sirolimus/therapeutic use	immune checkpoint inhibitors/therapeutic use	0.02127659574468085	34987517
myeloid-derived suppressor cells/metabolism	PDCD1	0.2659574468085107	33495297
sirolimus/therapeutic use	programmed cell death 1 receptor/antagonists & inhibitors	0.08510638297872342	34987517
myeloid-derived suppressor cells/metabolism	TIPARP	0.010638297872340427	33495297
carcinoma renal cell/drug therapy	colitis/chemically induced	0.5525051475634867	32130969
carcinoma renal cell/drug therapy	colitis/chemically induced	0.5525051475634867	35277350
ulcer/chemically induced	immune checkpoint inhibitors	0.31914893617021284	33746162
sirolimus/therapeutic use	cell line tumor	0.02127659574468085	34987517
carcinoma renal cell/drug therapy	hypophysitis/chemically induced	0.02127659574468085	32130969
carcinoma renal cell/drug therapy	angiogenesis inhibitors/therapeutic use	0.02127659574468085	32130969
esophagitis	ulcer/chemically induced	0.010638297872340427	33746162
sirolimus/therapeutic use	cd8-positive t-lymphocytes/immunology	0.010638297872340427	34987517
carcinoma renal cell/drug therapy	myocarditis/chemically induced	0.02127659574468085	32130969
carcinoma renal cell/drug therapy	hepatitis autoimmune/etiology	0.02127659574468085	32130969
sirolimus/therapeutic use	cytotoxicity immunologic	0.010638297872340427	34987517
carcinoma renal cell/drug therapy	myasthenia gravis/chemically induced	0.02127659574468085	32130969
psoriasis	immune checkpoint inhibitors	0.31914893617021284	35977003
carcinoma renal cell/drug therapy	immune checkpoint inhibitors/therapeutic use	0.04232441088995653	32130969
sirolimus/therapeutic use	CD8A	0.05319148936170214	34987517
ulcer/chemically induced	colitis/chemically induced	0.7446808510638299	33746162
melanoma/genetics	receptors cxcr6/genetics	0.010638297872340427	32603654
esophagitis	immune checkpoint inhibitors	0.31914893617021284	33746162
sirolimus/therapeutic use	MTOR	0.010638297872340427	34987517
melanoma/genetics	gene expression regulation/genetics	0.010638297872340427	32603654
sirolimus/therapeutic use	PDCD1	0.2659574468085107	34987517
melanoma/genetics	receptors cxcr3/genetics	0.010638297872340427	32603654
carcinoma renal cell/drug therapy	ipilimumab/therapeutic use	0.0006863417982155114	32130969
carcinoma renal cell/drug therapy	ipilimumab/therapeutic use	0.0006863417982155114	35277350
melanoma/genetics	cd8-positive t-lymphocytes/cytology	0.010638297872340427	32603654
melanoma/genetics	inflammation/drug therapy	0.02127659574468085	32603654
melanoma/genetics	immune checkpoint inhibitors/adverse effects	0.5638297872340425	32603654
melanoma/genetics	myeloid cells/cytology	0.010638297872340427	32603654
melanoma/genetics	ctla-4 antigen/immunology	0.010638297872340427	32603654
psoriasis	colitis/chemically induced	0.7446808510638299	35977003
colitis ulcerative/immunology	pyrimidines/therapeutic use	0.04232441088995653	34147519
esophagitis	colitis/chemically induced	0.7446808510638299	33746162
psoriasis	dermatitis	0.010638297872340427	35977003
colitis ulcerative/immunology	immune checkpoint inhibitors/adverse effects	0.3152596659803249	34338882
colitis ulcerative/immunology	immune checkpoint inhibitors/adverse effects	0.3152596659803249	34147519
colitis ulcerative/immunology	macrophages/drug effects	0.02127659574468085	34338882
colitis ulcerative/immunology	interferon-gamma/metabolism	0.02127659574468085	34147519
colitis ulcerative/immunology	immunologic memory/drug effects	0.02127659574468085	34147519
colitis ulcerative/immunology	colon/drug effects	0.0006863417982155114	34338882
colitis ulcerative/immunology	colon/drug effects	0.0006863417982155114	34147519
melanoma/genetics	colitis/drug therapy	0.031914893617021274	32603654
prednisolone/therapeutic use	nivolumab/adverse effects	0.1276595744680851	34716545
psoriasis	rna	0.010638297872340427	35977003
melanoma/genetics	receptors antigen t-cell/genetics	0.010638297872340427	32603654
colitis ulcerative/immunology	crohn disease/immunology	0.02127659574468085	34338882
melanoma/genetics	t-lymphocytes regulatory/cytology	0.010638297872340427	32603654
psoriasis	CTLA4	0.1276595744680851	35977003
psoriasis	CXCL10	0.010638297872340427	35977003
psoriasis	CXCL9	0.010638297872340427	35977003
prednisolone/therapeutic use	immune checkpoint inhibitors	0.31914893617021284	34716545
vitamin d	immune checkpoint inhibitors/adverse effects	0.5638297872340425	36338892
psoriasis	PDCD1	0.2659574468085107	35977003
psoriasis	TCIM	0.010638297872340427	35977003
psoriasis	TNF	0.031914893617021274	35977003
prednisolone/therapeutic use	lung neoplasms/drug therapy	0.02127659574468085	34716545
colitis ulcerative/immunology	piperidines/therapeutic use	0.04232441088995653	34147519
melanoma/genetics	chemokines/metabolism	0.010638297872340427	32603654
drug synergism	sirolimus/therapeutic use	0.02127659574468085	34987517
colitis ulcerative/immunology	programmed cell death 1 receptor/antagonists & inhibitors	0.1638069091741021	34147519
melanoma/genetics	multigene family	0.010638297872340427	32603654
drug synergism	myeloid-derived suppressor cells/metabolism	0.02127659574468085	33495297
colitis ulcerative/immunology	ctla-4 antigen/antagonists & inhibitors	0.06314344543582705	34147519
drug synergism	drug-related side effects and adverse reactions/prevention & control	0.02127659574468085	34987517
colitis ulcerative/immunology	graft vs host disease/immunology	0.02127659574468085	34338882
colitis ulcerative/immunology	cd8-positive t-lymphocytes/drug effects	0.00022878059940517045	34338882
colitis ulcerative/immunology	cd8-positive t-lymphocytes/drug effects	0.00022878059940517045	34147519
colitis ulcerative/immunology	phenotype	0.00022878059940517045	34338882
colitis ulcerative/immunology	phenotype	0.00022878059940517045	34147519
prednisolone/therapeutic use	colitis/chemically induced	0.7446808510638299	34716545
vitamin d	colitis/chemically induced	0.7446808510638299	36338892
melanoma/genetics	CTLA4	0.1276595744680851	32603654
colitis ulcerative/immunology	CD4	0.04232441088995653	34338882
colitis ulcerative/immunology	CD68	0.04232441088995653	34338882
colitis ulcerative/immunology	CD8A	0.002287805994051705	34338882
colitis ulcerative/immunology	CD8A	0.002287805994051705	34147519
melanoma/genetics	PDCD1	0.2659574468085107	32603654
colitis ulcerative/immunology	CTLA4	0.240219629375429	34147519
vitamin d	melanoma/drug therapy	0.05319148936170214	36338892
drug synergism	azoxymethane/adverse effects	0.02127659574468085	33495297
colitis ulcerative/immunology	PDCD1	0.4632807137954702	34147519
drug synergism	immune checkpoint inhibitors/administration & dosage	0.0837336993822924	33495297
drug synergism	growth inhibitors/therapeutic use	0.02127659574468085	34987517
drug synergism	colitis/chemically induced	0.9368565545641729	33495297
receptors cxcr6/genetics	gene expression regulation/genetics	0.010638297872340427	32603654
drug synergism	phthalazines/administration & dosage	0.02127659574468085	33495297
vitamin d	antineoplastic agents immunological/adverse effects	0.07446808510638298	36338892
receptors cxcr6/genetics	receptors cxcr3/genetics	0.010638297872340427	32603654
drug synergism	dextran sulfate/adverse effects	0.02127659574468085	33495297
host microbial interactions/drug effects	metabolome/drug effects	0.010638297872340427	34162429
receptors cxcr6/genetics	cd8-positive t-lymphocytes/cytology	0.010638297872340427	32603654
receptors cxcr6/genetics	inflammation/drug therapy	0.02127659574468085	32603654
receptors cxcr6/genetics	immune checkpoint inhibitors/adverse effects	0.5638297872340425	32603654
host microbial interactions/drug effects	immune checkpoint inhibitors/adverse effects	0.5638297872340425	34162429
drug synergism	colonic neoplasms/drug therapy	0.02127659574468085	33495297
receptors cxcr6/genetics	myeloid cells/cytology	0.010638297872340427	32603654
drug synergism	phosphatidylinositol 3-kinases/metabolism	0.02127659574468085	34987517
receptors cxcr6/genetics	ctla-4 antigen/immunology	0.010638297872340427	32603654
drug synergism	antineoplastic agents immunological/therapeutic use	0.06314344543582705	34987517
drug synergism	lymphocytes tumor-infiltrating/immunology	0.02127659574468085	34987517
drug synergism	colitis/etiology	0.04232441088995653	34987517
drug synergism	immune checkpoint inhibitors/therapeutic use	0.04232441088995653	34987517
drug synergism	programmed cell death 1 receptor/antagonists & inhibitors	0.1638069091741021	34987517
drug synergism	cell line tumor	0.00022878059940517045	33495297
drug synergism	cell line tumor	0.00022878059940517045	34987517
drug synergism	poly(adp-ribose) polymerase inhibitors/administration & dosage	0.02127659574468085	33495297
receptors cxcr3/genetics	cd8-positive t-lymphocytes/cytology	0.010638297872340427	32603654
drug synergism	cd8-positive t-lymphocytes/immunology	0.02127659574468085	34987517
receptors cxcr3/genetics	inflammation/drug therapy	0.02127659574468085	32603654
receptors cxcr3/genetics	immune checkpoint inhibitors/adverse effects	0.5638297872340425	32603654
receptors cxcr3/genetics	myeloid cells/cytology	0.010638297872340427	32603654
receptors cxcr3/genetics	ctla-4 antigen/immunology	0.010638297872340427	32603654
drug synergism	piperazines/administration & dosage	0.02127659574468085	33495297
drug synergism	cytotoxicity immunologic	0.02127659574468085	34987517
drug synergism	APC	0.04232441088995653	33495297
drug synergism	ARG1	0.02127659574468085	33495297
receptors cxcr6/genetics	colitis/drug therapy	0.031914893617021274	32603654
drug synergism	CD8A	0.10409517272935258	34987517
drug synergism	MTOR	0.02127659574468085	34987517
drug synergism	PARP1	0.02127659574468085	33495297
drug synergism	PDCD1	0.06863417982155114	33495297
drug synergism	PDCD1	0.06863417982155114	34987517
receptors cxcr6/genetics	receptors antigen t-cell/genetics	0.010638297872340427	32603654
drug synergism	TIPARP	0.02127659574468085	33495297
host microbial interactions/drug effects	dysbiosis/etiology	0.010638297872340427	34162429
receptors cxcr3/genetics	colitis/drug therapy	0.031914893617021274	32603654
host microbial interactions/drug effects	neoplasms/complications	0.031914893617021274	34162429
receptors cxcr6/genetics	t-lymphocytes regulatory/cytology	0.010638297872340427	32603654
receptors cxcr3/genetics	receptors antigen t-cell/genetics	0.010638297872340427	32603654
urothelium/drug effects	immune checkpoint inhibitors/administration & dosage	0.0425531914893617	32418993
urothelium/drug effects	colitis/chemically induced	0.7446808510638299	32418993
receptors cxcr6/genetics	chemokines/metabolism	0.010638297872340427	32603654
receptors cxcr3/genetics	t-lymphocytes regulatory/cytology	0.010638297872340427	32603654
receptors cxcr6/genetics	multigene family	0.010638297872340427	32603654
protective agents/pharmacology	mesalamine/pharmacology	0.010638297872340427	33506015
host microbial interactions/drug effects	colitis/etiology	0.02127659574468085	34162429
urothelium/drug effects	carcinoma non-small-cell lung/complications	0.010638297872340427	32418993
protective agents/pharmacology	colon/drug effects	0.031914893617021274	33506015
receptors cxcr3/genetics	chemokines/metabolism	0.010638297872340427	32603654
receptors cxcr3/genetics	multigene family	0.010638297872340427	32603654
host microbial interactions/drug effects	antineoplastic agents immunological/adverse effects	0.07446808510638298	34162429
receptors cxcr6/genetics	CTLA4	0.1276595744680851	32603654
urothelium/drug effects	drug-related side effects and adverse reactions	0.02127659574468085	32418993
urothelium/drug effects	melanoma/complications	0.031914893617021274	32418993
carcinoma non-small-cell lung	immune checkpoint inhibitors	0.31914893617021284	34106395
protective agents/pharmacology	colitis/chemically induced	0.7446808510638299	33506015
receptors cxcr6/genetics	PDCD1	0.2659574468085107	32603654
urothelium/drug effects	infliximab/administration & dosage	0.010638297872340427	32418993
host microbial interactions/drug effects	anti-bacterial agents/pharmacology	0.010638297872340427	34162429
receptors cxcr3/genetics	CTLA4	0.1276595744680851	32603654
receptors cxcr3/genetics	PDCD1	0.2659574468085107	32603654
protective agents/pharmacology	immune checkpoint inhibitors/pharmacology	0.0425531914893617	33506015
urothelium/drug effects	ACAD8	0.02127659574468085	32418993
adrenal cortex hormones/therapeutic use	inflammation/drug therapy	0.08373369938229239	36113896
adrenal cortex hormones/therapeutic use	immune checkpoint inhibitors/adverse effects	0.9667912881484545	34380976
urothelium/drug effects	CRP	0.010638297872340427	32418993
protective agents/pharmacology	programmed cell death 1 receptor/antagonists & inhibitors	0.08510638297872342	33506015
protective agents/pharmacology	trinitrobenzenesulfonic acid/adverse effects	0.010638297872340427	33506015
carcinoma non-small-cell lung	colitis/chemically induced	0.7446808510638299	34106395
pneumonia	immune checkpoint inhibitors/adverse effects	0.5638297872340425	35432346
adrenal cortex hormones/therapeutic use	immune checkpoint inhibitors	0.38176901729168156	36113896
adrenal cortex hormones/therapeutic use	immune checkpoint inhibitors	0.38176901729168156	32641348
adrenal cortex hormones/therapeutic use	skin neoplasms/drug therapy	0.08373369938229239	32641348
adrenal cortex hormones/therapeutic use	tumor necrosis factor inhibitors	0.0425531914893617	32641348
protective agents/pharmacology	ACAD8	0.02127659574468085	33506015
pneumonia	colitis	0.0425531914893617	35432346
immune system diseases/drug therapy	immune checkpoint inhibitors/adverse effects	0.5638297872340425	36159840
adrenal cortex hormones/therapeutic use	neoplasms/drug therapy	0.42644386737371137	34380976
protective agents/pharmacology	PDCD1	0.2659574468085107	33506015
adrenal cortex hormones/therapeutic use	recurrence	0.08373369938229239	26448188
adrenal cortex hormones/therapeutic use	diarrhea/chemically induced	0.00044761421622750735	36113896
adrenal cortex hormones/therapeutic use	diarrhea/chemically induced	0.00044761421622750735	26448188
adrenal cortex hormones/therapeutic use	diarrhea/chemically induced	0.00044761421622750735	34380976
adrenal cortex hormones/therapeutic use	diarrhea/chemically induced	0.00044761421622750735	32641348
carcinoma non-small-cell lung	cd8-positive t-lymphocytes	0.010638297872340427	34106395
glucocorticoids/therapeutic use	immune checkpoint inhibitors/adverse effects	0.5638297872340425	36377339
adrenal cortex hormones/therapeutic use	colitis/chemically induced	0.30067050314133364	36113896
adrenal cortex hormones/therapeutic use	colitis/chemically induced	0.30067050314133364	26448188
adrenal cortex hormones/therapeutic use	colitis/chemically induced	0.30067050314133364	34380976
adrenal cortex hormones/therapeutic use	colitis/chemically induced	0.30067050314133364	32641348
interleukin-17/genetics	micrornas/genetics	0.010638297872340427	33462141
glucocorticoids/therapeutic use	disease progression	0.010638297872340427	36377339
adrenal cortex hormones/therapeutic use	melanoma/drug therapy	0.19933589134746965	32641348
pneumonia	ligands	0.010638297872340427	35432346
interleukin-17/genetics	gene expression regulation neoplastic	0.010638297872340427	33462141
interleukin-17/genetics	lymphocytes tumor-infiltrating/metabolism	0.010638297872340427	33462141
glucocorticoids/therapeutic use	neoplasms/drug therapy	0.1276595744680851	36377339
immune system diseases/drug therapy	colitis/chemically induced	0.7446808510638299	36159840
glucocorticoids/therapeutic use	diarrhea/chemically induced	0.1595744680851064	36377339
adrenal cortex hormones/therapeutic use	biological products/therapeutic use	0.0425531914893617	34380976
thyroiditis/diagnostic imaging	adrenal gland diseases/diagnostic imaging	0.010638297872340427	33375984
interleukin-17/genetics	t-lymphocytes cytotoxic/immunology	0.010638297872340427	33462141
adrenal cortex hormones/therapeutic use	beclomethasone/adverse effects	0.0425531914893617	36113896
interleukin-17/genetics	tumor microenvironment/drug effects	0.010638297872340427	33462141
adrenal cortex hormones/therapeutic use	biomarkers/analysis	0.08373369938229239	26448188
pneumonia	CD274	0.1595744680851064	35432346
immune system diseases/drug therapy	antineoplastic agents immunological/therapeutic use	0.031914893617021274	36159840
interleukin-17/genetics	immune checkpoint inhibitors/administration & dosage	0.0425531914893617	33462141
thyroiditis/diagnostic imaging	myocarditis/diagnostic imaging	0.010638297872340427	33375984
pneumonia	CTLA4	0.1276595744680851	35432346
thyroiditis/diagnostic imaging	immune checkpoint inhibitors/adverse effects	0.5638297872340425	33375984
interleukin-17/genetics	ht29 cells	0.010638297872340427	33462141
glucocorticoids/therapeutic use	colitis/chemically induced	0.7446808510638299	36377339
glucocorticoids/therapeutic use	abdominal pain/chemically induced	0.010638297872340427	36377339
interleukin-17/genetics	colitis/chemically induced	0.7446808510638299	33462141
thyroiditis/diagnostic imaging	pancreatitis/diagnostic imaging	0.010638297872340427	33375984
thyroiditis/diagnostic imaging	neoplasms/diagnostic imaging	0.02127659574468085	33375984
pneumonia	PDCD1	0.2659574468085107	35432346
immune system diseases/drug therapy	gastrointestinal neoplasms/drug therapy	0.010638297872340427	36159840
interleukin-17/genetics	colorectal neoplasms/drug therapy	0.010638297872340427	33462141
interleukin-17/genetics	b7-h1 antigen/genetics	0.010638297872340427	33462141
adrenal cortex hormones/therapeutic use	SNCA	0.12357136462654053	32641348
adrenal cortex hormones/therapeutic use	TNF	0.12357136462654053	32641348
adrenal cortex hormones/therapeutic use	antineoplastic agents/adverse effects	0.0425531914893617	26448188
adrenal cortex hormones/therapeutic use	intestinal mucosa/chemistry	0.0425531914893617	26448188
ustekinumab/therapeutic use	colitis ulcerative/drug therapy	0.02127659574468085	33567198
adrenal cortex hormones/therapeutic use	leukemia lymphocytic chronic b-cell/drug therapy	0.0425531914893617	26448188
adrenal cortex hormones/therapeutic use	class i phosphatidylinositol 3-kinases/antagonists & inhibitors	0.0425531914893617	26448188
glucocorticoids/therapeutic use	antineoplastic agents immunological/therapeutic use	0.031914893617021274	36377339
adrenal cortex hormones/therapeutic use	purines/adverse effects	0.0425531914893617	26448188
thyroiditis/diagnostic imaging	sarcoidosis/diagnostic imaging	0.010638297872340427	33375984
adrenal cortex hormones/therapeutic use	colon/chemistry	0.0425531914893617	26448188
adrenal cortex hormones/therapeutic use	lymphocytosis/chemically induced	0.0425531914893617	26448188
ustekinumab/therapeutic use	immune checkpoint inhibitors/adverse effects	0.5638297872340425	33567198
adrenal cortex hormones/therapeutic use	protein kinase inhibitors/adverse effects	0.0425531914893617	26448188
adrenal cortex hormones/therapeutic use	apoptosis/drug effects	0.0425531914893617	26448188
adrenal cortex hormones/therapeutic use	quinazolinones/adverse effects	0.0425531914893617	26448188
thyroiditis/diagnostic imaging	hepatitis/diagnostic imaging	0.010638297872340427	33375984
adrenal cortex hormones/therapeutic use	lymphoma non-hodgkin/drug therapy	0.0425531914893617	26448188
adrenal cortex hormones/therapeutic use	PIK3CD	0.0425531914893617	26448188
immune system diseases/drug therapy	BTLA	0.010638297872340427	36159840
immune system diseases/drug therapy	CD274	0.1595744680851064	36159840
thyroiditis/diagnostic imaging	pericarditis/diagnostic imaging	0.010638297872340427	33375984
immune system diseases/drug therapy	CD28	0.010638297872340427	36159840
thyroiditis/diagnostic imaging	encephalitis/diagnostic imaging	0.010638297872340427	33375984
immune system diseases/drug therapy	CSF2	0.010638297872340427	36159840
immune system diseases/drug therapy	HAVCR2	0.010638297872340427	36159840
immune system diseases/drug therapy	IL15	0.010638297872340427	36159840
immune system diseases/drug therapy	IL17C	0.010638297872340427	36159840
immune system diseases/drug therapy	IL21	0.010638297872340427	36159840
immune system diseases/drug therapy	IL22	0.02127659574468085	36159840
immune system diseases/drug therapy	IL4	0.010638297872340427	36159840
thyroiditis/diagnostic imaging	colitis/diagnostic imaging	0.010638297872340427	33375984
immune system diseases/drug therapy	IL6	0.02127659574468085	36159840
immune system diseases/drug therapy	LIF	0.010638297872340427	36159840
colitis/therapy	immune checkpoint inhibitors	0.31914893617021284	33566423
immune system diseases/drug therapy	PDCD1	0.2659574468085107	36159840
glucocorticoids/therapeutic use	gastritis/complications	0.010638297872340427	36377339
glucocorticoids/therapeutic use	enterocolitis/chemically induced	0.02127659574468085	36377339
ustekinumab/therapeutic use	interleukin-23/antagonists & inhibitors	0.010638297872340427	33567198
colitis/therapy	immunologic factors	0.02127659574468085	33566423
thyroiditis/diagnostic imaging	pneumonia/diagnostic imaging	0.010638297872340427	33375984
virus diseases/etiology	immune checkpoint inhibitors/adverse effects	0.5638297872340425	34107499
ustekinumab/therapeutic use	interleukin-12/antagonists & inhibitors	0.010638297872340427	33567198
colitis ulcerative/drug therapy	crohn disease/drug therapy	0.02127659574468085	33058056
drug-related side effects and adverse reactions/prevention & control	growth inhibitors/therapeutic use	0.010638297872340427	34987517
escherichia coli infections/drug therapy	virus diseases/etiology	0.010638297872340427	34107499
escherichia coli infections/drug therapy	immune checkpoint inhibitors/adverse effects	0.5638297872340425	34107499
virus diseases/etiology	neoplasms/drug therapy	0.1276595744680851	34107499
virus diseases/etiology	diarrhea/chemically induced	0.1595744680851064	34107499
neoplasms	immune checkpoint inhibitors/adverse effects	0.7815216325556213	36389768
neoplasms	immune checkpoint inhibitors/adverse effects	0.7815216325556213	36189293
drug-related side effects and adverse reactions/prevention & control	phosphatidylinositol 3-kinases/metabolism	0.010638297872340427	34987517
virus diseases/etiology	clostridium infections/chemically induced	0.010638297872340427	34107499
drug-related side effects and adverse reactions/prevention & control	antineoplastic agents immunological/therapeutic use	0.031914893617021274	34987517
colitis ulcerative/drug therapy	interleukin-12/antagonists & inhibitors	0.02127659574468085	33567198
virus diseases/etiology	colitis/chemically induced	0.7446808510638299	34107499
drug-related side effects and adverse reactions/prevention & control	lymphocytes tumor-infiltrating/immunology	0.010638297872340427	34987517
neoplasms	immune checkpoint inhibitors	0.38176901729168156	35842365
neoplasms	immune checkpoint inhibitors	0.38176901729168156	32584703
escherichia coli infections/drug therapy	neoplasms/drug therapy	0.1276595744680851	34107499
drug-related side effects and adverse reactions/prevention & control	colitis/etiology	0.02127659574468085	34987517
virus diseases/etiology	anti-bacterial agents/adverse effects	0.010638297872340427	34107499
drug-related side effects and adverse reactions/prevention & control	immune checkpoint inhibitors/therapeutic use	0.02127659574468085	34987517
neoplasms	infliximab/adverse effects	0.16209570024735195	32584703
drug-related side effects and adverse reactions/prevention & control	programmed cell death 1 receptor/antagonists & inhibitors	0.08510638297872342	34987517
neoplasms	colitis	0.16209570024735195	35842365
drug-related side effects and adverse reactions/prevention & control	cell line tumor	0.02127659574468085	34987517
escherichia coli infections/drug therapy	diarrhea/chemically induced	0.1595744680851064	34107499
drug-related side effects and adverse reactions/prevention & control	cd8-positive t-lymphocytes/immunology	0.010638297872340427	34987517
escherichia coli infections/drug therapy	clostridium infections/chemically induced	0.010638297872340427	34107499
neoplasms	recurrence	0.08373369938229239	35842365
neoplasms	diarrhea/chemically induced	0.5072961117245084	32584703
skin neoplasms/complications	immune checkpoint inhibitors/pharmacology	0.0425531914893617	32404733
escherichia coli infections/drug therapy	colitis/chemically induced	0.7446808510638299	34107499
cd8-positive t-lymphocytes/cytology	inflammation/drug therapy	0.02127659574468085	32603654
drug-related side effects and adverse reactions/prevention & control	cytotoxicity immunologic	0.010638297872340427	34987517
skin neoplasms/complications	melanoma/complications	0.031914893617021274	32404733
neoplasms	colitis/chemically induced	0.7314819703289162	36389768
neoplasms	colitis/chemically induced	0.7314819703289162	36189293
neoplasms	colitis/chemically induced	0.7314819703289162	32584703
cd8-positive t-lymphocytes/cytology	immune checkpoint inhibitors/adverse effects	0.5638297872340425	32603654
escherichia coli infections/drug therapy	anti-bacterial agents/adverse effects	0.010638297872340427	34107499
cd8-positive t-lymphocytes/cytology	myeloid cells/cytology	0.010638297872340427	32603654
drug-related side effects and adverse reactions/prevention & control	CD8A	0.05319148936170214	34987517
cd8-positive t-lymphocytes/cytology	ctla-4 antigen/immunology	0.010638297872340427	32603654
drug-related side effects and adverse reactions/prevention & control	MTOR	0.010638297872340427	34987517
drug-related side effects and adverse reactions/prevention & control	PDCD1	0.2659574468085107	34987517
neoplasms	inflammatory bowel diseases	0.08373369938229239	35842365
skin neoplasms/complications	PDCD1	0.2659574468085107	32404733
nivolumab/adverse effects	pyrimidines/therapeutic use	0.240219629375429	33096100
cd8-positive t-lymphocytes/cytology	colitis/drug therapy	0.031914893617021274	32603654
nivolumab/adverse effects	immune checkpoint inhibitors/adverse effects	0.13951048248097603	34159488
nivolumab/adverse effects	immune checkpoint inhibitors/adverse effects	0.13951048248097603	33096100
nivolumab/adverse effects	immune checkpoint inhibitors/adverse effects	0.13951048248097603	33882697
nivolumab/adverse effects	immune checkpoint inhibitors/adverse effects	0.13951048248097603	33906378
nivolumab/adverse effects	immune checkpoint inhibitors/adverse effects	0.13951048248097603	34332139
nivolumab/adverse effects	immune checkpoint inhibitors/adverse effects	0.13951048248097603	31595568
nivolumab/adverse effects	immune checkpoint inhibitors/adverse effects	0.13951048248097603	32931028
nivolumab/adverse effects	immune checkpoint inhibitors/adverse effects	0.13951048248097603	32028372
nivolumab/adverse effects	immune checkpoint inhibitors/adverse effects	0.13951048248097603	33476895
immune checkpoint inhibitors/adverse effects	myeloid cells/cytology	0.5638297872340425	32603654
nivolumab/adverse effects	pneumonia/chemically induced	0.33932141684819905	35124713
immune checkpoint inhibitors/adverse effects	colitis ulcerative/physiopathology	0.5638297872340425	34821404
immune checkpoint inhibitors/adverse effects	myasthenia gravis/diagnosis	0.5638297872340425	34956219
neoplasms/diagnosis	dose-response relationship drug	0.02127659574468085	32540858
diabetes mellitus type 1/chemically induced	exanthema/chemically induced	0.010638297872340427	32130969
immune checkpoint inhibitors/adverse effects	ctla-4 antigen/immunology	0.5638297872340425	32603654
nivolumab/adverse effects	colitis/diagnosis	0.240219629375429	32028372
diabetes mellitus type 1/chemically induced	bevacizumab/administration & dosage	0.010638297872340427	32130969
immune checkpoint inhibitors/adverse effects	glycoproteins/metabolism	0.5638297872340425	32389505
immune checkpoint inhibitors/adverse effects	pancreatitis/diagnostic imaging	0.5638297872340425	33375984
immune checkpoint inhibitors/adverse effects	neoplasms/diagnostic imaging	0.3152596659803249	33375984
immune checkpoint inhibitors/adverse effects	neoplasms/diagnostic imaging	0.3152596659803249	31754740
nivolumab/adverse effects	immune checkpoint inhibitors	0.8084298483526631	35191192
nivolumab/adverse effects	immune checkpoint inhibitors	0.8084298483526631	34716545
nivolumab/adverse effects	immune checkpoint inhibitors	0.8084298483526631	35124713
neoplasms/diagnosis	programmed cell death 1 receptor/antagonists & inhibitors	0.08510638297872342	32540858
cd8-positive t-lymphocytes/cytology	receptors antigen t-cell/genetics	0.010638297872340427	32603654
immune checkpoint inhibitors/adverse effects	colitis/diagnosis	0.8123999084877602	32028372
diabetes mellitus type 1/chemically induced	pneumonia/chemically induced	0.031914893617021274	32130969
immune checkpoint inhibitors/adverse effects	immunosuppressive agents/therapeutic use	0.5638297872340425	34956219
immune checkpoint inhibitors/adverse effects	macrophages/drug effects	0.5638297872340425	34338882
diabetes mellitus type 1/chemically induced	fatigue/chemically induced	0.010638297872340427	32130969
immune checkpoint inhibitors/adverse effects	mycophenolic acid	0.5638297872340425	36504035
nivolumab/adverse effects	lung neoplasms/drug therapy	0.240219629375429	34716545
immune checkpoint inhibitors/adverse effects	interferon-gamma/metabolism	0.5638297872340425	34147519
cd8-positive t-lymphocytes/cytology	t-lymphocytes regulatory/cytology	0.010638297872340427	32603654
immune checkpoint inhibitors/adverse effects	immunologic memory/drug effects	0.5638297872340425	34147519
nivolumab/adverse effects	protein kinase inhibitors/therapeutic use	0.1276595744680851	33096100
immune checkpoint inhibitors/adverse effects	skin neoplasms/drug therapy	0.8123999084877602	32414860
diabetes mellitus type 1/chemically induced	pruritus/chemically induced	0.010638297872340427	32130969
immune checkpoint inhibitors/adverse effects	colon/drug effects	0.5962519769627883	34338882
immune checkpoint inhibitors/adverse effects	colon/drug effects	0.5962519769627883	34147519
nivolumab/adverse effects	squamous cell carcinoma of head and neck/drug therapy	0.1276595744680851	33476895
nivolumab/adverse effects	tongue neoplasms/drug therapy	0.1276595744680851	33476895
immune checkpoint inhibitors/adverse effects	infliximab/adverse effects	0.7815216325556213	32414860
immune checkpoint inhibitors/adverse effects	infliximab/adverse effects	0.7815216325556213	33454238
immune checkpoint inhibitors/adverse effects	lung neoplasms/drug therapy	0.8123999084877602	33173388
neoplasms/diagnosis	drugs investigational/administration & dosage	0.010638297872340427	32540858
immune checkpoint inhibitors/adverse effects	disease progression	0.5638297872340425	36377339
immune checkpoint inhibitors/adverse effects	colitis	0.9667912881484545	35432346
fatigue/chemically induced	pruritus/chemically induced	0.010638297872340427	32130969
immune checkpoint inhibitors/adverse effects	gastritis/chemically induced	0.5638297872340425	32621258
diabetes mellitus type 1/chemically induced	adrenal insufficiency/chemically induced	0.010638297872340427	32130969
immune checkpoint inhibitors/adverse effects	protein kinase inhibitors/therapeutic use	0.5638297872340425	33096100
immune checkpoint inhibitors/adverse effects	colitis/epidemiology	0.5638297872340425	32960847
immune checkpoint inhibitors/adverse effects	sarcoidosis/diagnostic imaging	0.5638297872340425	33375984
immune checkpoint inhibitors/adverse effects	squamous cell carcinoma of head and neck/drug therapy	0.5638297872340425	33476895
diabetes mellitus type 1/chemically induced	axitinib/administration & dosage	0.010638297872340427	32130969
immune checkpoint inhibitors/adverse effects	tongue neoplasms/drug therapy	0.5638297872340425	33476895
immune checkpoint inhibitors/adverse effects	carcinoma non-small-cell lung/drug therapy	0.8123999084877602	34992611
neoplasms/diagnosis	CD274	0.1595744680851064	32540858
cd8-positive t-lymphocytes/cytology	chemokines/metabolism	0.010638297872340427	32603654
immune checkpoint inhibitors/adverse effects	gentian violet	0.5638297872340425	32888202
fatigue/chemically induced	adrenal insufficiency/chemically induced	0.010638297872340427	32130969
immune checkpoint inhibitors/adverse effects	hepatitis/diagnostic imaging	0.5638297872340425	33375984
immune checkpoint inhibitors/adverse effects	chemical and drug induced liver injury/diagnosis	0.5638297872340425	33080231
cd8-positive t-lymphocytes/cytology	multigene family	0.010638297872340427	32603654
immune checkpoint inhibitors/adverse effects	b7-h1 antigen/antagonists & inhibitors	0.17476351048909314	32389505
immune checkpoint inhibitors/adverse effects	b7-h1 antigen/antagonists & inhibitors	0.17476351048909314	32702598
immune checkpoint inhibitors/adverse effects	b7-h1 antigen/antagonists & inhibitors	0.17476351048909314	32960847
immune checkpoint inhibitors/adverse effects	inflammatory bowel diseases/drug therapy	0.5962519769627883	33555016
immune checkpoint inhibitors/adverse effects	inflammatory bowel diseases/drug therapy	0.5962519769627883	35277350
fatigue/chemically induced	axitinib/administration & dosage	0.010638297872340427	32130969
immune checkpoint inhibitors/adverse effects	antibodies monoclonal humanized/therapeutic use	0.5638297872340425	33454238
immune checkpoint inhibitors/adverse effects	skin neoplasms/immunology	0.5638297872340425	34956219
immune checkpoint inhibitors/adverse effects	steroids/adverse effects	0.5638297872340425	33454238
immune checkpoint inhibitors/adverse effects	lymphocytes/drug effects	0.5638297872340425	32567084
immune checkpoint inhibitors/adverse effects	neoplasms/drug therapy	0.00710293900853693	33741313
immune checkpoint inhibitors/adverse effects	neoplasms/drug therapy	0.00710293900853693	33096100
immune checkpoint inhibitors/adverse effects	neoplasms/drug therapy	0.00710293900853693	31609734
immune checkpoint inhibitors/adverse effects	neoplasms/drug therapy	0.00710293900853693	33080231
immune checkpoint inhibitors/adverse effects	neoplasms/drug therapy	0.00710293900853693	33436487
immune checkpoint inhibitors/adverse effects	neoplasms/drug therapy	0.00710293900853693	33459466
immune checkpoint inhibitors/adverse effects	neoplasms/drug therapy	0.00710293900853693	34777387
immune checkpoint inhibitors/adverse effects	neoplasms/drug therapy	0.00710293900853693	34107499
immune checkpoint inhibitors/adverse effects	neoplasms/drug therapy	0.00710293900853693	34380976
immune checkpoint inhibitors/adverse effects	neoplasms/drug therapy	0.00710293900853693	32185493
immune checkpoint inhibitors/adverse effects	neoplasms/drug therapy	0.00710293900853693	36377339
immune checkpoint inhibitors/adverse effects	feces	0.5638297872340425	33290513
immune checkpoint inhibitors/adverse effects	colitis/drug therapy	0.5962519769627883	32603654
immune checkpoint inhibitors/adverse effects	colitis/drug therapy	0.5962519769627883	33436487
immune checkpoint inhibitors/adverse effects	crohn disease/physiopathology	0.5638297872340425	34821404
immune checkpoint inhibitors/adverse effects	diarrhea/chemically induced	0.4937906260562811	31609734
immune checkpoint inhibitors/adverse effects	diarrhea/chemically induced	0.4937906260562811	33436487
immune checkpoint inhibitors/adverse effects	diarrhea/chemically induced	0.4937906260562811	34107499
immune checkpoint inhibitors/adverse effects	diarrhea/chemically induced	0.4937906260562811	33173388
immune checkpoint inhibitors/adverse effects	diarrhea/chemically induced	0.4937906260562811	34158318
immune checkpoint inhibitors/adverse effects	diarrhea/chemically induced	0.4937906260562811	34380976
immune checkpoint inhibitors/adverse effects	diarrhea/chemically induced	0.4937906260562811	33290513
immune checkpoint inhibitors/adverse effects	diarrhea/chemically induced	0.4937906260562811	31595568
immune checkpoint inhibitors/adverse effects	diarrhea/chemically induced	0.4937906260562811	36377339
diabetes mellitus type 1/chemically induced	colitis/chemically induced	0.7446808510638299	32130969
immune checkpoint inhibitors/adverse effects	proton pump inhibitors/adverse effects	0.5638297872340425	35277350
immune checkpoint inhibitors/adverse effects	pericarditis/diagnostic imaging	0.5638297872340425	33375984
neoplasms/diagnosis	PDCD1	0.2659574468085107	32540858
immune checkpoint inhibitors/adverse effects	ipilimumab/adverse effects	0.38723672728592545	34159488
immune checkpoint inhibitors/adverse effects	ipilimumab/adverse effects	0.38723672728592545	33096100
immune checkpoint inhibitors/adverse effects	ipilimumab/adverse effects	0.38723672728592545	33882697
immune checkpoint inhibitors/adverse effects	ipilimumab/adverse effects	0.38723672728592545	34332139
immune checkpoint inhibitors/adverse effects	ipilimumab/adverse effects	0.38723672728592545	31595568
immune checkpoint inhibitors/adverse effects	ipilimumab/adverse effects	0.38723672728592545	32931028
immune checkpoint inhibitors/adverse effects	encephalitis/diagnostic imaging	0.5638297872340425	33375984
diabetes mellitus type 1/chemically induced	hypophysitis/chemically induced	0.010638297872340427	32130969
immune checkpoint inhibitors/adverse effects	dysbiosis/etiology	0.5638297872340425	34162429
immune checkpoint inhibitors/adverse effects	clostridium infections/chemically induced	0.5638297872340425	34107499
immune checkpoint inhibitors/adverse effects	anti-bacterial agents	0.5638297872340425	36043345
immune checkpoint inhibitors/adverse effects	interleukin-23/antagonists & inhibitors	0.5638297872340425	33567198
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.3102181023015856	34159488
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.3102181023015856	33741313
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.3102181023015856	32389505
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.3102181023015856	34751747
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.3102181023015856	32422528
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.3102181023015856	32702598
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.3102181023015856	31609734
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.3102181023015856	36389768
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.3102181023015856	33459466
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.3102181023015856	33268234
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.3102181023015856	33173388
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.3102181023015856	32888202
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.3102181023015856	32414860
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.3102181023015856	33290513
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.3102181023015856	32185493
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.3102181023015856	33454238
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.3102181023015856	33096100
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.3102181023015856	35277350
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.3102181023015856	33080231
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.3102181023015856	34777387
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.3102181023015856	32567084
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.3102181023015856	34380976
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.3102181023015856	31595568
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.3102181023015856	34956219
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.3102181023015856	32434876
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.3102181023015856	33555016
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.3102181023015856	33882697
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.3102181023015856	33906378
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.3102181023015856	32621258
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.3102181023015856	36338892
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.3102181023015856	36043345
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.3102181023015856	32931028
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.3102181023015856	36159840
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.3102181023015856	36504035
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.3102181023015856	34992611
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.3102181023015856	34332139
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.3102181023015856	34107499
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.3102181023015856	36189293
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.3102181023015856	34158318
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.3102181023015856	31754740
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.3102181023015856	36377339
diabetes mellitus type 1/chemically induced	angiogenesis inhibitors/therapeutic use	0.010638297872340427	32130969
fatigue/chemically induced	colitis/chemically induced	0.7446808510638299	32130969
immune checkpoint inhibitors/adverse effects	neoplasms/complications	0.17476351048909314	34162429
immune checkpoint inhibitors/adverse effects	neoplasms/complications	0.17476351048909314	34158318
immune checkpoint inhibitors/adverse effects	neoplasms/complications	0.17476351048909314	32960847
immune checkpoint inhibitors/adverse effects	abdominal pain/chemically induced	0.5638297872340425	36377339
immune checkpoint inhibitors/adverse effects	crohn disease/immunology	0.5638297872340425	34338882
immune checkpoint inhibitors/adverse effects	glucocorticoids/pharmacology	0.5638297872340425	32414860
fatigue/chemically induced	hypophysitis/chemically induced	0.010638297872340427	32130969
immune checkpoint inhibitors/adverse effects	cytomegalovirus infections/diagnosis	0.5638297872340425	32434876
immune checkpoint inhibitors/adverse effects	paclitaxel/therapeutic use	0.5638297872340425	33476895
diabetes mellitus type 1/chemically induced	myocarditis/chemically induced	0.010638297872340427	32130969
immune checkpoint inhibitors/adverse effects	receptors antigen t-cell/genetics	0.5638297872340425	32603654
fatigue/chemically induced	angiogenesis inhibitors/therapeutic use	0.010638297872340427	32130969
immune checkpoint inhibitors/adverse effects	biomarkers/metabolism	0.5638297872340425	32389505
immune checkpoint inhibitors/adverse effects	colitis/diagnostic imaging	0.5638297872340425	33375984
cd8-positive t-lymphocytes/cytology	CTLA4	0.1276595744680851	32603654
immune checkpoint inhibitors/adverse effects	anti-bacterial agents/adverse effects	0.5638297872340425	34107499
immune checkpoint inhibitors/adverse effects	oropharyngeal neoplasms/drug therapy	0.5638297872340425	33906378
diabetes mellitus type 1/chemically induced	hepatitis autoimmune/etiology	0.010638297872340427	32130969
immune checkpoint inhibitors/adverse effects	vitamin d/administration & dosage	0.5638297872340425	32567084
fatigue/chemically induced	myocarditis/chemically induced	0.010638297872340427	32130969
immune checkpoint inhibitors/adverse effects	melanoma/immunology	0.5638297872340425	34956219
immune checkpoint inhibitors/adverse effects	t-lymphocytes regulatory/cytology	0.5638297872340425	32603654
diabetes mellitus type 1/chemically induced	myasthenia gravis/chemically induced	0.010638297872340427	32130969
immune checkpoint inhibitors/adverse effects	intestinal mucosa/immunology	0.5638297872340425	33459466
immune checkpoint inhibitors/adverse effects	disease susceptibility	0.5638297872340425	32028372
fatigue/chemically induced	hepatitis autoimmune/etiology	0.010638297872340427	32130969
diabetes mellitus type 1/chemically induced	immune checkpoint inhibitors/therapeutic use	0.02127659574468085	32130969
cd8-positive t-lymphocytes/cytology	PDCD1	0.2659574468085107	32603654
immune checkpoint inhibitors/adverse effects	colitis ulcerative/chemically induced	0.5638297872340425	33476895
immune checkpoint inhibitors/adverse effects	feces/chemistry	0.5638297872340425	33436487
immune checkpoint inhibitors/adverse effects	melanoma/drug therapy	0.6209545977084994	33882697
immune checkpoint inhibitors/adverse effects	melanoma/drug therapy	0.6209545977084994	36338892
immune checkpoint inhibitors/adverse effects	melanoma/drug therapy	0.6209545977084994	32414860
immune checkpoint inhibitors/adverse effects	antineoplastic agents immunological/therapeutic use	0.5962519769627883	36159840
immune checkpoint inhibitors/adverse effects	antineoplastic agents immunological/therapeutic use	0.5962519769627883	36377339
gene expression regulation neoplastic	lymphocytes tumor-infiltrating/metabolism	0.010638297872340427	33462141
fatigue/chemically induced	myasthenia gravis/chemically induced	0.010638297872340427	32130969
immune checkpoint inhibitors/adverse effects	piperidines/therapeutic use	0.3152596659803249	33096100
immune checkpoint inhibitors/adverse effects	piperidines/therapeutic use	0.3152596659803249	34147519
immune checkpoint inhibitors/adverse effects	adrenal cortex hormones/pharmacology	0.5638297872340425	33268234
fatigue/chemically induced	immune checkpoint inhibitors/therapeutic use	0.02127659574468085	32130969
immune checkpoint inhibitors/adverse effects	immunocompromised host	0.5638297872340425	34956219
immune checkpoint inhibitors/adverse effects	colon/immunology	0.3152596659803249	33459466
immune checkpoint inhibitors/adverse effects	colon/immunology	0.3152596659803249	34777387
colitis ulcerative/physiopathology	crohn disease/physiopathology	0.010638297872340427	34821404
immune checkpoint inhibitors/adverse effects	dose-response relationship drug	0.8123999084877602	33290513
immune checkpoint inhibitors/adverse effects	neutrophils/drug effects	0.5638297872340425	32567084
immune checkpoint inhibitors/adverse effects	antibodies monoclonal/adverse effects	0.5638297872340425	32567084
immune checkpoint inhibitors/adverse effects	colitis/etiology	0.8123999084877602	34162429
immune checkpoint inhibitors/adverse effects	immunosuppressive agents/pharmacology	0.5638297872340425	32414860
immune checkpoint inhibitors/adverse effects	leukocyte l1 antigen complex/analysis	0.5638297872340425	33436487
immune checkpoint inhibitors/adverse effects	programmed cell death 1 receptor/antagonists & inhibitors	0.5086657887916448	34147519
immune checkpoint inhibitors/adverse effects	programmed cell death 1 receptor/antagonists & inhibitors	0.5086657887916448	32702598
immune checkpoint inhibitors/adverse effects	programmed cell death 1 receptor/antagonists & inhibitors	0.5086657887916448	32567084
immune checkpoint inhibitors/adverse effects	programmed cell death 1 receptor/antagonists & inhibitors	0.5086657887916448	32960847
immune checkpoint inhibitors/adverse effects	programmed cell death 1 receptor/antagonists & inhibitors	0.5086657887916448	33476895
immune checkpoint inhibitors/adverse effects	gastrointestinal neoplasms/drug therapy	0.5638297872340425	36159840
diabetes mellitus type 1/chemically induced	ipilimumab/therapeutic use	0.031914893617021274	32130969
immune checkpoint inhibitors/adverse effects	ligands	0.5638297872340425	35432346
immune checkpoint inhibitors/adverse effects	postoperative complications	0.5638297872340425	32028372
immune checkpoint inhibitors/adverse effects	melanoma/complications	0.9204738742502462	32567084
gene expression regulation neoplastic	t-lymphocytes cytotoxic/immunology	0.010638297872340427	33462141
immune checkpoint inhibitors/adverse effects	adenocarcinoma of lung/drug therapy	0.5638297872340425	32389505
immune checkpoint inhibitors/adverse effects	chemokines/metabolism	0.5638297872340425	32603654
immune checkpoint inhibitors/adverse effects	ctla-4 antigen/antagonists & inhibitors	0.17476351048909314	32567084
immune checkpoint inhibitors/adverse effects	ctla-4 antigen/antagonists & inhibitors	0.17476351048909314	32702598
immune checkpoint inhibitors/adverse effects	ctla-4 antigen/antagonists & inhibitors	0.17476351048909314	34147519
gene expression regulation neoplastic	tumor microenvironment/drug effects	0.010638297872340427	33462141
immune checkpoint inhibitors/adverse effects	t-lymphocyte subsets/immunology	0.5638297872340425	34777387
immune checkpoint inhibitors/adverse effects	mucositis/chemically induced	0.5638297872340425	32414860
immune checkpoint inhibitors/adverse effects	multigene family	0.5638297872340425	32603654
immune checkpoint inhibitors/adverse effects	gastritis/complications	0.5638297872340425	36377339
immune checkpoint inhibitors/adverse effects	biological products/therapeutic use	0.5638297872340425	34380976
fatigue/chemically induced	ipilimumab/therapeutic use	0.031914893617021274	32130969
immune checkpoint inhibitors/adverse effects	enterocolitis/chemically induced	0.3152596659803249	36377339
immune checkpoint inhibitors/adverse effects	enterocolitis/chemically induced	0.3152596659803249	34821404
immune checkpoint inhibitors/adverse effects	graft vs host disease/immunology	0.5638297872340425	34338882
immune checkpoint inhibitors/adverse effects	hepatitis/diagnosis	0.5638297872340425	32185493
immune checkpoint inhibitors/adverse effects	antineoplastic agents immunological/adverse effects	0.015059111849064102	32422528
immune checkpoint inhibitors/adverse effects	antineoplastic agents immunological/adverse effects	0.015059111849064102	32702598
immune checkpoint inhibitors/adverse effects	antineoplastic agents immunological/adverse effects	0.015059111849064102	32567084
immune checkpoint inhibitors/adverse effects	antineoplastic agents immunological/adverse effects	0.015059111849064102	36338892
immune checkpoint inhibitors/adverse effects	antineoplastic agents immunological/adverse effects	0.015059111849064102	32434876
immune checkpoint inhibitors/adverse effects	antineoplastic agents immunological/adverse effects	0.015059111849064102	34162429
immune checkpoint inhibitors/adverse effects	antineoplastic agents immunological/adverse effects	0.015059111849064102	33476895
immune checkpoint inhibitors/adverse effects	ipilimumab/therapeutic use	0.9204738742502462	35277350
immune checkpoint inhibitors/adverse effects	pneumonia/diagnostic imaging	0.5638297872340425	33375984
gene expression regulation neoplastic	immune checkpoint inhibitors/administration & dosage	0.0425531914893617	33462141
immune checkpoint inhibitors/adverse effects	interleukin-12/antagonists & inhibitors	0.5638297872340425	33567198
immune checkpoint inhibitors/adverse effects	cd8-positive t-lymphocytes/drug effects	0.3152596659803249	34338882
immune checkpoint inhibitors/adverse effects	cd8-positive t-lymphocytes/drug effects	0.3152596659803249	34147519
gene expression regulation neoplastic	ht29 cells	0.010638297872340427	33462141
immune checkpoint inhibitors/adverse effects	biomarkers/analysis	0.8123999084877602	33436487
immune checkpoint inhibitors/adverse effects	phenotype	0.3152596659803249	34338882
immune checkpoint inhibitors/adverse effects	phenotype	0.3152596659803249	34147519
gene expression regulation neoplastic	colitis/chemically induced	0.7446808510638299	33462141
immune checkpoint inhibitors/adverse effects	butyrates/metabolism	0.5638297872340425	33741313
immune checkpoint inhibitors/adverse effects	inflammatory bowel diseases/complications	0.8123999084877602	34158318
immune checkpoint inhibitors/adverse effects	anti-bacterial agents/pharmacology	0.5638297872340425	34162429
immune checkpoint inhibitors/adverse effects	steroids/therapeutic use	0.8123999084877602	33290513
immune checkpoint inhibitors/adverse effects	inflammation	0.5638297872340425	32888202
immune checkpoint inhibitors/adverse effects	prednisone/therapeutic use	0.5638297872340425	34956219
immune checkpoint inhibitors/adverse effects	BTLA	0.5638297872340425	36159840
gene expression regulation neoplastic	colorectal neoplasms/drug therapy	0.010638297872340427	33462141
immune checkpoint inhibitors/adverse effects	CD274	0.4937906260562811	36159840
immune checkpoint inhibitors/adverse effects	CD274	0.4937906260562811	32389505
immune checkpoint inhibitors/adverse effects	CD274	0.4937906260562811	34992611
immune checkpoint inhibitors/adverse effects	CD274	0.4937906260562811	32702598
immune checkpoint inhibitors/adverse effects	CD274	0.4937906260562811	33555016
immune checkpoint inhibitors/adverse effects	CD274	0.4937906260562811	33173388
immune checkpoint inhibitors/adverse effects	CD274	0.4937906260562811	34158318
immune checkpoint inhibitors/adverse effects	CD274	0.4937906260562811	32960847
immune checkpoint inhibitors/adverse effects	CD274	0.4937906260562811	35432346
immune checkpoint inhibitors/adverse effects	CD28	0.5638297872340425	36159840
immune checkpoint inhibitors/adverse effects	CD4	0.3152596659803249	33555016
immune checkpoint inhibitors/adverse effects	CD4	0.3152596659803249	34338882
immune checkpoint inhibitors/adverse effects	CD68	0.3152596659803249	33555016
immune checkpoint inhibitors/adverse effects	CD68	0.3152596659803249	34338882
immune checkpoint inhibitors/adverse effects	CD8A	0.6209545977084994	33555016
immune checkpoint inhibitors/adverse effects	CD8A	0.6209545977084994	34338882
immune checkpoint inhibitors/adverse effects	CD8A	0.6209545977084994	34147519
gene expression regulation neoplastic	b7-h1 antigen/genetics	0.010638297872340427	33462141
immune checkpoint inhibitors/adverse effects	CSF2	0.5638297872340425	36159840
tryptophan/pharmacology	neoplasms/drug therapy	0.1276595744680851	35236743
immune checkpoint inhibitors/adverse effects	CTLA4	0.5693618783586929	34992611
immune checkpoint inhibitors/adverse effects	CTLA4	0.5693618783586929	32702598
immune checkpoint inhibitors/adverse effects	CTLA4	0.5693618783586929	32603654
immune checkpoint inhibitors/adverse effects	CTLA4	0.5693618783586929	33555016
immune checkpoint inhibitors/adverse effects	CTLA4	0.5693618783586929	32567084
immune checkpoint inhibitors/adverse effects	CTLA4	0.5693618783586929	35432346
immune checkpoint inhibitors/adverse effects	CTLA4	0.5693618783586929	34147519
immune checkpoint inhibitors/adverse effects	HAVCR2	0.5638297872340425	36159840
immune checkpoint inhibitors/adverse effects	IL15	0.5638297872340425	36159840
immune checkpoint inhibitors/adverse effects	IL17C	0.5638297872340425	36159840
immune checkpoint inhibitors/adverse effects	IL21	0.5638297872340425	36159840
immune checkpoint inhibitors/adverse effects	IL22	0.8123999084877602	36159840
immune checkpoint inhibitors/adverse effects	IL4	0.5638297872340425	36159840
colitis ulcerative/physiopathology	enterocolitis/chemically induced	0.02127659574468085	34821404
immune checkpoint inhibitors/adverse effects	IL6	0.8123999084877602	36159840
immune checkpoint inhibitors/adverse effects	LIF	0.5638297872340425	36159840
immune checkpoint inhibitors/adverse effects	PDCD1	0.8888884976724405	36159840
immune checkpoint inhibitors/adverse effects	PDCD1	0.8888884976724405	34992611
immune checkpoint inhibitors/adverse effects	PDCD1	0.8888884976724405	32702598
immune checkpoint inhibitors/adverse effects	PDCD1	0.8888884976724405	32603654
immune checkpoint inhibitors/adverse effects	PDCD1	0.8888884976724405	33555016
immune checkpoint inhibitors/adverse effects	PDCD1	0.8888884976724405	33906378
immune checkpoint inhibitors/adverse effects	PDCD1	0.8888884976724405	33173388
immune checkpoint inhibitors/adverse effects	PDCD1	0.8888884976724405	32567084
immune checkpoint inhibitors/adverse effects	PDCD1	0.8888884976724405	34158318
immune checkpoint inhibitors/adverse effects	PDCD1	0.8888884976724405	32960847
immune checkpoint inhibitors/adverse effects	PDCD1	0.8888884976724405	35432346
immune checkpoint inhibitors/adverse effects	PDCD1	0.8888884976724405	34147519
immune checkpoint inhibitors/adverse effects	SNCA	0.9204738742502462	33476895
tryptophan/pharmacology	colitis/chemically induced	0.7446808510638299	35236743
exanthema/chemically induced	bevacizumab/administration & dosage	0.010638297872340427	32130969
exanthema/chemically induced	pneumonia/chemically induced	0.031914893617021274	32130969
exanthema/chemically induced	fatigue/chemically induced	0.010638297872340427	32130969
micrornas/genetics	gene expression regulation neoplastic	0.010638297872340427	33462141
micrornas/genetics	lymphocytes tumor-infiltrating/metabolism	0.010638297872340427	33462141
exanthema/chemically induced	pruritus/chemically induced	0.010638297872340427	32130969
tryptophan/pharmacology	immune checkpoint inhibitors/pharmacology	0.0425531914893617	35236743
exanthema/chemically induced	adrenal insufficiency/chemically induced	0.010638297872340427	32130969
micrornas/genetics	t-lymphocytes cytotoxic/immunology	0.010638297872340427	33462141
exanthema/chemically induced	axitinib/administration & dosage	0.010638297872340427	32130969
gene expression regulation neoplastic	APC	0.02127659574468085	33462141
micrornas/genetics	tumor microenvironment/drug effects	0.010638297872340427	33462141
gene expression regulation neoplastic	CD274	0.1595744680851064	33462141
gene expression regulation neoplastic	CD8A	0.05319148936170214	33462141
myasthenia gravis/diagnosis	immunosuppressive agents/therapeutic use	0.010638297872340427	34956219
exanthema/chemically induced	colitis/chemically induced	0.7446808510638299	32130969
gene expression regulation neoplastic	IL17A	0.02127659574468085	33462141
exanthema/chemically induced	hypophysitis/chemically induced	0.010638297872340427	32130969
micrornas/genetics	immune checkpoint inhibitors/administration & dosage	0.0425531914893617	33462141
exanthema/chemically induced	angiogenesis inhibitors/therapeutic use	0.010638297872340427	32130969
micrornas/genetics	ht29 cells	0.010638297872340427	33462141
gene expression regulation neoplastic	MIR15B	0.010638297872340427	33462141
gene expression regulation neoplastic	NRF1	0.010638297872340427	33462141
colitis/diagnosis	disease susceptibility	0.02127659574468085	32028372
micrornas/genetics	colitis/chemically induced	0.7446808510638299	33462141
exanthema/chemically induced	myocarditis/chemically induced	0.010638297872340427	32130969
gene expression regulation neoplastic	PDCD1	0.2659574468085107	33462141
colitis/diagnosis	immune checkpoint inhibitors/pharmacology	0.0837336993822924	32298485
exanthema/chemically induced	hepatitis autoimmune/etiology	0.010638297872340427	32130969
colitis/diagnosis	inflammatory bowel diseases	0.04232441088995653	32298485
micrornas/genetics	colorectal neoplasms/drug therapy	0.010638297872340427	33462141
exanthema/chemically induced	myasthenia gravis/chemically induced	0.010638297872340427	32130969
exanthema/chemically induced	immune checkpoint inhibitors/therapeutic use	0.02127659574468085	32130969
tryptophan/pharmacology	AHR	0.010638297872340427	35236743
myasthenia gravis/diagnosis	skin neoplasms/immunology	0.010638297872340427	34956219
micrornas/genetics	b7-h1 antigen/genetics	0.010638297872340427	33462141
colitis/diagnosis	postoperative complications	0.02127659574468085	32028372
lymphocytes tumor-infiltrating/metabolism	t-lymphocytes cytotoxic/immunology	0.010638297872340427	33462141
lymphocytes tumor-infiltrating/metabolism	tumor microenvironment/drug effects	0.010638297872340427	33462141
myasthenia gravis/diagnosis	colitis/chemically induced	0.7446808510638299	34956219
colitis/diagnosis	gastrointestinal tract/metabolism	0.02127659574468085	32298485
tryptophan/pharmacology	IL22	0.02127659574468085	35236743
exanthema/chemically induced	ipilimumab/therapeutic use	0.031914893617021274	32130969
colitis/diagnosis	b7-h1 antigen/metabolism	0.02127659574468085	32298485
lymphocytes tumor-infiltrating/metabolism	immune checkpoint inhibitors/administration & dosage	0.0425531914893617	33462141
myasthenia gravis/diagnosis	melanoma/immunology	0.010638297872340427	34956219
lymphocytes tumor-infiltrating/metabolism	ht29 cells	0.010638297872340427	33462141
lymphocytes tumor-infiltrating/metabolism	colitis/chemically induced	0.7446808510638299	33462141
colitis/diagnosis	CD274	0.2951269732326699	32298485
inflammation/drug therapy	immune checkpoint inhibitors/adverse effects	0.8123999084877602	32603654
inflammation/drug therapy	myeloid cells/cytology	0.02127659574468085	32603654
myasthenia gravis/diagnosis	immunocompromised host	0.010638297872340427	34956219
bevacizumab/administration & dosage	pneumonia/chemically induced	0.031914893617021274	32130969
lymphocytes tumor-infiltrating/metabolism	colorectal neoplasms/drug therapy	0.010638297872340427	33462141
inflammation/drug therapy	ctla-4 antigen/immunology	0.02127659574468085	32603654
bevacizumab/administration & dosage	fatigue/chemically induced	0.010638297872340427	32130969
lymphocytes tumor-infiltrating/metabolism	b7-h1 antigen/genetics	0.010638297872340427	33462141
colitis/diagnosis	PDCD1	0.4632807137954702	32298485
bevacizumab/administration & dosage	pruritus/chemically induced	0.010638297872340427	32130969
inflammation/drug therapy	immune checkpoint inhibitors	0.5387783115991764	36113896
micrornas/genetics	APC	0.02127659574468085	33462141
micrornas/genetics	CD274	0.1595744680851064	33462141
micrornas/genetics	CD8A	0.05319148936170214	33462141
bevacizumab/administration & dosage	adrenal insufficiency/chemically induced	0.010638297872340427	32130969
bevacizumab/administration & dosage	axitinib/administration & dosage	0.010638297872340427	32130969
micrornas/genetics	IL17A	0.02127659574468085	33462141
micrornas/genetics	MIR15B	0.010638297872340427	33462141
micrornas/genetics	NRF1	0.010638297872340427	33462141
micrornas/genetics	PDCD1	0.2659574468085107	33462141
myasthenia gravis/diagnosis	prednisone/therapeutic use	0.010638297872340427	34956219
bevacizumab/administration & dosage	colitis/chemically induced	0.7446808510638299	32130969
bevacizumab/administration & dosage	hypophysitis/chemically induced	0.010638297872340427	32130969
bevacizumab/administration & dosage	angiogenesis inhibitors/therapeutic use	0.010638297872340427	32130969
inflammation/drug therapy	colitis/drug therapy	0.06314344543582705	32603654
inflammation/drug therapy	diarrhea/chemically induced	0.2951269732326699	36113896
immunosuppressive agents/therapeutic use	skin neoplasms/immunology	0.010638297872340427	34956219
bevacizumab/administration & dosage	myocarditis/chemically induced	0.010638297872340427	32130969
bevacizumab/administration & dosage	hepatitis autoimmune/etiology	0.010638297872340427	32130969
metabolome/drug effects	immune checkpoint inhibitors/adverse effects	0.5638297872340425	34162429
bevacizumab/administration & dosage	myasthenia gravis/chemically induced	0.010638297872340427	32130969
inflammation/drug therapy	colitis/chemically induced	0.9368565545641729	36113896
lymphocytes tumor-infiltrating/metabolism	APC	0.02127659574468085	33462141
bevacizumab/administration & dosage	immune checkpoint inhibitors/therapeutic use	0.02127659574468085	32130969
lymphocytes tumor-infiltrating/metabolism	CD274	0.1595744680851064	33462141
immunosuppressive agents/therapeutic use	colitis/chemically induced	0.7446808510638299	34956219
lymphocytes tumor-infiltrating/metabolism	CD8A	0.05319148936170214	33462141
inflammation/drug therapy	receptors antigen t-cell/genetics	0.02127659574468085	32603654
lymphocytes tumor-infiltrating/metabolism	IL17A	0.02127659574468085	33462141
lymphocytes tumor-infiltrating/metabolism	MIR15B	0.010638297872340427	33462141
inflammation/drug therapy	t-lymphocytes regulatory/cytology	0.02127659574468085	32603654
bevacizumab/administration & dosage	ipilimumab/therapeutic use	0.031914893617021274	32130969
immunosuppressive agents/therapeutic use	melanoma/immunology	0.010638297872340427	34956219
lymphocytes tumor-infiltrating/metabolism	NRF1	0.010638297872340427	33462141
lymphocytes tumor-infiltrating/metabolism	PDCD1	0.2659574468085107	33462141
immunosuppressive agents/therapeutic use	immunocompromised host	0.010638297872340427	34956219
inflammation/drug therapy	chemokines/metabolism	0.02127659574468085	32603654
ctla-4 antigen/immunology	colitis/drug therapy	0.031914893617021274	32603654
metabolome/drug effects	dysbiosis/etiology	0.010638297872340427	34162429
inflammation/drug therapy	multigene family	0.02127659574468085	32603654
programmed cell death 1 receptor/metabolism	colitis/diagnosis	0.02127659574468085	32298485
metabolome/drug effects	neoplasms/complications	0.031914893617021274	34162429
inflammation/drug therapy	beclomethasone/adverse effects	0.02127659574468085	36113896
glucocorticoids	diarrhea/chemically induced	0.1595744680851064	36096534
ctla-4 antigen/immunology	receptors antigen t-cell/genetics	0.010638297872340427	32603654
immunosuppressive agents/therapeutic use	prednisone/therapeutic use	0.010638297872340427	34956219
glucocorticoids	colitis/chemically induced	0.7446808510638299	36096534
ctla-4 antigen/immunology	t-lymphocytes regulatory/cytology	0.010638297872340427	32603654
inflammation/drug therapy	CTLA4	0.240219629375429	32603654
metabolome/drug effects	colitis/etiology	0.02127659574468085	34162429
programmed cell death 1 receptor/metabolism	immune checkpoint inhibitors/pharmacology	0.0425531914893617	32298485
inflammation/drug therapy	PDCD1	0.4632807137954702	32603654
programmed cell death 1 receptor/metabolism	inflammatory bowel diseases	0.02127659574468085	32298485
ctla-4 antigen/immunology	chemokines/metabolism	0.010638297872340427	32603654
ctla-4 antigen/immunology	multigene family	0.010638297872340427	32603654
metabolome/drug effects	antineoplastic agents immunological/adverse effects	0.07446808510638298	34162429
macrophages/drug effects	colon/drug effects	0.031914893617021274	34338882
programmed cell death 1 receptor/metabolism	gastrointestinal tract/metabolism	0.010638297872340427	32298485
antibodies monoclonal humanized/adverse effects	immune checkpoint inhibitors/adverse effects	0.5638297872340425	34956219
metabolome/drug effects	anti-bacterial agents/pharmacology	0.010638297872340427	34162429
programmed cell death 1 receptor/metabolism	b7-h1 antigen/metabolism	0.010638297872340427	32298485
antibodies monoclonal humanized/adverse effects	myasthenia gravis/diagnosis	0.010638297872340427	34956219
antibodies monoclonal humanized/adverse effects	immunosuppressive agents/therapeutic use	0.010638297872340427	34956219
programmed cell death 1 receptor/metabolism	CD274	0.1595744680851064	32298485
ctla-4 antigen/immunology	CTLA4	0.1276595744680851	32603654
programmed cell death 1 receptor/metabolism	PDCD1	0.2659574468085107	32298485
glucocorticoids	CHI3L1	0.010638297872340427	36096534
glucocorticoids	CXCL8	0.010638297872340427	36096534
ctla-4 antigen/immunology	PDCD1	0.2659574468085107	32603654
macrophages/drug effects	crohn disease/immunology	0.010638297872340427	34338882
glucocorticoids	IL17A	0.02127659574468085	36096534
glucocorticoids	IL6	0.02127659574468085	36096534
arthritis/chemically induced	immune checkpoint inhibitors	0.31914893617021284	36096534
antibodies monoclonal humanized/adverse effects	skin neoplasms/immunology	0.010638297872340427	34956219
arthritis/chemically induced	glucocorticoids	0.010638297872340427	36096534
colon/diagnostic imaging	drug resistance/immunology	0.010638297872340427	32414860
pneumonia/chemically induced	fatigue/chemically induced	0.031914893617021274	32130969
colon/diagnostic imaging	immune checkpoint inhibitors/adverse effects	0.5638297872340425	32414860
pneumonia/chemically induced	immune checkpoint inhibitors	0.6891766882516188	35124713
interferon-gamma/metabolism	immunologic memory/drug effects	0.010638297872340427	34147519
antibodies monoclonal humanized/adverse effects	colitis/chemically induced	0.7446808510638299	34956219
pneumonia/chemically induced	pruritus/chemically induced	0.031914893617021274	32130969
pneumonia/chemically induced	antibodies monoclonal humanized/administration & dosage	0.031914893617021274	32540858
arthritis/chemically induced	diarrhea/chemically induced	0.1595744680851064	36096534
interferon-gamma/metabolism	colon/drug effects	0.031914893617021274	34147519
arthritis/chemically induced	colitis/chemically induced	0.7446808510638299	36096534
antibodies monoclonal humanized/adverse effects	melanoma/immunology	0.010638297872340427	34956219
colon/diagnostic imaging	skin neoplasms/drug therapy	0.02127659574468085	32414860
colon/diagnostic imaging	infliximab/adverse effects	0.0425531914893617	32414860
pneumonia/chemically induced	adrenal insufficiency/chemically induced	0.031914893617021274	32130969
pneumonia/chemically induced	carcinoma non-small-cell lung/drug therapy	0.06314344543582703	35124713
macrophages/drug effects	graft vs host disease/immunology	0.010638297872340427	34338882
pneumonia/chemically induced	axitinib/administration & dosage	0.031914893617021274	32130969
antibodies monoclonal humanized/adverse effects	immunocompromised host	0.010638297872340427	34956219
macrophages/drug effects	cd8-positive t-lymphocytes/drug effects	0.02127659574468085	34338882
macrophages/drug effects	phenotype	0.02127659574468085	34338882
pneumonia/chemically induced	immune checkpoint inhibitors/administration & dosage	0.12357136462654054	32540858
macrophages/drug effects	CD4	0.02127659574468085	34338882
pneumonia/chemically induced	colitis/chemically induced	0.40837336993822926	35124713
pneumonia/chemically induced	colitis/chemically induced	0.40837336993822926	32540858
pneumonia/chemically induced	colitis/chemically induced	0.40837336993822926	32130969
macrophages/drug effects	CD68	0.02127659574468085	34338882
macrophages/drug effects	CD8A	0.05319148936170214	34338882
colon/diagnostic imaging	colitis/chemically induced	0.7446808510638299	32414860
pneumonia/chemically induced	hypophysitis/chemically induced	0.031914893617021274	32130969
colon/diagnostic imaging	glucocorticoids/pharmacology	0.010638297872340427	32414860
pneumonia/chemically induced	angiogenesis inhibitors/therapeutic use	0.031914893617021274	32130969
interferon-gamma/metabolism	piperidines/therapeutic use	0.02127659574468085	34147519
arthritis/chemically induced	CHI3L1	0.010638297872340427	36096534
arthritis/chemically induced	CXCL8	0.010638297872340427	36096534
pneumonia/chemically induced	myocarditis/chemically induced	0.031914893617021274	32130969
arthritis/chemically induced	IL17A	0.02127659574468085	36096534
antibodies monoclonal humanized/adverse effects	prednisone/therapeutic use	0.010638297872340427	34956219
arthritis/chemically induced	IL6	0.02127659574468085	36096534
interferon-gamma/metabolism	programmed cell death 1 receptor/antagonists & inhibitors	0.08510638297872342	34147519
pneumonia/chemically induced	hepatitis autoimmune/etiology	0.031914893617021274	32130969
interferon-gamma/metabolism	ctla-4 antigen/antagonists & inhibitors	0.031914893617021274	34147519
colon/diagnostic imaging	melanoma/drug therapy	0.05319148936170214	32414860
pneumonia/chemically induced	dose-response relationship drug	0.06314344543582703	32540858
myeloid cells/cytology	ctla-4 antigen/immunology	0.010638297872340427	32603654
pneumonia/chemically induced	myasthenia gravis/chemically induced	0.031914893617021274	32130969
pneumonia/chemically induced	immune checkpoint inhibitors/therapeutic use	0.06314344543582703	32130969
pneumonia/chemically induced	programmed cell death 1 receptor/antagonists & inhibitors	0.23651935185461492	32540858
colon/diagnostic imaging	immunosuppressive agents/pharmacology	0.010638297872340427	32414860
interferon-gamma/metabolism	cd8-positive t-lymphocytes/drug effects	0.02127659574468085	34147519
interferon-gamma/metabolism	phenotype	0.02127659574468085	34147519
colon/diagnostic imaging	mucositis/chemically induced	0.010638297872340427	32414860
myeloid cells/cytology	colitis/drug therapy	0.031914893617021274	32603654
pyrimidines/therapeutic use	immune checkpoint inhibitors/adverse effects	0.3152596659803249	33096100
pyrimidines/therapeutic use	immune checkpoint inhibitors/adverse effects	0.3152596659803249	34147519
pneumonia/chemically induced	ipilimumab/therapeutic use	0.0020441049207722837	35124713
pneumonia/chemically induced	ipilimumab/therapeutic use	0.0020441049207722837	32130969
interferon-gamma/metabolism	CD8A	0.05319148936170214	34147519
pneumonia/chemically induced	drugs investigational/administration & dosage	0.031914893617021274	32540858
interferon-gamma/metabolism	CTLA4	0.1276595744680851	34147519
myeloid cells/cytology	receptors antigen t-cell/genetics	0.010638297872340427	32603654
myeloid cells/cytology	t-lymphocytes regulatory/cytology	0.010638297872340427	32603654
interferon-gamma/metabolism	PDCD1	0.2659574468085107	34147519
pyrimidines/therapeutic use	interferon-gamma/metabolism	0.02127659574468085	34147519
pyrimidines/therapeutic use	immunologic memory/drug effects	0.02127659574468085	34147519
pneumonia/chemically induced	CD274	0.4100519232490824	32540858
pyrimidines/therapeutic use	colon/drug effects	0.06314344543582705	34147519
colitis collagenous/drug therapy	immune checkpoint inhibitors/pharmacology	0.0425531914893617	32404733
pyrimidines/therapeutic use	protein kinase inhibitors/therapeutic use	0.02127659574468085	33096100
mesalamine/pharmacology	colon/drug effects	0.031914893617021274	33506015
colitis collagenous/drug therapy	melanoma/complications	0.031914893617021274	32404733
pneumonia/chemically induced	PDCD1	0.6091283459162664	32540858
myeloid cells/cytology	chemokines/metabolism	0.010638297872340427	32603654
pyrimidines/therapeutic use	neoplasms/drug therapy	0.240219629375429	33096100
myeloid cells/cytology	multigene family	0.010638297872340427	32603654
pyrimidines/therapeutic use	ipilimumab/adverse effects	0.18325326012354154	33096100
drug resistance/immunology	immune checkpoint inhibitors/adverse effects	0.5638297872340425	32414860
pyrimidines/therapeutic use	colitis/chemically induced	0.9368565545641729	33096100
colitis collagenous/drug therapy	PDCD1	0.2659574468085107	32404733
mesalamine/pharmacology	colitis/chemically induced	0.7446808510638299	33506015
neoplasm recurrence local/drug therapy	immune checkpoint inhibitors	0.31914893617021284	35801666
glycoproteins/metabolism	b7-h1 antigen/antagonists & inhibitors	0.031914893617021274	32389505
drug resistance/immunology	skin neoplasms/drug therapy	0.02127659574468085	32414860
drug resistance/immunology	infliximab/adverse effects	0.0425531914893617	32414860
myeloid cells/cytology	CTLA4	0.1276595744680851	32603654
pyrimidines/therapeutic use	piperidines/therapeutic use	0.00022878059940517045	33096100
pyrimidines/therapeutic use	piperidines/therapeutic use	0.00022878059940517045	34147519
mesalamine/pharmacology	immune checkpoint inhibitors/pharmacology	0.0425531914893617	33506015
pyrimidines/therapeutic use	programmed cell death 1 receptor/antagonists & inhibitors	0.1638069091741021	34147519
myeloid cells/cytology	PDCD1	0.2659574468085107	32603654
glycoproteins/metabolism	colitis/chemically induced	0.7446808510638299	32389505
mesalamine/pharmacology	programmed cell death 1 receptor/antagonists & inhibitors	0.08510638297872342	33506015
pyrimidines/therapeutic use	ctla-4 antigen/antagonists & inhibitors	0.06314344543582705	34147519
mesalamine/pharmacology	trinitrobenzenesulfonic acid/adverse effects	0.010638297872340427	33506015
glycoproteins/metabolism	biomarkers/metabolism	0.010638297872340427	32389505
neoplasms/diagnosis	pneumonia/chemically induced	0.031914893617021274	32540858
neoplasm recurrence local/drug therapy	colitis/chemically induced	0.7446808510638299	35801666
drug resistance/immunology	colitis/chemically induced	0.7446808510638299	32414860
pyrimidines/therapeutic use	cd8-positive t-lymphocytes/drug effects	0.04232441088995653	34147519
neoplasm recurrence local/drug therapy	endometrial neoplasms/drug therapy	0.010638297872340427	35801666
drug resistance/immunology	glucocorticoids/pharmacology	0.010638297872340427	32414860
pyrimidines/therapeutic use	phenotype	0.04232441088995653	34147519
neoplasms/diagnosis	antibodies monoclonal humanized/administration & dosage	0.010638297872340427	32540858
neoplasm recurrence local/drug therapy	antibodies monoclonal humanized	0.010638297872340427	35801666
pyrimidines/therapeutic use	CD8A	0.10409517272935258	34147519
drug resistance/immunology	melanoma/drug therapy	0.05319148936170214	32414860
pyrimidines/therapeutic use	CTLA4	0.240219629375429	34147519
mesalamine/pharmacology	ACAD8	0.02127659574468085	33506015
glycoproteins/metabolism	adenocarcinoma of lung/drug therapy	0.010638297872340427	32389505
drug resistance/immunology	immunosuppressive agents/pharmacology	0.010638297872340427	32414860
pyrimidines/therapeutic use	PDCD1	0.4632807137954702	34147519
neoplasms/diagnosis	immune checkpoint inhibitors/administration & dosage	0.0425531914893617	32540858
neoplasms/diagnosis	colitis/chemically induced	0.7446808510638299	32540858
drug resistance/immunology	mucositis/chemically induced	0.010638297872340427	32414860
myocarditis/diagnostic imaging	immune checkpoint inhibitors/adverse effects	0.5638297872340425	33375984
mesalamine/pharmacology	PDCD1	0.2659574468085107	33506015
myocarditis/diagnostic imaging	pancreatitis/diagnostic imaging	0.010638297872340427	33375984
myocarditis/diagnostic imaging	neoplasms/diagnostic imaging	0.02127659574468085	33375984
glycoproteins/metabolism	CD274	0.1595744680851064	32389505
immunologic memory/drug effects	colon/drug effects	0.031914893617021274	34147519
myocarditis/diagnostic imaging	sarcoidosis/diagnostic imaging	0.010638297872340427	33375984
myocarditis/diagnostic imaging	hepatitis/diagnostic imaging	0.010638297872340427	33375984
neoplasm recurrence local/drug therapy	PDCD1	0.2659574468085107	35801666
pancreatitis/diagnostic imaging	neoplasms/diagnostic imaging	0.02127659574468085	33375984
immune checkpoint inhibitors	glucocorticoids	0.3191489361702128	36096534
myocarditis/diagnostic imaging	pericarditis/diagnostic imaging	0.010638297872340427	33375984
myocarditis/diagnostic imaging	encephalitis/diagnostic imaging	0.010638297872340427	33375984
colitis ulcerative/drug therapy	immune checkpoint inhibitors/adverse effects	0.8123999084877602	33567198
immune checkpoint inhibitors	skin neoplasms/drug therapy	0.5387783115991764	32641348
immune checkpoint inhibitors	infliximab/adverse effects	0.3817690172916815	32162824
immune checkpoint inhibitors	infliximab/adverse effects	0.3817690172916815	32584703
immune checkpoint inhibitors	lung neoplasms/drug therapy	0.5387783115991764	34716545
immune checkpoint inhibitors	diarrhea/therapy	0.3191489361702128	32780984
antibodies monoclonal humanized/administration & dosage	dose-response relationship drug	0.02127659574468085	32540858
immune checkpoint inhibitors	tumor necrosis factor inhibitors	0.3191489361702128	32641348
immune checkpoint inhibitors	colitis	0.09419409929690137	33314269
immune checkpoint inhibitors	colitis	0.09419409929690137	35842365
immune checkpoint inhibitors	colitis	0.09419409929690137	32780983
pancreatitis/diagnostic imaging	sarcoidosis/diagnostic imaging	0.010638297872340427	33375984
antibodies monoclonal humanized/administration & dosage	programmed cell death 1 receptor/antagonists & inhibitors	0.08510638297872342	32540858
colitis ulcerative/drug therapy	immune checkpoint inhibitors	0.5387783115991764	33058056
immune checkpoint inhibitors	carcinoma non-small-cell lung/drug therapy	0.5387783115991764	35124713
pancreatitis/diagnostic imaging	hepatitis/diagnostic imaging	0.010638297872340427	33375984
myocarditis/diagnostic imaging	colitis/diagnostic imaging	0.010638297872340427	33375984
immune checkpoint inhibitors	inflammatory bowel diseases/drug therapy	0.6891766882516188	33314269
immune checkpoint inhibitors	colitis microscopic/chemically induced	0.09951956074124914	34170536
immune checkpoint inhibitors	colitis microscopic/chemically induced	0.09951956074124914	32401685
immune checkpoint inhibitors	colitis/drug therapy	0.6891766882516188	32780984
pancreatitis/diagnostic imaging	pericarditis/diagnostic imaging	0.010638297872340427	33375984
immune checkpoint inhibitors	recurrence	0.5387783115991764	35842365
pancreatitis/diagnostic imaging	encephalitis/diagnostic imaging	0.010638297872340427	33375984
immune checkpoint inhibitors	diarrhea/chemically induced	0.558656159277793	32641348
immune checkpoint inhibitors	diarrhea/chemically induced	0.558656159277793	36113896
immune checkpoint inhibitors	diarrhea/chemically induced	0.558656159277793	35917654
immune checkpoint inhibitors	diarrhea/chemically induced	0.558656159277793	36096534
immune checkpoint inhibitors	diarrhea/chemically induced	0.558656159277793	32584703
immune checkpoint inhibitors	immunologic factors	0.09951956074124914	33566405
immune checkpoint inhibitors	immunologic factors	0.09951956074124914	33566423
immune checkpoint inhibitors	ipilimumab/adverse effects	0.59522065669559	35191192
immune checkpoint inhibitors	ipilimumab/adverse effects	0.59522065669559	32934876
immune checkpoint inhibitors	ipilimumab/adverse effects	0.59522065669559	35917654
colitis ulcerative/drug therapy	interleukin-23/antagonists & inhibitors	0.02127659574468085	33567198
antibodies monoclonal humanized/administration & dosage	drugs investigational/administration & dosage	0.010638297872340427	32540858
immune checkpoint inhibitors	neoplasms/therapy	0.3191489361702128	32780984
immunologic memory/drug effects	piperidines/therapeutic use	0.02127659574468085	34147519
immune checkpoint inhibitors	colitis/chemically induced	0.8253264548783232	34081152
immune checkpoint inhibitors	colitis/chemically induced	0.8253264548783232	34716545
immune checkpoint inhibitors	colitis/chemically induced	0.8253264548783232	32162824
immune checkpoint inhibitors	colitis/chemically induced	0.8253264548783232	36096534
immune checkpoint inhibitors	colitis/chemically induced	0.8253264548783232	35307927
immune checkpoint inhibitors	colitis/chemically induced	0.8253264548783232	35191192
immune checkpoint inhibitors	colitis/chemically induced	0.8253264548783232	34106395
immune checkpoint inhibitors	colitis/chemically induced	0.8253264548783232	34515105
immune checkpoint inhibitors	colitis/chemically induced	0.8253264548783232	35977003
immune checkpoint inhibitors	colitis/chemically induced	0.8253264548783232	35296560
immune checkpoint inhibitors	colitis/chemically induced	0.8253264548783232	34256056
immune checkpoint inhibitors	colitis/chemically induced	0.8253264548783232	35801666
immune checkpoint inhibitors	colitis/chemically induced	0.8253264548783232	32641348
immune checkpoint inhibitors	colitis/chemically induced	0.8253264548783232	33566405
immune checkpoint inhibitors	colitis/chemically induced	0.8253264548783232	35917654
immune checkpoint inhibitors	colitis/chemically induced	0.8253264548783232	32934876
immune checkpoint inhibitors	colitis/chemically induced	0.8253264548783232	36113896
immune checkpoint inhibitors	colitis/chemically induced	0.8253264548783232	35124713
immune checkpoint inhibitors	colitis/chemically induced	0.8253264548783232	31864555
immune checkpoint inhibitors	colitis/chemically induced	0.8253264548783232	33746162
immune checkpoint inhibitors	colitis/chemically induced	0.8253264548783232	32584703
pancreatitis/diagnostic imaging	colitis/diagnostic imaging	0.010638297872340427	33375984
immune checkpoint inhibitors	endometrial neoplasms/drug therapy	0.3191489361702128	35801666
immunologic memory/drug effects	programmed cell death 1 receptor/antagonists & inhibitors	0.08510638297872342	34147519
immune checkpoint inhibitors	dermatitis	0.3191489361702128	35977003
antibodies monoclonal humanized/administration & dosage	CD274	0.1595744680851064	32540858
immune checkpoint inhibitors	antibodies monoclonal humanized	0.3191489361702128	35801666
immunologic memory/drug effects	ctla-4 antigen/antagonists & inhibitors	0.031914893617021274	34147519
myocarditis/diagnostic imaging	pneumonia/diagnostic imaging	0.010638297872340427	33375984
immune checkpoint inhibitors	melanoma/drug therapy	0.5138404611115063	32162824
immune checkpoint inhibitors	melanoma/drug therapy	0.5138404611115063	32641348
immune checkpoint inhibitors	crohn disease/drug therapy	0.3191489361702128	33058056
antibodies monoclonal humanized/administration & dosage	PDCD1	0.2659574468085107	32540858
immune checkpoint inhibitors	drug-related side effects and adverse reactions/diagnosis	0.3191489361702128	35191192
colitis	CD274	0.11831935782280446	35432346
colitis	CD274	0.11831935782280446	33314269
immune checkpoint inhibitors	inflammatory bowel diseases	0.5387783115991764	35842365
immunologic memory/drug effects	cd8-positive t-lymphocytes/drug effects	0.02127659574468085	34147519
colitis	CTLA4	0.07795406527166249	35432346
colitis	CTLA4	0.07795406527166249	33314269
immune checkpoint inhibitors	drug-related side effects and adverse reactions	0.5387783115991764	32162824
pancreatitis/diagnostic imaging	pneumonia/diagnostic imaging	0.010638297872340427	33375984
immunologic memory/drug effects	phenotype	0.02127659574468085	34147519
colitis	PDCD1	0.28698137826483744	35432346
colitis	PDCD1	0.28698137826483744	33314269
skin neoplasms/drug therapy	infliximab/adverse effects	0.0837336993822924	32414860
immune checkpoint inhibitors	lung neoplasms	0.3191489361702128	31864555
immune checkpoint inhibitors	cd8-positive t-lymphocytes	0.3191489361702128	34106395
skin neoplasms/drug therapy	tumor necrosis factor inhibitors	0.02127659574468085	32641348
immune checkpoint inhibitors	beclomethasone/adverse effects	0.3191489361702128	36113896
immune checkpoint inhibitors	ipilimumab/therapeutic use	0.6891766882516188	35124713
immunologic memory/drug effects	CD8A	0.05319148936170214	34147519
immune checkpoint inhibitors	cytomegalovirus infections/complications	0.3191489361702128	35307927
immunologic memory/drug effects	CTLA4	0.1276595744680851	34147519
immune checkpoint inhibitors	inflammatory bowel diseases/complications	0.5387783115991764	32401685
immune checkpoint inhibitors	rna	0.3191489361702128	35977003
immune checkpoint inhibitors	steroids/therapeutic use	0.5387783115991764	31864555
skin neoplasms/drug therapy	diarrhea/chemically induced	0.2951269732326699	32641348
skin neoplasms/complications	colitis collagenous/drug therapy	0.010638297872340427	32404733
immunologic memory/drug effects	PDCD1	0.2659574468085107	34147519
immune checkpoint inhibitors	CD274	0.9213565623286142	32934876
immune checkpoint inhibitors	CD274	0.9213565623286142	33314269
immune checkpoint inhibitors	CD274	0.9213565623286142	35917654
immune checkpoint inhibitors	CHI3L1	0.3191489361702128	36096534
skin neoplasms/drug therapy	colitis/chemically induced	0.5525051475634867	32414860
skin neoplasms/drug therapy	colitis/chemically induced	0.5525051475634867	32641348
immune checkpoint inhibitors	CTLA4	0.3202770366269383	35977003
immune checkpoint inhibitors	CTLA4	0.3202770366269383	35917654
immune checkpoint inhibitors	CTLA4	0.3202770366269383	35191192
immune checkpoint inhibitors	CTLA4	0.3202770366269383	32934876
immune checkpoint inhibitors	CTLA4	0.3202770366269383	33314269
immune checkpoint inhibitors	CXCL10	0.3191489361702128	35977003
immune checkpoint inhibitors	CXCL8	0.3191489361702128	36096534
immune checkpoint inhibitors	CXCL9	0.3191489361702128	35977003
gastritis/chemically induced	colitis/chemically induced	0.7446808510638299	32621258
skin neoplasms/drug therapy	glucocorticoids/pharmacology	0.02127659574468085	32414860
immune checkpoint inhibitors	IL17A	0.5387783115991764	36096534
immune checkpoint inhibitors	IL6	0.5387783115991764	36096534
immune checkpoint inhibitors	LTF	0.3191489361702128	32584703
pruritus/chemically induced	adrenal insufficiency/chemically induced	0.010638297872340427	32130969
immune checkpoint inhibitors	PDCD1	0.8945356519637592	35801666
immune checkpoint inhibitors	PDCD1	0.8945356519637592	35977003
immune checkpoint inhibitors	PDCD1	0.8945356519637592	32401685
immune checkpoint inhibitors	PDCD1	0.8945356519637592	35917654
immune checkpoint inhibitors	PDCD1	0.8945356519637592	35191192
immune checkpoint inhibitors	PDCD1	0.8945356519637592	33314269
immune checkpoint inhibitors	SNCA	0.2379815582942914	32934876
immune checkpoint inhibitors	SNCA	0.2379815582942914	32641348
immune checkpoint inhibitors	TCIM	0.3191489361702128	35977003
immune checkpoint inhibitors	TNF	0.030288561964728	32162824
immune checkpoint inhibitors	TNF	0.030288561964728	35977003
immune checkpoint inhibitors	TNF	0.030288561964728	32641348
pruritus/chemically induced	axitinib/administration & dosage	0.010638297872340427	32130969
neoplasms/diagnostic imaging	sarcoidosis/diagnostic imaging	0.02127659574468085	33375984
skin neoplasms/drug therapy	melanoma/drug therapy	0.002287805994051705	32414860
skin neoplasms/drug therapy	melanoma/drug therapy	0.002287805994051705	32641348
neoplasms/diagnostic imaging	hepatitis/diagnostic imaging	0.02127659574468085	33375984
pruritus/chemically induced	colitis/chemically induced	0.7446808510638299	32130969
skin neoplasms/drug therapy	immunosuppressive agents/pharmacology	0.02127659574468085	32414860
azoxymethane/adverse effects	colonic neoplasms/drug therapy	0.010638297872340427	33495297
pruritus/chemically induced	hypophysitis/chemically induced	0.010638297872340427	32130969
neoplasms/diagnostic imaging	pericarditis/diagnostic imaging	0.02127659574468085	33375984
neoplasms/diagnostic imaging	encephalitis/diagnostic imaging	0.02127659574468085	33375984
pruritus/chemically induced	angiogenesis inhibitors/therapeutic use	0.010638297872340427	32130969
skin neoplasms/drug therapy	mucositis/chemically induced	0.02127659574468085	32414860
neoplasms/diagnostic imaging	colitis/chemically induced	0.9368565545641729	31754740
pruritus/chemically induced	myocarditis/chemically induced	0.010638297872340427	32130969
neoplasms/diagnostic imaging	colitis/diagnostic imaging	0.02127659574468085	33375984
azoxymethane/adverse effects	cell line tumor	0.02127659574468085	33495297
pruritus/chemically induced	hepatitis autoimmune/etiology	0.010638297872340427	32130969
mycophenolic acid	colitis/chemically induced	0.7446808510638299	36504035
azoxymethane/adverse effects	poly(adp-ribose) polymerase inhibitors/administration & dosage	0.010638297872340427	33495297
pruritus/chemically induced	myasthenia gravis/chemically induced	0.010638297872340427	32130969
pruritus/chemically induced	immune checkpoint inhibitors/therapeutic use	0.02127659574468085	32130969
azoxymethane/adverse effects	piperazines/administration & dosage	0.010638297872340427	33495297
azoxymethane/adverse effects	APC	0.02127659574468085	33495297
azoxymethane/adverse effects	ARG1	0.010638297872340427	33495297
pruritus/chemically induced	ipilimumab/therapeutic use	0.031914893617021274	32130969
skin neoplasms/drug therapy	SNCA	0.06314344543582705	32641348
skin neoplasms/drug therapy	TNF	0.06314344543582705	32641348
neoplasms/diagnostic imaging	pneumonia/diagnostic imaging	0.02127659574468085	33375984
protein kinase inhibitors/therapeutic use	neoplasms/drug therapy	0.1276595744680851	33096100
azoxymethane/adverse effects	PARP1	0.010638297872340427	33495297
azoxymethane/adverse effects	PDCD1	0.2659574468085107	33495297
azoxymethane/adverse effects	TIPARP	0.010638297872340427	33495297
protein kinase inhibitors/therapeutic use	ipilimumab/adverse effects	0.09574468085106383	33096100
protein kinase inhibitors/therapeutic use	colitis/chemically induced	0.7446808510638299	33096100
diarrhea/chemically induced	clostridium infections/chemically induced	0.15957446808510636	34107499
diarrhea/chemically induced	colitis/chemically induced	0.057662245639450264	32641348
diarrhea/chemically induced	colitis/chemically induced	0.057662245639450264	31609734
diarrhea/chemically induced	colitis/chemically induced	0.057662245639450264	36113896
diarrhea/chemically induced	colitis/chemically induced	0.057662245639450264	34107499
diarrhea/chemically induced	colitis/chemically induced	0.057662245639450264	33173388
diarrhea/chemically induced	colitis/chemically induced	0.057662245639450264	34158318
diarrhea/chemically induced	colitis/chemically induced	0.057662245639450264	34380976
diarrhea/chemically induced	colitis/chemically induced	0.057662245639450264	33290513
diarrhea/chemically induced	colitis/chemically induced	0.057662245639450264	31595568
diarrhea/chemically induced	colitis/chemically induced	0.057662245639450264	35917654
diarrhea/chemically induced	colitis/chemically induced	0.057662245639450264	36096534
diarrhea/chemically induced	colitis/chemically induced	0.057662245639450264	36377339
diarrhea/chemically induced	colitis/chemically induced	0.057662245639450264	26448188
diarrhea/chemically induced	colitis/chemically induced	0.057662245639450264	32584703
colon/drug effects	colitis/chemically induced	0.9849004804392587	33506015
diarrhea/chemically induced	neoplasms/complications	0.41005192324908235	34158318
diarrhea/chemically induced	abdominal pain/chemically induced	0.15957446808510636	36377339
colon/drug effects	crohn disease/immunology	0.031914893617021274	34338882
gentian violet	colitis/chemically induced	0.7446808510638299	32888202
protein kinase inhibitors/therapeutic use	piperidines/therapeutic use	0.02127659574468085	33096100
diarrhea/chemically induced	anti-bacterial agents/adverse effects	0.15957446808510636	34107499
colon/drug effects	immune checkpoint inhibitors/pharmacology	0.12357136462654054	33506015
colon/drug effects	piperidines/therapeutic use	0.06314344543582703	34147519
diarrhea/chemically induced	feces/chemistry	0.15957446808510636	33436487
diarrhea/chemically induced	melanoma/drug therapy	0.5894134264370904	32641348
diarrhea/chemically induced	antineoplastic agents immunological/therapeutic use	0.41005192324908235	36377339
antibodies monoclonal humanized/administration & dosage	immune checkpoint inhibitors/administration & dosage	0.0425531914893617	32540858
colon/drug effects	programmed cell death 1 receptor/antagonists & inhibitors	0.01838202381307631	33506015
colon/drug effects	programmed cell death 1 receptor/antagonists & inhibitors	0.01838202381307631	34147519
diarrhea/chemically induced	dose-response relationship drug	0.2951269732326699	33290513
diarrhea/chemically induced	leukocyte l1 antigen complex/analysis	0.15957446808510636	33436487
antibodies monoclonal humanized/administration & dosage	colitis/chemically induced	0.7446808510638299	32540858
colon/drug effects	trinitrobenzenesulfonic acid/adverse effects	0.031914893617021274	33506015
colon/drug effects	ctla-4 antigen/antagonists & inhibitors	0.09369311569335442	34147519
skin neoplasms/immunology	colitis/chemically induced	0.7446808510638299	34956219
diarrhea/chemically induced	gastritis/complications	0.15957446808510636	36377339
diarrhea/chemically induced	biological products/therapeutic use	0.15957446808510636	34380976
diarrhea/chemically induced	enterocolitis/chemically induced	0.2951269732326699	36377339
colon/drug effects	graft vs host disease/immunology	0.031914893617021274	34338882
diarrhea/chemically induced	beclomethasone/adverse effects	0.15957446808510636	36113896
colon/drug effects	cd8-positive t-lymphocytes/drug effects	0.0006863417982155113	34338882
colon/drug effects	cd8-positive t-lymphocytes/drug effects	0.0006863417982155113	34147519
diarrhea/chemically induced	biomarkers/analysis	0.0240219629375429	26448188
diarrhea/chemically induced	biomarkers/analysis	0.0240219629375429	33436487
skin neoplasms/immunology	melanoma/immunology	0.010638297872340427	34956219
colon/drug effects	phenotype	0.0006863417982155113	34338882
colon/drug effects	phenotype	0.0006863417982155113	34147519
diarrhea/chemically induced	inflammatory bowel diseases/complications	0.2951269732326699	34158318
diarrhea/chemically induced	steroids/therapeutic use	0.2951269732326699	33290513
colon/drug effects	ACAD8	0.06314344543582703	33506015
diarrhea/chemically induced	CD274	0.44304864917240466	35917654
diarrhea/chemically induced	CD274	0.44304864917240466	33173388
diarrhea/chemically induced	CD274	0.44304864917240466	34158318
colon/drug effects	CD4	0.06314344543582703	34338882
colon/drug effects	CD68	0.06314344543582703	34338882
diarrhea/chemically induced	CHI3L1	0.15957446808510636	36096534
colon/drug effects	CD8A	0.006714213243412611	34338882
colon/drug effects	CD8A	0.006714213243412611	34147519
diarrhea/chemically induced	CTLA4	0.892764266875473	35917654
colon/drug effects	CTLA4	0.33932141684819905	34147519
diarrhea/chemically induced	CXCL8	0.15957446808510636	36096534
skin neoplasms/immunology	immunocompromised host	0.010638297872340427	34956219
diarrhea/chemically induced	IL17A	0.2951269732326699	36096534
diarrhea/chemically induced	IL6	0.2951269732326699	36096534
diarrhea/chemically induced	LTF	0.15957446808510636	32584703
colon/drug effects	PDCD1	0.17158544955387783	33506015
colon/drug effects	PDCD1	0.17158544955387783	34147519
gentian violet	inflammation	0.010638297872340427	32888202
diarrhea/chemically induced	PDCD1	0.8275677077512593	35917654
diarrhea/chemically induced	PDCD1	0.8275677077512593	33173388
diarrhea/chemically induced	PDCD1	0.8275677077512593	34158318
diarrhea/chemically induced	SNCA	0.41005192324908235	32641348
diarrhea/chemically induced	TNF	0.41005192324908235	32641348
diarrhea/chemically induced	antineoplastic agents/adverse effects	0.15957446808510636	26448188
diarrhea/chemically induced	intestinal mucosa/chemistry	0.15957446808510636	26448188
diarrhea/chemically induced	leukemia lymphocytic chronic b-cell/drug therapy	0.15957446808510636	26448188
diarrhea/chemically induced	class i phosphatidylinositol 3-kinases/antagonists & inhibitors	0.15957446808510636	26448188
diarrhea/chemically induced	purines/adverse effects	0.15957446808510636	26448188
diarrhea/chemically induced	colon/chemistry	0.15957446808510636	26448188
diarrhea/chemically induced	lymphocytosis/chemically induced	0.15957446808510636	26448188
diarrhea/chemically induced	protein kinase inhibitors/adverse effects	0.15957446808510636	26448188
diarrhea/chemically induced	apoptosis/drug effects	0.15957446808510636	26448188
diarrhea/chemically induced	quinazolinones/adverse effects	0.15957446808510636	26448188
diarrhea/chemically induced	lymphoma non-hodgkin/drug therapy	0.15957446808510636	26448188
diarrhea/chemically induced	PIK3CD	0.15957446808510636	26448188
infliximab/adverse effects	antibodies monoclonal humanized/therapeutic use	0.0425531914893617	33454238
immunologic factors	colitis/chemically induced	0.9368565545641729	33566405
infliximab/adverse effects	steroids/adverse effects	0.0425531914893617	33454238
colitis/epidemiology	b7-h1 antigen/antagonists & inhibitors	0.031914893617021274	32960847
infliximab/adverse effects	diarrhea/chemically induced	0.5072961117245084	32584703
ht29 cells	APC	0.02127659574468085	33462141
ht29 cells	CD274	0.1595744680851064	33462141
infliximab/adverse effects	colitis/chemically induced	0.30067050314133364	32162824
infliximab/adverse effects	colitis/chemically induced	0.30067050314133364	32414860
infliximab/adverse effects	colitis/chemically induced	0.30067050314133364	33454238
infliximab/adverse effects	colitis/chemically induced	0.30067050314133364	32584703
ht29 cells	CD8A	0.05319148936170214	33462141
infliximab/adverse effects	glucocorticoids/pharmacology	0.0425531914893617	32414860
skin neoplasms/immunology	prednisone/therapeutic use	0.010638297872340427	34956219
ht29 cells	IL17A	0.02127659574468085	33462141
colitis/epidemiology	neoplasms/complications	0.031914893617021274	32960847
t-lymphocytes cytotoxic/immunology	tumor microenvironment/drug effects	0.010638297872340427	33462141
ht29 cells	MIR15B	0.010638297872340427	33462141
infliximab/adverse effects	melanoma/drug therapy	0.013134935846881177	32162824
infliximab/adverse effects	melanoma/drug therapy	0.013134935846881177	32414860
ht29 cells	NRF1	0.010638297872340427	33462141
ht29 cells	PDCD1	0.2659574468085107	33462141
infliximab/adverse effects	immunosuppressive agents/pharmacology	0.0425531914893617	32414860
infliximab/adverse effects	drug-related side effects and adverse reactions	0.08373369938229239	32162824
t-lymphocytes cytotoxic/immunology	immune checkpoint inhibitors/administration & dosage	0.0425531914893617	33462141
infliximab/adverse effects	mucositis/chemically induced	0.0425531914893617	32414860
t-lymphocytes cytotoxic/immunology	ht29 cells	0.010638297872340427	33462141
anti-bacterial agents	colitis/chemically induced	0.7446808510638299	36043345
t-lymphocytes cytotoxic/immunology	colitis/chemically induced	0.7446808510638299	33462141
t-lymphocytes cytotoxic/immunology	colorectal neoplasms/drug therapy	0.010638297872340427	33462141
colitis/epidemiology	programmed cell death 1 receptor/antagonists & inhibitors	0.08510638297872342	32960847
t-lymphocytes cytotoxic/immunology	b7-h1 antigen/genetics	0.010638297872340427	33462141
steroids/adverse effects	colitis/chemically induced	0.7446808510638299	33454238
infliximab/adverse effects	LTF	0.0425531914893617	32584703
infliximab/adverse effects	TNF	0.12357136462654053	32162824
proton pump inhibitors/adverse effects	colitis/chemically induced	0.7446808510638299	35277350
lung neoplasms/drug therapy	diarrhea/chemically induced	0.2951269732326699	33173388
colitis/epidemiology	CD274	0.1595744680851064	32960847
lung neoplasms/drug therapy	colitis/chemically induced	0.5525051475634867	34716545
lung neoplasms/drug therapy	colitis/chemically induced	0.5525051475634867	33173388
colitis/epidemiology	PDCD1	0.2659574468085107	32960847
proton pump inhibitors/adverse effects	ipilimumab/therapeutic use	0.031914893617021274	35277350
t-lymphocytes cytotoxic/immunology	APC	0.02127659574468085	33462141
t-lymphocytes cytotoxic/immunology	CD274	0.1595744680851064	33462141
t-lymphocytes cytotoxic/immunology	CD8A	0.05319148936170214	33462141
sarcoidosis/diagnostic imaging	hepatitis/diagnostic imaging	0.010638297872340427	33375984
t-lymphocytes cytotoxic/immunology	IL17A	0.02127659574468085	33462141
lung neoplasms/drug therapy	CD274	0.2951269732326699	33173388
t-lymphocytes cytotoxic/immunology	MIR15B	0.010638297872340427	33462141
t-lymphocytes cytotoxic/immunology	NRF1	0.010638297872340427	33462141
sarcoidosis/diagnostic imaging	pericarditis/diagnostic imaging	0.010638297872340427	33375984
t-lymphocytes cytotoxic/immunology	PDCD1	0.2659574468085107	33462141
sarcoidosis/diagnostic imaging	encephalitis/diagnostic imaging	0.010638297872340427	33375984
pericarditis/diagnostic imaging	encephalitis/diagnostic imaging	0.010638297872340427	33375984
lung neoplasms/drug therapy	PDCD1	0.4632807137954702	33173388
pericarditis/diagnostic imaging	colitis/diagnostic imaging	0.010638297872340427	33375984
sarcoidosis/diagnostic imaging	colitis/diagnostic imaging	0.010638297872340427	33375984
hepatitis/diagnostic imaging	pericarditis/diagnostic imaging	0.010638297872340427	33375984
diarrhea/therapy	colitis/drug therapy	0.031914893617021274	32780984
hepatitis/diagnostic imaging	encephalitis/diagnostic imaging	0.010638297872340427	33375984
diarrhea/therapy	neoplasms/therapy	0.010638297872340427	32780984
lymphocytes/drug effects	colitis/chemically induced	0.7446808510638299	32567084
pericarditis/diagnostic imaging	pneumonia/diagnostic imaging	0.010638297872340427	33375984
hepatitis/diagnostic imaging	colitis/diagnostic imaging	0.010638297872340427	33375984
lymphocytes/drug effects	vitamin d/administration & dosage	0.010638297872340427	32567084
interleukin-23/antagonists & inhibitors	interleukin-12/antagonists & inhibitors	0.010638297872340427	33567198
sarcoidosis/diagnostic imaging	pneumonia/diagnostic imaging	0.010638297872340427	33375984
lymphocytes/drug effects	neutrophils/drug effects	0.010638297872340427	32567084
lymphocytes/drug effects	antibodies monoclonal/adverse effects	0.010638297872340427	32567084
lymphocytes/drug effects	programmed cell death 1 receptor/antagonists & inhibitors	0.08510638297872342	32567084
ipilimumab/adverse effects	colitis/chemically induced	0.06114028197916452	34159488
ipilimumab/adverse effects	colitis/chemically induced	0.06114028197916452	33096100
ipilimumab/adverse effects	colitis/chemically induced	0.06114028197916452	33882697
ipilimumab/adverse effects	colitis/chemically induced	0.06114028197916452	34332139
ipilimumab/adverse effects	colitis/chemically induced	0.06114028197916452	31595568
ipilimumab/adverse effects	colitis/chemically induced	0.06114028197916452	32931028
ipilimumab/adverse effects	colitis/chemically induced	0.06114028197916452	35917654
ipilimumab/adverse effects	colitis/chemically induced	0.06114028197916452	35191192
ipilimumab/adverse effects	colitis/chemically induced	0.06114028197916452	32934876
lymphocytes/drug effects	melanoma/complications	0.031914893617021274	32567084
lymphocytes/drug effects	ctla-4 antigen/antagonists & inhibitors	0.031914893617021274	32567084
hepatitis/diagnostic imaging	pneumonia/diagnostic imaging	0.010638297872340427	33375984
ipilimumab/adverse effects	melanoma/drug therapy	0.40242469177744167	33882697
lymphocytes/drug effects	antineoplastic agents immunological/adverse effects	0.07446808510638298	32567084
ipilimumab/adverse effects	piperidines/therapeutic use	0.18325326012354154	33096100
ipilimumab/adverse effects	drug-related side effects and adverse reactions/diagnosis	0.09574468085106383	35191192
disease progression	neoplasms/drug therapy	0.1276595744680851	36377339
disease progression	diarrhea/chemically induced	0.1595744680851064	36377339
squamous cell carcinoma of head and neck/drug therapy	tongue neoplasms/drug therapy	0.010638297872340427	33476895
disease progression	colitis/chemically induced	0.7446808510638299	36377339
disease progression	abdominal pain/chemically induced	0.010638297872340427	36377339
lymphocytes/drug effects	CTLA4	0.1276595744680851	32567084
disease progression	antineoplastic agents immunological/therapeutic use	0.031914893617021274	36377339
ipilimumab/adverse effects	CD274	0.4386048484497357	32934876
ipilimumab/adverse effects	CD274	0.4386048484497357	35917654
lymphocytes/drug effects	PDCD1	0.2659574468085107	32567084
ipilimumab/adverse effects	CTLA4	0.08650330140520421	35191192
ipilimumab/adverse effects	CTLA4	0.08650330140520421	32934876
ipilimumab/adverse effects	CTLA4	0.08650330140520421	35917654
disease progression	gastritis/complications	0.010638297872340427	36377339
disease progression	enterocolitis/chemically induced	0.02127659574468085	36377339
squamous cell carcinoma of head and neck/drug therapy	paclitaxel/therapeutic use	0.010638297872340427	33476895
ipilimumab/adverse effects	PDCD1	0.7501982764851278	35191192
ipilimumab/adverse effects	PDCD1	0.7501982764851278	35917654
ipilimumab/adverse effects	SNCA	0.2631523977201515	32934876
chemical and drug induced liver injury/diagnosis	neoplasms/drug therapy	0.1276595744680851	33080231
neoplasms/drug therapy	colitis/drug therapy	0.33932141684819905	33436487
neoplasms/drug therapy	diarrhea/chemically induced	0.02146669245206154	31609734
neoplasms/drug therapy	diarrhea/chemically induced	0.02146669245206154	33436487
neoplasms/drug therapy	diarrhea/chemically induced	0.02146669245206154	34107499
neoplasms/drug therapy	diarrhea/chemically induced	0.02146669245206154	34380976
neoplasms/drug therapy	diarrhea/chemically induced	0.02146669245206154	36377339
neoplasms/drug therapy	ipilimumab/adverse effects	0.7244915402020913	33096100
neoplasms/drug therapy	clostridium infections/chemically induced	0.1276595744680851	34107499
squamous cell carcinoma of head and neck/drug therapy	colitis ulcerative/chemically induced	0.010638297872340427	33476895
chemical and drug induced liver injury/diagnosis	colitis/chemically induced	0.7446808510638299	33080231
encephalitis/diagnostic imaging	colitis/diagnostic imaging	0.010638297872340427	33375984
neoplasms/drug therapy	colitis/chemically induced	0.13102727028986286	33741313
neoplasms/drug therapy	colitis/chemically induced	0.13102727028986286	33096100
neoplasms/drug therapy	colitis/chemically induced	0.13102727028986286	31609734
neoplasms/drug therapy	colitis/chemically induced	0.13102727028986286	33080231
neoplasms/drug therapy	colitis/chemically induced	0.13102727028986286	35236743
neoplasms/drug therapy	colitis/chemically induced	0.13102727028986286	33459466
neoplasms/drug therapy	colitis/chemically induced	0.13102727028986286	34777387
neoplasms/drug therapy	colitis/chemically induced	0.13102727028986286	34107499
neoplasms/drug therapy	colitis/chemically induced	0.13102727028986286	34380976
neoplasms/drug therapy	colitis/chemically induced	0.13102727028986286	32185493
neoplasms/drug therapy	colitis/chemically induced	0.13102727028986286	36377339
neoplasms/drug therapy	abdominal pain/chemically induced	0.1276595744680851	36377339
squamous cell carcinoma of head and neck/drug therapy	programmed cell death 1 receptor/antagonists & inhibitors	0.08510638297872342	33476895
neoplasms/drug therapy	anti-bacterial agents/adverse effects	0.1276595744680851	34107499
neoplasms/drug therapy	intestinal mucosa/immunology	0.1276595744680851	33459466
neoplasms/drug therapy	feces/chemistry	0.1276595744680851	33436487
tumor necrosis factor inhibitors	diarrhea/chemically induced	0.1595744680851064	32641348
neoplasms/drug therapy	antineoplastic agents immunological/therapeutic use	0.33932141684819905	36377339
neoplasms/drug therapy	immune checkpoint inhibitors/pharmacology	0.42644386737371137	35236743
neoplasms/drug therapy	piperidines/therapeutic use	0.240219629375429	33096100
squamous cell carcinoma of head and neck/drug therapy	antineoplastic agents immunological/adverse effects	0.07446808510638298	33476895
tumor necrosis factor inhibitors	colitis/chemically induced	0.7446808510638299	32641348
encephalitis/diagnostic imaging	pneumonia/diagnostic imaging	0.010638297872340427	33375984
neoplasms/drug therapy	colon/immunology	0.015099519560741249	33459466
neoplasms/drug therapy	colon/immunology	0.015099519560741249	34777387
colitis/chemically induced	phthalazines/administration & dosage	0.7446808510638299	33495297
neoplasms/drug therapy	leukocyte l1 antigen complex/analysis	0.1276595744680851	33436487
colitis/chemically induced	neoplasms/complications	0.9849004804392587	34158318
colitis/chemically induced	abdominal pain/chemically induced	0.7446808510638299	36377339
colitis/chemically induced	hypophysitis/chemically induced	0.7446808510638299	32130969
tumor necrosis factor inhibitors	melanoma/drug therapy	0.05319148936170214	32641348
colitis/chemically induced	glucocorticoids/pharmacology	0.7446808510638299	32414860
colitis/chemically induced	dextran sulfate/adverse effects	0.7446808510638299	33495297
colitis/chemically induced	cytomegalovirus infections/diagnosis	0.7446808510638299	32434876
neoplasms/drug therapy	t-lymphocyte subsets/immunology	0.1276595744680851	34777387
colitis/chemically induced	endometrial neoplasms/drug therapy	0.7446808510638299	35801666
colitis/chemically induced	angiogenesis inhibitors/therapeutic use	0.7446808510638299	32130969
colitis/chemically induced	biomarkers/metabolism	0.7446808510638299	32389505
neoplasms/drug therapy	gastritis/complications	0.1276595744680851	36377339
colitis/chemically induced	dermatitis	0.7446808510638299	35977003
neoplasms/drug therapy	biological products/therapeutic use	0.1276595744680851	34380976
colitis/chemically induced	colorectal neoplasms/drug therapy	0.7446808510638299	33462141
neoplasms/drug therapy	enterocolitis/chemically induced	0.240219629375429	36377339
colitis/chemically induced	anti-bacterial agents/adverse effects	0.7446808510638299	34107499
colitis/chemically induced	oropharyngeal neoplasms/drug therapy	0.7446808510638299	33906378
colitis/chemically induced	vitamin d/administration & dosage	0.7446808510638299	32567084
colitis/chemically induced	carcinoma non-small-cell lung/complications	0.7446808510638299	32418993
neoplasms/drug therapy	hepatitis/diagnosis	0.1276595744680851	32185493
colitis/chemically induced	melanoma/immunology	0.7446808510638299	34956219
colitis/chemically induced	b7-h1 antigen/genetics	0.7446808510638299	33462141
immune checkpoint inhibitors/administration & dosage	ht29 cells	0.0425531914893617	33462141
colitis/chemically induced	myocarditis/chemically induced	0.7446808510638299	32130969
colitis/chemically induced	antibodies monoclonal humanized	0.7446808510638299	35801666
squamous cell carcinoma of head and neck/drug therapy	SNCA	0.031914893617021274	33476895
immune checkpoint inhibitors/administration & dosage	colitis/chemically induced	0.30067050314133364	33495297
immune checkpoint inhibitors/administration & dosage	colitis/chemically induced	0.30067050314133364	32540858
immune checkpoint inhibitors/administration & dosage	colitis/chemically induced	0.30067050314133364	32418993
immune checkpoint inhibitors/administration & dosage	colitis/chemically induced	0.30067050314133364	33462141
neoplasms/drug therapy	biomarkers/analysis	0.240219629375429	33436487
colitis/chemically induced	colonic neoplasms/drug therapy	0.7446808510638299	33495297
immune checkpoint inhibitors/administration & dosage	phthalazines/administration & dosage	0.0425531914893617	33495297
colitis/chemically induced	intestinal mucosa/immunology	0.7446808510638299	33459466
neoplasms/drug therapy	butyrates/metabolism	0.1276595744680851	33741313
colitis/chemically induced	melanoma/drug therapy	0.22049170230364465	32641348
colitis/chemically induced	melanoma/drug therapy	0.22049170230364465	32162824
colitis/chemically induced	melanoma/drug therapy	0.22049170230364465	33882697
colitis/chemically induced	melanoma/drug therapy	0.22049170230364465	36338892
colitis/chemically induced	melanoma/drug therapy	0.22049170230364465	32414860
immune checkpoint inhibitors/administration & dosage	dextran sulfate/adverse effects	0.0425531914893617	33495297
colitis/chemically induced	antineoplastic agents immunological/therapeutic use	0.8407687028140014	36159840
colitis/chemically induced	antineoplastic agents immunological/therapeutic use	0.8407687028140014	36377339
colitis/chemically induced	immune checkpoint inhibitors/pharmacology	0.9500554352990866	33506015
colitis/chemically induced	immune checkpoint inhibitors/pharmacology	0.9500554352990866	35236743
colitis/chemically induced	hepatitis autoimmune/etiology	0.7446808510638299	32130969
neoplasms/drug therapy	AHR	0.1276595744680851	35236743
colitis/chemically induced	piperidines/therapeutic use	0.9368565545641729	33096100
immune checkpoint inhibitors/administration & dosage	colorectal neoplasms/drug therapy	0.0425531914893617	33462141
colitis/chemically induced	adrenal cortex hormones/pharmacology	0.7446808510638299	33268234
immune checkpoint inhibitors/administration & dosage	carcinoma non-small-cell lung/complications	0.0425531914893617	32418993
colitis/chemically induced	drug-related side effects and adverse reactions/diagnosis	0.7446808510638299	35191192
immune checkpoint inhibitors/administration & dosage	b7-h1 antigen/genetics	0.0425531914893617	33462141
colitis/chemically induced	immunocompromised host	0.7446808510638299	34956219
immune checkpoint inhibitors/administration & dosage	colonic neoplasms/drug therapy	0.0425531914893617	33495297
tumor necrosis factor inhibitors	SNCA	0.031914893617021274	32641348
colitis/chemically induced	colon/immunology	0.5525051475634866	33459466
colitis/chemically induced	colon/immunology	0.5525051475634866	34777387
colitis/chemically induced	dose-response relationship drug	0.5525051475634866	33290513
colitis/chemically induced	dose-response relationship drug	0.5525051475634866	32540858
tumor necrosis factor inhibitors	TNF	0.031914893617021274	32641348
colitis/chemically induced	neutrophils/drug effects	0.7446808510638299	32567084
colitis/chemically induced	myasthenia gravis/chemically induced	0.7446808510638299	32130969
colitis/chemically induced	antibodies monoclonal/adverse effects	0.7446808510638299	32567084
colitis/chemically induced	immunosuppressive agents/pharmacology	0.7446808510638299	32414860
immune checkpoint inhibitors/administration & dosage	dose-response relationship drug	0.08373369938229239	32540858
colitis/chemically induced	immune checkpoint inhibitors/therapeutic use	0.9368565545641729	32130969
neoplasms/drug therapy	IL22	0.240219629375429	35236743
colitis/chemically induced	programmed cell death 1 receptor/antagonists & inhibitors	0.9759540087242369	32540858
colitis/chemically induced	programmed cell death 1 receptor/antagonists & inhibitors	0.9759540087242369	32567084
colitis/chemically induced	programmed cell death 1 receptor/antagonists & inhibitors	0.9759540087242369	32702598
colitis/chemically induced	programmed cell death 1 receptor/antagonists & inhibitors	0.9759540087242369	33506015
immune checkpoint inhibitors/administration & dosage	programmed cell death 1 receptor/antagonists & inhibitors	0.3036385297135498	32540858
colitis/chemically induced	drug-related side effects and adverse reactions	0.5525051475634866	32162824
colitis/chemically induced	drug-related side effects and adverse reactions	0.5525051475634866	32418993
immune checkpoint inhibitors/administration & dosage	drug-related side effects and adverse reactions	0.08373369938229239	32418993
colitis/chemically induced	gastrointestinal neoplasms/drug therapy	0.7446808510638299	36159840
immune checkpoint inhibitors/administration & dosage	melanoma/complications	0.12357136462654053	32418993
colitis	inflammatory bowel diseases/drug therapy	0.12357136462654053	33314269
immune checkpoint inhibitors/administration & dosage	cell line tumor	0.08373369938229239	33495297
colitis/chemically induced	melanoma/complications	0.8407687028140014	32418993
colitis/chemically induced	melanoma/complications	0.8407687028140014	32567084
colitis/chemically induced	cell line tumor	0.9368565545641729	33495297
colitis/chemically induced	adenocarcinoma of lung/drug therapy	0.7446808510638299	32389505
colitis	recurrence	0.08373369938229239	35842365
immune checkpoint inhibitors/administration & dosage	poly(adp-ribose) polymerase inhibitors/administration & dosage	0.0425531914893617	33495297
colitis/chemically induced	trinitrobenzenesulfonic acid/adverse effects	0.7446808510638299	33506015
immune checkpoint inhibitors/administration & dosage	infliximab/administration & dosage	0.0425531914893617	32418993
colitis/chemically induced	ctla-4 antigen/antagonists & inhibitors	0.8407687028140014	32567084
colitis/chemically induced	ctla-4 antigen/antagonists & inhibitors	0.8407687028140014	32702598
colitis/chemically induced	t-lymphocyte subsets/immunology	0.7446808510638299	34777387
colitis/chemically induced	mucositis/chemically induced	0.7446808510638299	32414860
tongue neoplasms/drug therapy	paclitaxel/therapeutic use	0.010638297872340427	33476895
colitis/chemically induced	poly(adp-ribose) polymerase inhibitors/administration & dosage	0.7446808510638299	33495297
colitis/chemically induced	gastritis/complications	0.7446808510638299	36377339
immune checkpoint inhibitors/administration & dosage	drugs investigational/administration & dosage	0.0425531914893617	32540858
colitis/chemically induced	infliximab/administration & dosage	0.7446808510638299	32418993
colitis/chemically induced	biological products/therapeutic use	0.7446808510638299	34380976
colitis/chemically induced	enterocolitis/chemically induced	0.9368565545641729	36377339
feces	diarrhea/chemically induced	0.1595744680851064	33290513
immune checkpoint inhibitors/administration & dosage	piperazines/administration & dosage	0.0425531914893617	33495297
colitis/chemically induced	lung neoplasms	0.7446808510638299	31864555
colitis/chemically induced	cd8-positive t-lymphocytes	0.7446808510638299	34106395
immune checkpoint inhibitors/administration & dosage	ACAD8	0.08373369938229239	32418993
immune checkpoint inhibitors/administration & dosage	APC	0.0013726835964310226	33495297
immune checkpoint inhibitors/administration & dosage	APC	0.0013726835964310226	33462141
colitis/chemically induced	beclomethasone/adverse effects	0.7446808510638299	36113896
immune checkpoint inhibitors/administration & dosage	ARG1	0.0425531914893617	33495297
colitis/chemically induced	hepatitis/diagnosis	0.7446808510638299	32185493
colitis/chemically induced	antineoplastic agents immunological/adverse effects	0.7508879831259971	32422528
colitis/chemically induced	antineoplastic agents immunological/adverse effects	0.7508879831259971	32702598
colitis/chemically induced	antineoplastic agents immunological/adverse effects	0.7508879831259971	32567084
colitis/chemically induced	antineoplastic agents immunological/adverse effects	0.7508879831259971	36338892
colitis/chemically induced	antineoplastic agents immunological/adverse effects	0.7508879831259971	32434876
immune checkpoint inhibitors/administration & dosage	CD274	0.11831935782280446	32540858
immune checkpoint inhibitors/administration & dosage	CD274	0.11831935782280446	33462141
colitis/chemically induced	ipilimumab/therapeutic use	0.40837336993822926	35124713
colitis/chemically induced	ipilimumab/therapeutic use	0.40837336993822926	32130969
colitis/chemically induced	ipilimumab/therapeutic use	0.40837336993822926	35277350
axitinib/administration & dosage	colitis/chemically induced	0.7446808510638299	32130969
tongue neoplasms/drug therapy	colitis ulcerative/chemically induced	0.010638297872340427	33476895
feces	colitis/chemically induced	0.7446808510638299	33290513
immune checkpoint inhibitors/administration & dosage	CD8A	0.19933589134746965	33462141
colitis	inflammatory bowel diseases	0.08373369938229239	35842365
colitis/chemically induced	drugs investigational/administration & dosage	0.7446808510638299	32540858
colitis/chemically induced	biomarkers/analysis	0.9368565545641729	26448188
immune checkpoint inhibitors/administration & dosage	CRP	0.0425531914893617	32418993
axitinib/administration & dosage	hypophysitis/chemically induced	0.010638297872340427	32130969
colitis/chemically induced	cytomegalovirus infections/complications	0.7446808510638299	35307927
colitis/chemically induced	butyrates/metabolism	0.7446808510638299	33741313
colitis/chemically induced	inflammatory bowel diseases/complications	0.9368565545641729	34158318
immune checkpoint inhibitors/administration & dosage	IL17A	0.08373369938229239	33462141
colitis	ligands	0.0425531914893617	35432346
axitinib/administration & dosage	angiogenesis inhibitors/therapeutic use	0.010638297872340427	32130969
colitis/chemically induced	rna	0.7446808510638299	35977003
colitis/chemically induced	steroids/therapeutic use	0.5525051475634866	33290513
colitis/chemically induced	steroids/therapeutic use	0.5525051475634866	31864555
colitis/chemically induced	piperazines/administration & dosage	0.7446808510638299	33495297
immune checkpoint inhibitors/administration & dosage	MIR15B	0.0425531914893617	33462141
colitis/chemically induced	inflammation	0.7446808510638299	32888202
immune checkpoint inhibitors/administration & dosage	NRF1	0.0425531914893617	33462141
immune checkpoint inhibitors/administration & dosage	PARP1	0.0425531914893617	33495297
colitis/chemically induced	prednisone/therapeutic use	0.7446808510638299	34956219
tongue neoplasms/drug therapy	programmed cell death 1 receptor/antagonists & inhibitors	0.08510638297872342	33476895
immune checkpoint inhibitors/administration & dosage	PDCD1	0.05618952084291824	33495297
immune checkpoint inhibitors/administration & dosage	PDCD1	0.05618952084291824	32540858
immune checkpoint inhibitors/administration & dosage	PDCD1	0.05618952084291824	33462141
colitis/chemically induced	ACAD8	0.5525051475634866	32418993
colitis/chemically induced	ACAD8	0.5525051475634866	33506015
immune checkpoint inhibitors/administration & dosage	TIPARP	0.0425531914893617	33495297
colitis/chemically induced	AHR	0.7446808510638299	35236743
axitinib/administration & dosage	myocarditis/chemically induced	0.010638297872340427	32130969
colitis/chemically induced	APC	0.5525051475634866	33495297
colitis/chemically induced	APC	0.5525051475634866	33462141
colitis/chemically induced	ARG1	0.7446808510638299	33495297
colitis/chemically induced	BTLA	0.7446808510638299	36159840
colitis/chemically induced	CD274	0.6776529551092445	36159840
colitis/chemically induced	CD274	0.6776529551092445	32389505
colitis/chemically induced	CD274	0.6776529551092445	34992611
colitis/chemically induced	CD274	0.6776529551092445	32702598
colitis/chemically induced	CD274	0.6776529551092445	33555016
colitis/chemically induced	CD274	0.6776529551092445	33173388
colitis/chemically induced	CD274	0.6776529551092445	34158318
colitis/chemically induced	CD274	0.6776529551092445	35917654
colitis/chemically induced	CD274	0.6776529551092445	32540858
colitis/chemically induced	CD274	0.6776529551092445	32934876
colitis/chemically induced	CD274	0.6776529551092445	33462141
colitis/chemically induced	CD28	0.7446808510638299	36159840
colitis/chemically induced	CD4	0.9368565545641729	33555016
colitis/chemically induced	CD68	0.9368565545641729	33555016
colitis/chemically induced	CD8A	0.9856748147757071	33555016
colitis/chemically induced	CD8A	0.9856748147757071	33462141
axitinib/administration & dosage	hepatitis autoimmune/etiology	0.010638297872340427	32130969
colitis/chemically induced	CHI3L1	0.7446808510638299	36096534
dysbiosis/etiology	neoplasms/complications	0.031914893617021274	34162429
colitis/chemically induced	CRP	0.7446808510638299	32418993
colitis/chemically induced	CSF2	0.7446808510638299	36159840
dextran sulfate/adverse effects	cell line tumor	0.02127659574468085	33495297
feces	dose-response relationship drug	0.02127659574468085	33290513
colitis/chemically induced	CTLA4	0.8460030101172487	34992611
colitis/chemically induced	CTLA4	0.8460030101172487	32702598
colitis/chemically induced	CTLA4	0.8460030101172487	33555016
colitis/chemically induced	CTLA4	0.8460030101172487	35977003
colitis/chemically induced	CTLA4	0.8460030101172487	32567084
colitis/chemically induced	CTLA4	0.8460030101172487	35917654
colitis/chemically induced	CTLA4	0.8460030101172487	35191192
colitis/chemically induced	CTLA4	0.8460030101172487	32934876
colitis/chemically induced	CXCL10	0.7446808510638299	35977003
tongue neoplasms/drug therapy	antineoplastic agents immunological/adverse effects	0.07446808510638298	33476895
colitis/chemically induced	CXCL8	0.7446808510638299	36096534
dextran sulfate/adverse effects	poly(adp-ribose) polymerase inhibitors/administration & dosage	0.010638297872340427	33495297
axitinib/administration & dosage	myasthenia gravis/chemically induced	0.010638297872340427	32130969
colitis/chemically induced	CXCL9	0.7446808510638299	35977003
colitis/chemically induced	HAVCR2	0.7446808510638299	36159840
colitis/chemically induced	IL15	0.7446808510638299	36159840
axitinib/administration & dosage	immune checkpoint inhibitors/therapeutic use	0.02127659574468085	32130969
colitis/chemically induced	IL17A	0.5525051475634866	33462141
colitis/chemically induced	IL17A	0.5525051475634866	36096534
colitis/chemically induced	IL17C	0.7446808510638299	36159840
colitis/chemically induced	IL21	0.7446808510638299	36159840
colitis/chemically induced	IL22	0.5525051475634866	36159840
colitis/chemically induced	IL22	0.5525051475634866	35236743
colitis/chemically induced	IL4	0.7446808510638299	36159840
colitis/chemically induced	IL6	0.5525051475634866	36159840
colitis/chemically induced	IL6	0.5525051475634866	36096534
colitis/chemically induced	LIF	0.7446808510638299	36159840
dextran sulfate/adverse effects	piperazines/administration & dosage	0.010638297872340427	33495297
colitis/chemically induced	LTF	0.7446808510638299	32584703
colitis/chemically induced	MIR15B	0.7446808510638299	33462141
dextran sulfate/adverse effects	APC	0.02127659574468085	33495297
dysbiosis/etiology	colitis/etiology	0.02127659574468085	34162429
dextran sulfate/adverse effects	ARG1	0.010638297872340427	33495297
colitis/chemically induced	NRF1	0.7446808510638299	33462141
colitis/chemically induced	PARP1	0.7446808510638299	33495297
colitis/chemically induced	PDCD1	0.9497845874787667	36159840
colitis/chemically induced	PDCD1	0.9497845874787667	33495297
colitis/chemically induced	PDCD1	0.9497845874787667	35801666
colitis/chemically induced	PDCD1	0.9497845874787667	34992611
colitis/chemically induced	PDCD1	0.9497845874787667	32702598
colitis/chemically induced	PDCD1	0.9497845874787667	33555016
colitis/chemically induced	PDCD1	0.9497845874787667	33906378
colitis/chemically induced	PDCD1	0.9497845874787667	35977003
colitis/chemically induced	PDCD1	0.9497845874787667	33173388
colitis/chemically induced	PDCD1	0.9497845874787667	32567084
colitis/chemically induced	PDCD1	0.9497845874787667	34158318
colitis/chemically induced	PDCD1	0.9497845874787667	35917654
colitis/chemically induced	PDCD1	0.9497845874787667	35191192
colitis/chemically induced	PDCD1	0.9497845874787667	32540858
colitis/chemically induced	PDCD1	0.9497845874787667	33462141
colitis/chemically induced	PDCD1	0.9497845874787667	33506015
colitis/chemically induced	SNCA	0.8407687028140014	32934876
colitis/chemically induced	SNCA	0.8407687028140014	32641348
colitis/chemically induced	TCIM	0.7446808510638299	35977003
colitis/chemically induced	TIPARP	0.7446808510638299	33495297
colitis/chemically induced	TNF	0.40837336993822926	32162824
colitis/chemically induced	TNF	0.40837336993822926	35977003
colitis/chemically induced	TNF	0.40837336993822926	32641348
colitis/chemically induced	antineoplastic agents/adverse effects	0.7446808510638299	26448188
axitinib/administration & dosage	ipilimumab/therapeutic use	0.031914893617021274	32130969
colitis/chemically induced	intestinal mucosa/chemistry	0.7446808510638299	26448188
colitis/chemically induced	leukemia lymphocytic chronic b-cell/drug therapy	0.7446808510638299	26448188
colitis/chemically induced	class i phosphatidylinositol 3-kinases/antagonists & inhibitors	0.7446808510638299	26448188
colitis/chemically induced	purines/adverse effects	0.7446808510638299	26448188
dextran sulfate/adverse effects	PARP1	0.010638297872340427	33495297
feces	steroids/therapeutic use	0.02127659574468085	33290513
dextran sulfate/adverse effects	PDCD1	0.2659574468085107	33495297
colitis/chemically induced	colon/chemistry	0.7446808510638299	26448188
colitis/chemically induced	lymphocytosis/chemically induced	0.7446808510638299	26448188
dextran sulfate/adverse effects	TIPARP	0.010638297872340427	33495297
dysbiosis/etiology	antineoplastic agents immunological/adverse effects	0.07446808510638298	34162429
colitis/chemically induced	protein kinase inhibitors/adverse effects	0.7446808510638299	26448188
colitis/chemically induced	apoptosis/drug effects	0.7446808510638299	26448188
colitis/chemically induced	quinazolinones/adverse effects	0.7446808510638299	26448188
tongue neoplasms/drug therapy	SNCA	0.031914893617021274	33476895
colitis/chemically induced	lymphoma non-hodgkin/drug therapy	0.7446808510638299	26448188
colitis/chemically induced	PIK3CD	0.7446808510638299	26448188
dysbiosis/etiology	anti-bacterial agents/pharmacology	0.010638297872340427	34162429
phthalazines/administration & dosage	dextran sulfate/adverse effects	0.010638297872340427	33495297
adrenal insufficiency/chemically induced	axitinib/administration & dosage	0.010638297872340427	32130969
phthalazines/administration & dosage	colonic neoplasms/drug therapy	0.010638297872340427	33495297
clostridium infections/chemically induced	colitis/chemically induced	0.7446808510638299	34107499
cytomegalovirus infections/diagnosis	antineoplastic agents immunological/adverse effects	0.07446808510638298	32434876
clostridium infections/chemically induced	anti-bacterial agents/adverse effects	0.010638297872340427	34107499
adrenal insufficiency/chemically induced	colitis/chemically induced	0.7446808510638299	32130969
adrenal insufficiency/chemically induced	hypophysitis/chemically induced	0.010638297872340427	32130969
phthalazines/administration & dosage	cell line tumor	0.02127659574468085	33495297
adrenal insufficiency/chemically induced	angiogenesis inhibitors/therapeutic use	0.010638297872340427	32130969
phthalazines/administration & dosage	poly(adp-ribose) polymerase inhibitors/administration & dosage	0.010638297872340427	33495297
tumor microenvironment/drug effects	immune checkpoint inhibitors/administration & dosage	0.0425531914893617	33462141
adrenal insufficiency/chemically induced	myocarditis/chemically induced	0.010638297872340427	32130969
tumor microenvironment/drug effects	ht29 cells	0.010638297872340427	33462141
tumor microenvironment/drug effects	colitis/chemically induced	0.7446808510638299	33462141
adrenal insufficiency/chemically induced	hepatitis autoimmune/etiology	0.010638297872340427	32130969
phthalazines/administration & dosage	piperazines/administration & dosage	0.010638297872340427	33495297
adrenal insufficiency/chemically induced	myasthenia gravis/chemically induced	0.010638297872340427	32130969
tumor microenvironment/drug effects	colorectal neoplasms/drug therapy	0.010638297872340427	33462141
paclitaxel/therapeutic use	colitis ulcerative/chemically induced	0.010638297872340427	33476895
phthalazines/administration & dosage	APC	0.02127659574468085	33495297
adrenal insufficiency/chemically induced	immune checkpoint inhibitors/therapeutic use	0.02127659574468085	32130969
phthalazines/administration & dosage	ARG1	0.010638297872340427	33495297
tumor microenvironment/drug effects	b7-h1 antigen/genetics	0.010638297872340427	33462141
paclitaxel/therapeutic use	programmed cell death 1 receptor/antagonists & inhibitors	0.08510638297872342	33476895
paclitaxel/therapeutic use	antineoplastic agents immunological/adverse effects	0.07446808510638298	33476895
phthalazines/administration & dosage	PARP1	0.010638297872340427	33495297
adrenal insufficiency/chemically induced	ipilimumab/therapeutic use	0.031914893617021274	32130969
phthalazines/administration & dosage	PDCD1	0.2659574468085107	33495297
phthalazines/administration & dosage	TIPARP	0.010638297872340427	33495297
colitis microscopic/chemically induced	inflammatory bowel diseases/complications	0.04232441088995653	32401685
growth inhibitors/therapeutic use	phosphatidylinositol 3-kinases/metabolism	0.010638297872340427	34987517
growth inhibitors/therapeutic use	antineoplastic agents immunological/therapeutic use	0.031914893617021274	34987517
growth inhibitors/therapeutic use	lymphocytes tumor-infiltrating/immunology	0.010638297872340427	34987517
paclitaxel/therapeutic use	SNCA	0.031914893617021274	33476895
growth inhibitors/therapeutic use	colitis/etiology	0.02127659574468085	34987517
growth inhibitors/therapeutic use	immune checkpoint inhibitors/therapeutic use	0.02127659574468085	34987517
growth inhibitors/therapeutic use	programmed cell death 1 receptor/antagonists & inhibitors	0.08510638297872342	34987517
growth inhibitors/therapeutic use	cell line tumor	0.02127659574468085	34987517
endometrial neoplasms/drug therapy	antibodies monoclonal humanized	0.010638297872340427	35801666
tumor microenvironment/drug effects	APC	0.02127659574468085	33462141
tumor microenvironment/drug effects	CD274	0.1595744680851064	33462141
colitis microscopic/chemically induced	PDCD1	0.4632807137954702	32401685
growth inhibitors/therapeutic use	cd8-positive t-lymphocytes/immunology	0.010638297872340427	34987517
tumor microenvironment/drug effects	CD8A	0.05319148936170214	33462141
neoplasms/complications	colitis/etiology	0.06314344543582703	34162429
neoplasms/complications	programmed cell death 1 receptor/antagonists & inhibitors	0.23651935185461492	32960847
growth inhibitors/therapeutic use	cytotoxicity immunologic	0.010638297872340427	34987517
tumor microenvironment/drug effects	IL17A	0.02127659574468085	33462141
growth inhibitors/therapeutic use	CD8A	0.05319148936170214	34987517
colitis/drug therapy	diarrhea/chemically induced	0.4100519232490824	33436487
tumor microenvironment/drug effects	MIR15B	0.010638297872340427	33462141
tumor microenvironment/drug effects	NRF1	0.010638297872340427	33462141
tumor microenvironment/drug effects	PDCD1	0.2659574468085107	33462141
growth inhibitors/therapeutic use	MTOR	0.010638297872340427	34987517
growth inhibitors/therapeutic use	PDCD1	0.2659574468085107	34987517
colitis/drug therapy	neoplasms/therapy	0.031914893617021274	32780984
neoplasms/complications	antineoplastic agents immunological/adverse effects	0.20925218584942262	34162429
carcinoma non-small-cell lung/drug therapy	colitis/chemically induced	0.5525051475634867	35124713
carcinoma non-small-cell lung/drug therapy	colitis/chemically induced	0.5525051475634867	34992611
colitis/drug therapy	receptors antigen t-cell/genetics	0.031914893617021274	32603654
neoplasms/complications	inflammatory bowel diseases/complications	0.06314344543582703	34158318
neoplasms/complications	anti-bacterial agents/pharmacology	0.031914893617021274	34162429
ht29 cells	colitis/chemically induced	0.7446808510638299	33462141
colitis/drug therapy	t-lymphocytes regulatory/cytology	0.031914893617021274	32603654
endometrial neoplasms/drug therapy	PDCD1	0.2659574468085107	35801666
neoplasms/complications	CD274	0.06527707319984483	34158318
neoplasms/complications	CD274	0.06527707319984483	32960847
ht29 cells	colorectal neoplasms/drug therapy	0.010638297872340427	33462141
ht29 cells	b7-h1 antigen/genetics	0.010638297872340427	33462141
colitis/drug therapy	feces/chemistry	0.031914893617021274	33436487
b7-h1 antigen/antagonists & inhibitors	colitis/chemically induced	0.8407687028140014	32389505
b7-h1 antigen/antagonists & inhibitors	colitis/chemically induced	0.8407687028140014	32702598
b7-h1 antigen/antagonists & inhibitors	neoplasms/complications	0.09369311569335442	32960847
vitamin d/administration & dosage	programmed cell death 1 receptor/antagonists & inhibitors	0.08510638297872342	32567084
receptors antigen t-cell/genetics	t-lymphocytes regulatory/cytology	0.010638297872340427	32603654
vitamin d/administration & dosage	melanoma/complications	0.031914893617021274	32567084
vitamin d/administration & dosage	ctla-4 antigen/antagonists & inhibitors	0.031914893617021274	32567084
b7-h1 antigen/antagonists & inhibitors	biomarkers/metabolism	0.031914893617021274	32389505
colitis/drug therapy	leukocyte l1 antigen complex/analysis	0.031914893617021274	33436487
neoplasms/complications	PDCD1	0.17158544955387783	34158318
neoplasms/complications	PDCD1	0.17158544955387783	32960847
vitamin d/administration & dosage	antineoplastic agents immunological/adverse effects	0.07446808510638298	32567084
colitis/drug therapy	chemokines/metabolism	0.031914893617021274	32603654
receptors antigen t-cell/genetics	chemokines/metabolism	0.010638297872340427	32603654
colitis/drug therapy	multigene family	0.031914893617021274	32603654
receptors antigen t-cell/genetics	multigene family	0.010638297872340427	32603654
vitamin d/administration & dosage	CTLA4	0.1276595744680851	32567084
carcinoma non-small-cell lung/drug therapy	ipilimumab/therapeutic use	0.06314344543582705	35124713
colitis/drug therapy	biomarkers/analysis	0.06314344543582703	33436487
b7-h1 antigen/antagonists & inhibitors	programmed cell death 1 receptor/antagonists & inhibitors	0.01838202381307631	32702598
b7-h1 antigen/antagonists & inhibitors	programmed cell death 1 receptor/antagonists & inhibitors	0.01838202381307631	32960847
vitamin d/administration & dosage	PDCD1	0.2659574468085107	32567084
abdominal pain/chemically induced	antineoplastic agents immunological/therapeutic use	0.031914893617021274	36377339
receptors antigen t-cell/genetics	CTLA4	0.1276595744680851	32603654
b7-h1 antigen/antagonists & inhibitors	adenocarcinoma of lung/drug therapy	0.031914893617021274	32389505
b7-h1 antigen/antagonists & inhibitors	ctla-4 antigen/antagonists & inhibitors	0.09369311569335442	32702598
carcinoma non-small-cell lung/drug therapy	CD274	0.2951269732326699	34992611
receptors antigen t-cell/genetics	PDCD1	0.2659574468085107	32603654
carcinoma non-small-cell lung/drug therapy	CTLA4	0.240219629375429	34992611
colitis/drug therapy	CTLA4	0.33932141684819905	32603654
b7-h1 antigen/antagonists & inhibitors	antineoplastic agents immunological/adverse effects	0.20925218584942262	32702598
carcinoma non-small-cell lung/complications	drug-related side effects and adverse reactions	0.02127659574468085	32418993
angiogenesis inhibitors/therapeutic use	myocarditis/chemically induced	0.010638297872340427	32130969
carcinoma non-small-cell lung/complications	melanoma/complications	0.031914893617021274	32418993
abdominal pain/chemically induced	gastritis/complications	0.010638297872340427	36377339
carcinoma non-small-cell lung/drug therapy	PDCD1	0.4632807137954702	34992611
colitis/drug therapy	PDCD1	0.6091283459162664	32603654
angiogenesis inhibitors/therapeutic use	hepatitis autoimmune/etiology	0.010638297872340427	32130969
abdominal pain/chemically induced	enterocolitis/chemically induced	0.02127659574468085	36377339
carcinoma non-small-cell lung/complications	infliximab/administration & dosage	0.010638297872340427	32418993
angiogenesis inhibitors/therapeutic use	myasthenia gravis/chemically induced	0.010638297872340427	32130969
angiogenesis inhibitors/therapeutic use	immune checkpoint inhibitors/therapeutic use	0.02127659574468085	32130969
b7-h1 antigen/antagonists & inhibitors	CD274	0.0033944078063919306	32389505
b7-h1 antigen/antagonists & inhibitors	CD274	0.0033944078063919306	32702598
b7-h1 antigen/antagonists & inhibitors	CD274	0.0033944078063919306	32960847
recurrence	diarrhea/chemically induced	0.2951269732326699	26448188
b7-h1 antigen/antagonists & inhibitors	CTLA4	0.33932141684819905	32702598
carcinoma non-small-cell lung/complications	ACAD8	0.02127659574468085	32418993
carcinoma non-small-cell lung/complications	CRP	0.010638297872340427	32418993
angiogenesis inhibitors/therapeutic use	ipilimumab/therapeutic use	0.031914893617021274	32130969
recurrence	colitis/chemically induced	0.9368565545641729	26448188
azoxymethane/adverse effects	immune checkpoint inhibitors/administration & dosage	0.0425531914893617	33495297
b7-h1 antigen/antagonists & inhibitors	PDCD1	0.17158544955387783	32702598
b7-h1 antigen/antagonists & inhibitors	PDCD1	0.17158544955387783	32960847
azoxymethane/adverse effects	colitis/chemically induced	0.7446808510638299	33495297
azoxymethane/adverse effects	phthalazines/administration & dosage	0.010638297872340427	33495297
azoxymethane/adverse effects	dextran sulfate/adverse effects	0.010638297872340427	33495297
melanoma/immunology	immunocompromised host	0.010638297872340427	34956219
inflammatory bowel diseases/drug therapy	proton pump inhibitors/adverse effects	0.031914893617021274	35277350
recurrence	inflammatory bowel diseases	0.04232441088995653	35842365
hypophysitis/chemically induced	angiogenesis inhibitors/therapeutic use	0.010638297872340427	32130969
inflammatory bowel diseases/drug therapy	colitis/chemically induced	0.8407687028140014	33555016
inflammatory bowel diseases/drug therapy	colitis/chemically induced	0.8407687028140014	35277350
hypophysitis/chemically induced	myocarditis/chemically induced	0.010638297872340427	32130969
melanoma/immunology	prednisone/therapeutic use	0.010638297872340427	34956219
hypophysitis/chemically induced	hepatitis autoimmune/etiology	0.010638297872340427	32130969
biomarkers/metabolism	adenocarcinoma of lung/drug therapy	0.010638297872340427	32389505
recurrence	biomarkers/analysis	0.04232441088995653	26448188
hypophysitis/chemically induced	myasthenia gravis/chemically induced	0.010638297872340427	32130969
melanoma/drug therapy	SNCA	0.1527856524723225	32641348
hypophysitis/chemically induced	immune checkpoint inhibitors/therapeutic use	0.02127659574468085	32130969
melanoma/drug therapy	TNF	0.0067142132434126105	32162824
melanoma/drug therapy	TNF	0.0067142132434126105	32641348
antineoplastic agents immunological/therapeutic use	lymphocytes tumor-infiltrating/immunology	0.031914893617021274	34987517
biomarkers/metabolism	CD274	0.1595744680851064	32389505
antineoplastic agents immunological/therapeutic use	colitis/etiology	0.06314344543582703	34987517
hypophysitis/chemically induced	ipilimumab/therapeutic use	0.031914893617021274	32130969
antineoplastic agents immunological/therapeutic use	immune checkpoint inhibitors/therapeutic use	0.06314344543582703	34987517
antineoplastic agents immunological/therapeutic use	programmed cell death 1 receptor/antagonists & inhibitors	0.23651935185461492	34987517
antineoplastic agents immunological/therapeutic use	gastrointestinal neoplasms/drug therapy	0.031914893617021274	36159840
antineoplastic agents immunological/therapeutic use	cell line tumor	0.06314344543582703	34987517
inflammatory bowel diseases/drug therapy	ipilimumab/therapeutic use	0.09369311569335442	35277350
recurrence	antineoplastic agents/adverse effects	0.02127659574468085	26448188
recurrence	intestinal mucosa/chemistry	0.02127659574468085	26448188
recurrence	leukemia lymphocytic chronic b-cell/drug therapy	0.02127659574468085	26448188
recurrence	class i phosphatidylinositol 3-kinases/antagonists & inhibitors	0.02127659574468085	26448188
antineoplastic agents immunological/therapeutic use	gastritis/complications	0.031914893617021274	36377339
recurrence	purines/adverse effects	0.02127659574468085	26448188
recurrence	colon/chemistry	0.02127659574468085	26448188
antineoplastic agents immunological/therapeutic use	enterocolitis/chemically induced	0.06314344543582703	36377339
recurrence	lymphocytosis/chemically induced	0.02127659574468085	26448188
recurrence	protein kinase inhibitors/adverse effects	0.02127659574468085	26448188
recurrence	apoptosis/drug effects	0.02127659574468085	26448188
recurrence	quinazolinones/adverse effects	0.02127659574468085	26448188
antineoplastic agents immunological/therapeutic use	cd8-positive t-lymphocytes/immunology	0.031914893617021274	34987517
b7-h1 antigen/genetics	APC	0.02127659574468085	33462141
recurrence	lymphoma non-hodgkin/drug therapy	0.02127659574468085	26448188
b7-h1 antigen/genetics	CD274	0.1595744680851064	33462141
recurrence	PIK3CD	0.02127659574468085	26448188
b7-h1 antigen/genetics	CD8A	0.05319148936170214	33462141
inflammatory bowel diseases/drug therapy	CD274	0.06527707319984483	33555016
inflammatory bowel diseases/drug therapy	CD274	0.06527707319984483	33314269
inflammatory bowel diseases/drug therapy	CD4	0.06314344543582703	33555016
inflammatory bowel diseases/drug therapy	CD68	0.06314344543582703	33555016
b7-h1 antigen/genetics	IL17A	0.02127659574468085	33462141
inflammatory bowel diseases/drug therapy	CD8A	0.1527856524723225	33555016
b7-h1 antigen/genetics	MIR15B	0.010638297872340427	33462141
inflammatory bowel diseases/drug therapy	CTLA4	0.042016054429888705	33555016
inflammatory bowel diseases/drug therapy	CTLA4	0.042016054429888705	33314269
b7-h1 antigen/genetics	NRF1	0.010638297872340427	33462141
antineoplastic agents immunological/therapeutic use	cytotoxicity immunologic	0.031914893617021274	34987517
b7-h1 antigen/genetics	PDCD1	0.2659574468085107	33462141
antineoplastic agents immunological/therapeutic use	BTLA	0.031914893617021274	36159840
colitis/diagnostic imaging	pneumonia/diagnostic imaging	0.010638297872340427	33375984
antineoplastic agents immunological/therapeutic use	CD274	0.4100519232490824	36159840
antineoplastic agents immunological/therapeutic use	CD28	0.031914893617021274	36159840
antineoplastic agents immunological/therapeutic use	CD8A	0.1527856524723225	34987517
antineoplastic agents immunological/therapeutic use	CSF2	0.031914893617021274	36159840
inflammatory bowel diseases/drug therapy	PDCD1	0.17158544955387783	33555016
inflammatory bowel diseases/drug therapy	PDCD1	0.17158544955387783	33314269
antineoplastic agents immunological/therapeutic use	HAVCR2	0.031914893617021274	36159840
antineoplastic agents immunological/therapeutic use	IL15	0.031914893617021274	36159840
myocarditis/chemically induced	hepatitis autoimmune/etiology	0.010638297872340427	32130969
antineoplastic agents immunological/therapeutic use	IL17C	0.031914893617021274	36159840
antineoplastic agents immunological/therapeutic use	IL21	0.031914893617021274	36159840
antineoplastic agents immunological/therapeutic use	IL22	0.06314344543582703	36159840
myocarditis/chemically induced	myasthenia gravis/chemically induced	0.010638297872340427	32130969
antineoplastic agents immunological/therapeutic use	IL4	0.031914893617021274	36159840
antineoplastic agents immunological/therapeutic use	IL6	0.06314344543582703	36159840
myocarditis/chemically induced	immune checkpoint inhibitors/therapeutic use	0.02127659574468085	32130969
antineoplastic agents immunological/therapeutic use	LIF	0.031914893617021274	36159840
antibodies monoclonal humanized/therapeutic use	steroids/adverse effects	0.010638297872340427	33454238
antineoplastic agents immunological/therapeutic use	MTOR	0.031914893617021274	34987517
antineoplastic agents immunological/therapeutic use	PDCD1	0.17158544955387783	36159840
antineoplastic agents immunological/therapeutic use	PDCD1	0.17158544955387783	34987517
myocarditis/chemically induced	ipilimumab/therapeutic use	0.031914893617021274	32130969
antibodies monoclonal humanized/therapeutic use	colitis/chemically induced	0.7446808510638299	33454238
crohn disease/physiopathology	enterocolitis/chemically induced	0.02127659574468085	34821404
crohn disease/immunology	graft vs host disease/immunology	0.010638297872340427	34338882
crohn disease/immunology	cd8-positive t-lymphocytes/drug effects	0.02127659574468085	34338882
crohn disease/immunology	phenotype	0.02127659574468085	34338882
dermatitis	rna	0.010638297872340427	35977003
crohn disease/immunology	CD4	0.02127659574468085	34338882
crohn disease/immunology	CD68	0.02127659574468085	34338882
dermatitis	CTLA4	0.1276595744680851	35977003
crohn disease/immunology	CD8A	0.05319148936170214	34338882
dermatitis	CXCL10	0.010638297872340427	35977003
dermatitis	CXCL9	0.010638297872340427	35977003
antibodies monoclonal/adverse effects	CTLA4	0.1276595744680851	32567084
dermatitis	PDCD1	0.2659574468085107	35977003
dermatitis	TCIM	0.010638297872340427	35977003
dermatitis	TNF	0.031914893617021274	35977003
antibodies monoclonal/adverse effects	PDCD1	0.2659574468085107	32567084
colorectal neoplasms/drug therapy	b7-h1 antigen/genetics	0.010638297872340427	33462141
diarrhea/chemically induced	ipilimumab/adverse effects	0.4386048484497356	31595568
diarrhea/chemically induced	ipilimumab/adverse effects	0.4386048484497356	35917654
antibodies monoclonal humanized	PDCD1	0.2659574468085107	35801666
colitis/etiology	immune checkpoint inhibitors/therapeutic use	0.04232441088995653	34987517
colitis/etiology	programmed cell death 1 receptor/antagonists & inhibitors	0.1638069091741021	34987517
multigene family	CTLA4	0.1276595744680851	32603654
immune checkpoint inhibitors/pharmacology	inflammatory bowel diseases	0.08373369938229239	32298485
colitis/etiology	cell line tumor	0.04232441088995653	34987517
glucocorticoids/pharmacology	melanoma/drug therapy	0.05319148936170214	32414860
immune checkpoint inhibitors/pharmacology	programmed cell death 1 receptor/antagonists & inhibitors	0.3036385297135498	33506015
multigene family	PDCD1	0.2659574468085107	32603654
immune checkpoint inhibitors/pharmacology	melanoma/complications	0.12357136462654053	32404733
colitis/etiology	cd8-positive t-lymphocytes/immunology	0.02127659574468085	34987517
immune checkpoint inhibitors/pharmacology	trinitrobenzenesulfonic acid/adverse effects	0.0425531914893617	33506015
glucocorticoids/pharmacology	immunosuppressive agents/pharmacology	0.010638297872340427	32414860
colitis/etiology	antineoplastic agents immunological/adverse effects	0.14413177762525742	34162429
colorectal neoplasms/drug therapy	APC	0.02127659574468085	33462141
t-lymphocytes regulatory/cytology	chemokines/metabolism	0.010638297872340427	32603654
colorectal neoplasms/drug therapy	CD274	0.1595744680851064	33462141
t-lymphocytes regulatory/cytology	multigene family	0.010638297872340427	32603654
colorectal neoplasms/drug therapy	CD8A	0.05319148936170214	33462141
immune checkpoint inhibitors/pharmacology	gastrointestinal tract/metabolism	0.0425531914893617	32298485
colorectal neoplasms/drug therapy	IL17A	0.02127659574468085	33462141
colitis/etiology	anti-bacterial agents/pharmacology	0.02127659574468085	34162429
glucocorticoids/pharmacology	mucositis/chemically induced	0.010638297872340427	32414860
colorectal neoplasms/drug therapy	MIR15B	0.010638297872340427	33462141
colitis/etiology	cytotoxicity immunologic	0.02127659574468085	34987517
colorectal neoplasms/drug therapy	NRF1	0.010638297872340427	33462141
colorectal neoplasms/drug therapy	PDCD1	0.2659574468085107	33462141
immune checkpoint inhibitors/pharmacology	b7-h1 antigen/metabolism	0.0425531914893617	32298485
colitis/etiology	CD8A	0.10409517272935258	34987517
t-lymphocytes regulatory/cytology	CTLA4	0.1276595744680851	32603654
poly(adp-ribose) polymerase inhibitors/administration & dosage	piperazines/administration & dosage	0.010638297872340427	33495297
immune checkpoint inhibitors/pharmacology	ACAD8	0.08373369938229239	33506015
immune checkpoint inhibitors/pharmacology	AHR	0.0425531914893617	35236743
t-lymphocytes regulatory/cytology	PDCD1	0.2659574468085107	32603654
immune checkpoint inhibitors/pharmacology	CD274	0.5072961117245084	32298485
poly(adp-ribose) polymerase inhibitors/administration & dosage	APC	0.02127659574468085	33495297
poly(adp-ribose) polymerase inhibitors/administration & dosage	ARG1	0.010638297872340427	33495297
colitis/etiology	MTOR	0.02127659574468085	34987517
colitis/etiology	PDCD1	0.4632807137954702	34987517
immune checkpoint inhibitors/pharmacology	IL22	0.08373369938229239	35236743
immune checkpoint inhibitors/pharmacology	PDCD1	0.05618952084291824	32298485
immune checkpoint inhibitors/pharmacology	PDCD1	0.05618952084291824	32404733
immune checkpoint inhibitors/pharmacology	PDCD1	0.05618952084291824	33506015
poly(adp-ribose) polymerase inhibitors/administration & dosage	PARP1	0.010638297872340427	33495297
poly(adp-ribose) polymerase inhibitors/administration & dosage	PDCD1	0.2659574468085107	33495297
colonic neoplasms/drug therapy	cell line tumor	0.02127659574468085	33495297
poly(adp-ribose) polymerase inhibitors/administration & dosage	TIPARP	0.010638297872340427	33495297
colonic neoplasms/drug therapy	poly(adp-ribose) polymerase inhibitors/administration & dosage	0.010638297872340427	33495297
immunosuppressive agents/pharmacology	mucositis/chemically induced	0.010638297872340427	32414860
gastritis/complications	enterocolitis/chemically induced	0.02127659574468085	36377339
hepatitis autoimmune/etiology	myasthenia gravis/chemically induced	0.010638297872340427	32130969
colonic neoplasms/drug therapy	piperazines/administration & dosage	0.010638297872340427	33495297
hepatitis autoimmune/etiology	immune checkpoint inhibitors/therapeutic use	0.02127659574468085	32130969
colonic neoplasms/drug therapy	APC	0.02127659574468085	33495297
colonic neoplasms/drug therapy	ARG1	0.010638297872340427	33495297
dextran sulfate/adverse effects	colonic neoplasms/drug therapy	0.010638297872340427	33495297
colonic neoplasms/drug therapy	PARP1	0.010638297872340427	33495297
colonic neoplasms/drug therapy	PDCD1	0.2659574468085107	33495297
colonic neoplasms/drug therapy	TIPARP	0.010638297872340427	33495297
hepatitis autoimmune/etiology	ipilimumab/therapeutic use	0.031914893617021274	32130969
intestinal mucosa/immunology	colon/immunology	0.02127659574468085	33459466
b7-h1 antigen/metabolism	PDCD1	0.2659574468085107	32298485
inflammatory bowel diseases/complications	CD274	0.2951269732326699	34158318
immune checkpoint inhibitors/therapeutic use	programmed cell death 1 receptor/antagonists & inhibitors	0.1638069091741021	34987517
immune checkpoint inhibitors/therapeutic use	cell line tumor	0.04232441088995653	34987517
oropharyngeal neoplasms/drug therapy	PDCD1	0.2659574468085107	33906378
infliximab/administration & dosage	ACAD8	0.02127659574468085	32418993
immune checkpoint inhibitors/therapeutic use	cd8-positive t-lymphocytes/immunology	0.02127659574468085	34987517
inflammatory bowel diseases/complications	PDCD1	0.06863417982155114	32401685
inflammatory bowel diseases/complications	PDCD1	0.06863417982155114	34158318
immune checkpoint inhibitors/therapeutic use	ipilimumab/therapeutic use	0.06314344543582705	32130969
infliximab/administration & dosage	CRP	0.010638297872340427	32418993
piperidines/therapeutic use	programmed cell death 1 receptor/antagonists & inhibitors	0.1638069091741021	34147519
vitamin d/administration & dosage	neutrophils/drug effects	0.010638297872340427	32567084
vitamin d/administration & dosage	antibodies monoclonal/adverse effects	0.010638297872340427	32567084
immune checkpoint inhibitors/therapeutic use	cytotoxicity immunologic	0.02127659574468085	34987517
piperidines/therapeutic use	ctla-4 antigen/antagonists & inhibitors	0.06314344543582705	34147519
disease susceptibility	postoperative complications	0.010638297872340427	32028372
immune checkpoint inhibitors/therapeutic use	CD8A	0.10409517272935258	34987517
piperidines/therapeutic use	cd8-positive t-lymphocytes/drug effects	0.04232441088995653	34147519
piperidines/therapeutic use	phenotype	0.04232441088995653	34147519
immune checkpoint inhibitors/therapeutic use	MTOR	0.02127659574468085	34987517
immune checkpoint inhibitors/therapeutic use	PDCD1	0.4632807137954702	34987517
piperidines/therapeutic use	CD8A	0.10409517272935258	34147519
piperidines/therapeutic use	CTLA4	0.240219629375429	34147519
phosphatidylinositol 3-kinases/metabolism	antineoplastic agents immunological/therapeutic use	0.031914893617021274	34987517
rna	CTLA4	0.1276595744680851	35977003
rna	CXCL10	0.010638297872340427	35977003
piperidines/therapeutic use	PDCD1	0.4632807137954702	34147519
phosphatidylinositol 3-kinases/metabolism	lymphocytes tumor-infiltrating/immunology	0.010638297872340427	34987517
rna	CXCL9	0.010638297872340427	35977003
phosphatidylinositol 3-kinases/metabolism	colitis/etiology	0.02127659574468085	34987517
phosphatidylinositol 3-kinases/metabolism	immune checkpoint inhibitors/therapeutic use	0.02127659574468085	34987517
phosphatidylinositol 3-kinases/metabolism	programmed cell death 1 receptor/antagonists & inhibitors	0.08510638297872342	34987517
phosphatidylinositol 3-kinases/metabolism	cell line tumor	0.02127659574468085	34987517
leukocyte l1 antigen complex/analysis	biomarkers/analysis	0.02127659574468085	33436487
rna	PDCD1	0.2659574468085107	35977003
rna	TCIM	0.010638297872340427	35977003
rna	TNF	0.031914893617021274	35977003
phosphatidylinositol 3-kinases/metabolism	cd8-positive t-lymphocytes/immunology	0.010638297872340427	34987517
lymphocytes tumor-infiltrating/immunology	colitis/etiology	0.02127659574468085	34987517
lymphocytes tumor-infiltrating/immunology	immune checkpoint inhibitors/therapeutic use	0.02127659574468085	34987517
lymphocytes tumor-infiltrating/immunology	programmed cell death 1 receptor/antagonists & inhibitors	0.08510638297872342	34987517
lymphocytes tumor-infiltrating/immunology	cell line tumor	0.02127659574468085	34987517
phosphatidylinositol 3-kinases/metabolism	cytotoxicity immunologic	0.010638297872340427	34987517
phosphatidylinositol 3-kinases/metabolism	CD8A	0.05319148936170214	34987517
lymphocytes tumor-infiltrating/immunology	cd8-positive t-lymphocytes/immunology	0.010638297872340427	34987517
phosphatidylinositol 3-kinases/metabolism	MTOR	0.010638297872340427	34987517
phosphatidylinositol 3-kinases/metabolism	PDCD1	0.2659574468085107	34987517
programmed cell death 1 receptor/antagonists & inhibitors	melanoma/complications	0.23651935185461495	32567084
programmed cell death 1 receptor/antagonists & inhibitors	cell line tumor	0.16380690917410204	34987517
programmed cell death 1 receptor/antagonists & inhibitors	trinitrobenzenesulfonic acid/adverse effects	0.0851063829787234	33506015
lymphocytes tumor-infiltrating/immunology	cytotoxicity immunologic	0.010638297872340427	34987517
programmed cell death 1 receptor/antagonists & inhibitors	ctla-4 antigen/antagonists & inhibitors	0.00041777326847900685	32567084
programmed cell death 1 receptor/antagonists & inhibitors	ctla-4 antigen/antagonists & inhibitors	0.00041777326847900685	32702598
programmed cell death 1 receptor/antagonists & inhibitors	ctla-4 antigen/antagonists & inhibitors	0.00041777326847900685	34147519
lung neoplasms	steroids/therapeutic use	0.02127659574468085	31864555
programmed cell death 1 receptor/antagonists & inhibitors	cd8-positive t-lymphocytes/immunology	0.0851063829787234	34987517
colitis ulcerative/chemically induced	programmed cell death 1 receptor/antagonists & inhibitors	0.08510638297872342	33476895
lymphocytes tumor-infiltrating/immunology	CD8A	0.05319148936170214	34987517
programmed cell death 1 receptor/antagonists & inhibitors	antineoplastic agents immunological/adverse effects	0.012337984124876841	32567084
programmed cell death 1 receptor/antagonists & inhibitors	antineoplastic agents immunological/adverse effects	0.012337984124876841	32702598
programmed cell death 1 receptor/antagonists & inhibitors	antineoplastic agents immunological/adverse effects	0.012337984124876841	33476895
programmed cell death 1 receptor/antagonists & inhibitors	cd8-positive t-lymphocytes/drug effects	0.16380690917410204	34147519
piperazines/administration & dosage	APC	0.02127659574468085	33495297
programmed cell death 1 receptor/antagonists & inhibitors	drugs investigational/administration & dosage	0.0851063829787234	32540858
piperazines/administration & dosage	ARG1	0.010638297872340427	33495297
programmed cell death 1 receptor/antagonists & inhibitors	phenotype	0.16380690917410204	34147519
programmed cell death 1 receptor/antagonists & inhibitors	cytotoxicity immunologic	0.0851063829787234	34987517
programmed cell death 1 receptor/antagonists & inhibitors	ACAD8	0.16380690917410204	33506015
colitis ulcerative/chemically induced	antineoplastic agents immunological/adverse effects	0.07446808510638298	33476895
programmed cell death 1 receptor/antagonists & inhibitors	CD274	0.1128229388964722	32540858
programmed cell death 1 receptor/antagonists & inhibitors	CD274	0.1128229388964722	32702598
programmed cell death 1 receptor/antagonists & inhibitors	CD274	0.1128229388964722	32960847
lymphocytes tumor-infiltrating/immunology	MTOR	0.010638297872340427	34987517
programmed cell death 1 receptor/antagonists & inhibitors	CD8A	0.05604334027836758	34987517
programmed cell death 1 receptor/antagonists & inhibitors	CD8A	0.05604334027836758	34147519
lymphocytes tumor-infiltrating/immunology	PDCD1	0.2659574468085107	34987517
programmed cell death 1 receptor/antagonists & inhibitors	CTLA4	0.06236201957938463	32567084
programmed cell death 1 receptor/antagonists & inhibitors	CTLA4	0.06236201957938463	32702598
programmed cell death 1 receptor/antagonists & inhibitors	CTLA4	0.06236201957938463	34147519
piperazines/administration & dosage	PARP1	0.010638297872340427	33495297
piperazines/administration & dosage	PDCD1	0.2659574468085107	33495297
programmed cell death 1 receptor/antagonists & inhibitors	MTOR	0.0851063829787234	34987517
piperazines/administration & dosage	TIPARP	0.010638297872340427	33495297
programmed cell death 1 receptor/antagonists & inhibitors	PDCD1	0.00030768409823736525	34147519
programmed cell death 1 receptor/antagonists & inhibitors	PDCD1	0.00030768409823736525	32702598
programmed cell death 1 receptor/antagonists & inhibitors	PDCD1	0.00030768409823736525	32567084
programmed cell death 1 receptor/antagonists & inhibitors	PDCD1	0.00030768409823736525	32960847
programmed cell death 1 receptor/antagonists & inhibitors	PDCD1	0.00030768409823736525	32540858
programmed cell death 1 receptor/antagonists & inhibitors	PDCD1	0.00030768409823736525	34987517
programmed cell death 1 receptor/antagonists & inhibitors	PDCD1	0.00030768409823736525	33506015
programmed cell death 1 receptor/antagonists & inhibitors	SNCA	0.23651935185461495	33476895
colitis ulcerative/chemically induced	SNCA	0.031914893617021274	33476895
drug-related side effects and adverse reactions	melanoma/complications	0.06314344543582705	32418993
drug-related side effects and adverse reactions	infliximab/administration & dosage	0.02127659574468085	32418993
feces/chemistry	leukocyte l1 antigen complex/analysis	0.010638297872340427	33436487
graft vs host disease/immunology	cd8-positive t-lymphocytes/drug effects	0.02127659574468085	34338882
graft vs host disease/immunology	phenotype	0.02127659574468085	34338882
drug-related side effects and adverse reactions	ACAD8	0.04232441088995653	32418993
feces/chemistry	biomarkers/analysis	0.02127659574468085	33436487
drug-related side effects and adverse reactions	CRP	0.02127659574468085	32418993
graft vs host disease/immunology	CD4	0.02127659574468085	34338882
graft vs host disease/immunology	CD68	0.02127659574468085	34338882
graft vs host disease/immunology	CD8A	0.05319148936170214	34338882
drug-related side effects and adverse reactions	TNF	0.06314344543582705	32162824
cytotoxicity immunologic	CD8A	0.05319148936170214	34987517
gastrointestinal tract/metabolism	b7-h1 antigen/metabolism	0.010638297872340427	32298485
cytotoxicity immunologic	MTOR	0.010638297872340427	34987517
melanoma/drug therapy	immunosuppressive agents/pharmacology	0.05319148936170213	32414860
cytotoxicity immunologic	PDCD1	0.2659574468085107	34987517
melanoma/drug therapy	drug-related side effects and adverse reactions	0.10409517272935256	32162824
gastrointestinal tract/metabolism	CD274	0.1595744680851064	32298485
melanoma/drug therapy	mucositis/chemically induced	0.05319148936170213	32414860
gastrointestinal neoplasms/drug therapy	BTLA	0.010638297872340427	36159840
gastrointestinal neoplasms/drug therapy	CD274	0.1595744680851064	36159840
gastrointestinal neoplasms/drug therapy	CD28	0.010638297872340427	36159840
melanoma/drug therapy	antineoplastic agents immunological/adverse effects	0.32685057872309825	36338892
gastrointestinal neoplasms/drug therapy	CSF2	0.010638297872340427	36159840
gastrointestinal tract/metabolism	PDCD1	0.2659574468085107	32298485
gastrointestinal neoplasms/drug therapy	HAVCR2	0.010638297872340427	36159840
gastrointestinal neoplasms/drug therapy	IL15	0.010638297872340427	36159840
gastrointestinal neoplasms/drug therapy	IL17C	0.010638297872340427	36159840
gastrointestinal neoplasms/drug therapy	IL21	0.010638297872340427	36159840
gastrointestinal neoplasms/drug therapy	IL22	0.02127659574468085	36159840
gastrointestinal neoplasms/drug therapy	IL4	0.010638297872340427	36159840
gastrointestinal neoplasms/drug therapy	IL6	0.02127659574468085	36159840
gastrointestinal neoplasms/drug therapy	LIF	0.010638297872340427	36159840
gastrointestinal neoplasms/drug therapy	PDCD1	0.2659574468085107	36159840
cd8-positive t-lymphocytes/immunology	cytotoxicity immunologic	0.010638297872340427	34987517
cd8-positive t-lymphocytes/immunology	CD8A	0.05319148936170214	34987517
cd8-positive t-lymphocytes/immunology	MTOR	0.010638297872340427	34987517
cd8-positive t-lymphocytes/immunology	PDCD1	0.2659574468085107	34987517
ACAD8	CRP	0.02127659574468085	32418993
drug-related side effects and adverse reactions/diagnosis	CTLA4	0.1276595744680851	35191192
ligands	CD274	0.1595744680851064	35432346
ligands	CTLA4	0.1276595744680851	35432346
drug-related side effects and adverse reactions/diagnosis	PDCD1	0.2659574468085107	35191192
ACAD8	PDCD1	0.4632807137954702	33506015
ligands	PDCD1	0.2659574468085107	35432346
AHR	IL22	0.02127659574468085	35236743
inflammatory bowel diseases	gastrointestinal tract/metabolism	0.02127659574468085	32298485
inflammatory bowel diseases	b7-h1 antigen/metabolism	0.02127659574468085	32298485
APC	ARG1	0.02127659574468085	33495297
APC	CD274	0.2951269732326699	33462141
APC	CD8A	0.10409517272935258	33462141
antineoplastic agents immunological/adverse effects	anti-bacterial agents/pharmacology	0.07446808510638298	34162429
inflammatory bowel diseases	CD274	0.2951269732326699	32298485
antineoplastic agents immunological/adverse effects	CD274	0.7168043066411085	32702598
APC	IL17A	0.04232441088995653	33462141
antineoplastic agents immunological/adverse effects	CTLA4	0.21807328735592107	32567084
antineoplastic agents immunological/adverse effects	CTLA4	0.21807328735592107	32702598
melanoma/complications	ctla-4 antigen/antagonists & inhibitors	0.09369311569335442	32567084
APC	MIR15B	0.02127659574468085	33462141
melanoma/complications	infliximab/administration & dosage	0.031914893617021274	32418993
APC	NRF1	0.02127659574468085	33462141
APC	PARP1	0.02127659574468085	33495297
APC	PDCD1	0.06863417982155114	33495297
APC	PDCD1	0.06863417982155114	33462141
antineoplastic agents immunological/adverse effects	PDCD1	0.6018086520195671	32567084
antineoplastic agents immunological/adverse effects	PDCD1	0.6018086520195671	32702598
antineoplastic agents immunological/adverse effects	SNCA	0.2092521858494226	33476895
melanoma/complications	antineoplastic agents immunological/adverse effects	0.20925218584942262	32567084
APC	TIPARP	0.02127659574468085	33495297
inflammatory bowel diseases	PDCD1	0.4632807137954702	32298485
melanoma/complications	ACAD8	0.06314344543582703	32418993
melanoma/complications	CRP	0.031914893617021274	32418993
melanoma/complications	CTLA4	0.33932141684819905	32567084
melanoma/complications	PDCD1	0.17158544955387783	32567084
melanoma/complications	PDCD1	0.17158544955387783	32404733
ARG1	PARP1	0.010638297872340427	33495297
ARG1	PDCD1	0.2659574468085107	33495297
cell line tumor	poly(adp-ribose) polymerase inhibitors/administration & dosage	0.02127659574468085	33495297
ARG1	TIPARP	0.010638297872340427	33495297
cell line tumor	cd8-positive t-lymphocytes/immunology	0.02127659574468085	34987517
BTLA	CD274	0.1595744680851064	36159840
BTLA	CD28	0.010638297872340427	36159840
cell line tumor	piperazines/administration & dosage	0.02127659574468085	33495297
cell line tumor	cytotoxicity immunologic	0.02127659574468085	34987517
BTLA	CSF2	0.010638297872340427	36159840
cell line tumor	APC	0.04232441088995653	33495297
cell line tumor	ARG1	0.02127659574468085	33495297
immunocompromised host	prednisone/therapeutic use	0.010638297872340427	34956219
BTLA	HAVCR2	0.010638297872340427	36159840
BTLA	IL15	0.010638297872340427	36159840
BTLA	IL17C	0.010638297872340427	36159840
cell line tumor	CD8A	0.10409517272935258	34987517
BTLA	IL21	0.010638297872340427	36159840
BTLA	IL22	0.02127659574468085	36159840
BTLA	IL4	0.010638297872340427	36159840
BTLA	IL6	0.02127659574468085	36159840
BTLA	LIF	0.010638297872340427	36159840
BTLA	PDCD1	0.2659574468085107	36159840
cell line tumor	MTOR	0.02127659574468085	34987517
cell line tumor	PARP1	0.02127659574468085	33495297
cell line tumor	PDCD1	0.06863417982155114	33495297
cell line tumor	PDCD1	0.06863417982155114	34987517
cell line tumor	TIPARP	0.02127659574468085	33495297
CD274	CD28	0.15957446808510636	36159840
CD274	CD4	0.2951269732326699	33555016
CD274	CD68	0.2951269732326699	33555016
CD274	CD8A	0.1788268528741806	33555016
CD274	CD8A	0.1788268528741806	33462141
CD274	CSF2	0.15957446808510636	36159840
CD274	CTLA4	0.00032479323499700523	34992611
CD274	CTLA4	0.00032479323499700523	32702598
CD274	CTLA4	0.00032479323499700523	33555016
CD274	CTLA4	0.00032479323499700523	35917654
CD274	CTLA4	0.00032479323499700523	35432346
CD274	CTLA4	0.00032479323499700523	32934876
CD274	CTLA4	0.00032479323499700523	33314269
CD274	HAVCR2	0.15957446808510636	36159840
CD274	IL15	0.15957446808510636	36159840
CD274	IL17A	0.2951269732326699	33462141
CD274	IL17C	0.15957446808510636	36159840
CD274	IL21	0.15957446808510636	36159840
CD274	IL22	0.2951269732326699	36159840
CD274	IL4	0.15957446808510636	36159840
cd8-positive t-lymphocytes/drug effects	phenotype	0.00022878059940517045	34338882
cd8-positive t-lymphocytes/drug effects	phenotype	0.00022878059940517045	34147519
CD274	IL6	0.2951269732326699	36159840
CD274	LIF	0.15957446808510636	36159840
colon/immunology	t-lymphocyte subsets/immunology	0.02127659574468085	34777387
CD274	MIR15B	0.15957446808510636	33462141
CD274	NRF1	0.15957446808510636	33462141
CD274	PDCD1	1.345997632416698e-07	36159840
CD274	PDCD1	1.345997632416698e-07	34992611
CD274	PDCD1	1.345997632416698e-07	32702598
CD274	PDCD1	1.345997632416698e-07	33555016
CD274	PDCD1	1.345997632416698e-07	33173388
CD274	PDCD1	1.345997632416698e-07	33462141
CD274	PDCD1	1.345997632416698e-07	34158318
CD274	PDCD1	1.345997632416698e-07	32960847
CD274	PDCD1	1.345997632416698e-07	32298485
CD274	PDCD1	1.345997632416698e-07	35917654
CD274	PDCD1	1.345997632416698e-07	32540858
CD274	PDCD1	1.345997632416698e-07	33314269
CD274	PDCD1	1.345997632416698e-07	35432346
adenocarcinoma of lung/drug therapy	CD274	0.1595744680851064	32389505
CD274	SNCA	0.41005192324908235	32934876
cd8-positive t-lymphocytes/drug effects	CD4	0.04232441088995653	34338882
cd8-positive t-lymphocytes/drug effects	CD68	0.04232441088995653	34338882
cd8-positive t-lymphocytes/drug effects	CD8A	0.002287805994051705	34338882
cd8-positive t-lymphocytes/drug effects	CD8A	0.002287805994051705	34147519
cd8-positive t-lymphocytes/drug effects	CTLA4	0.240219629375429	34147519
cd8-positive t-lymphocytes/drug effects	PDCD1	0.4632807137954702	34147519
CD28	CSF2	0.010638297872340427	36159840
CD28	HAVCR2	0.010638297872340427	36159840
CD28	IL15	0.010638297872340427	36159840
CD28	IL17C	0.010638297872340427	36159840
CD28	IL21	0.010638297872340427	36159840
CD28	IL22	0.02127659574468085	36159840
CD28	IL4	0.010638297872340427	36159840
CD28	IL6	0.02127659574468085	36159840
CD28	LIF	0.010638297872340427	36159840
drugs investigational/administration & dosage	CD274	0.1595744680851064	32540858
CD28	PDCD1	0.2659574468085107	36159840
trinitrobenzenesulfonic acid/adverse effects	ACAD8	0.02127659574468085	33506015
drugs investigational/administration & dosage	PDCD1	0.2659574468085107	32540858
CD4	CD68	0.00022878059940517045	33555016
CD4	CD68	0.00022878059940517045	34338882
CD4	CD8A	0.002287805994051705	33555016
CD4	CD8A	0.002287805994051705	34338882
trinitrobenzenesulfonic acid/adverse effects	PDCD1	0.2659574468085107	33506015
CD4	CTLA4	0.240219629375429	33555016
dose-response relationship drug	programmed cell death 1 receptor/antagonists & inhibitors	0.1638069091741021	32540858
chemokines/metabolism	multigene family	0.010638297872340427	32603654
CD4	PDCD1	0.4632807137954702	33555016
biomarkers/analysis	antineoplastic agents/adverse effects	0.02127659574468085	26448188
biomarkers/analysis	intestinal mucosa/chemistry	0.02127659574468085	26448188
biomarkers/analysis	leukemia lymphocytic chronic b-cell/drug therapy	0.02127659574468085	26448188
biomarkers/analysis	class i phosphatidylinositol 3-kinases/antagonists & inhibitors	0.02127659574468085	26448188
biomarkers/analysis	purines/adverse effects	0.02127659574468085	26448188
CD68	CD8A	0.002287805994051705	33555016
CD68	CD8A	0.002287805994051705	34338882
biomarkers/analysis	colon/chemistry	0.02127659574468085	26448188
biomarkers/analysis	lymphocytosis/chemically induced	0.02127659574468085	26448188
biomarkers/analysis	protein kinase inhibitors/adverse effects	0.02127659574468085	26448188
biomarkers/analysis	apoptosis/drug effects	0.02127659574468085	26448188
chemokines/metabolism	CTLA4	0.1276595744680851	32603654
CD68	CTLA4	0.240219629375429	33555016
biomarkers/analysis	quinazolinones/adverse effects	0.02127659574468085	26448188
biomarkers/analysis	lymphoma non-hodgkin/drug therapy	0.02127659574468085	26448188
dose-response relationship drug	drugs investigational/administration & dosage	0.02127659574468085	32540858
biomarkers/analysis	PIK3CD	0.02127659574468085	26448188
chemokines/metabolism	PDCD1	0.2659574468085107	32603654
dose-response relationship drug	steroids/therapeutic use	0.04232441088995653	33290513
CD68	PDCD1	0.4632807137954702	33555016
dose-response relationship drug	CD274	0.2951269732326699	32540858
ctla-4 antigen/antagonists & inhibitors	antineoplastic agents immunological/adverse effects	0.013890961176926982	32567084
ctla-4 antigen/antagonists & inhibitors	antineoplastic agents immunological/adverse effects	0.013890961176926982	32702598
ctla-4 antigen/antagonists & inhibitors	cd8-positive t-lymphocytes/drug effects	0.06314344543582703	34147519
ctla-4 antigen/antagonists & inhibitors	phenotype	0.06314344543582703	34147519
CD8A	CTLA4	0.12054726330635734	33555016
CD8A	CTLA4	0.12054726330635734	34147519
CD8A	IL17A	0.10409517272935256	33462141
dose-response relationship drug	PDCD1	0.4632807137954702	32540858
ctla-4 antigen/antagonists & inhibitors	CD274	0.4100519232490824	32702598
phenotype	CD4	0.04232441088995653	34338882
CD8A	MIR15B	0.05319148936170213	33462141
phenotype	CD68	0.04232441088995653	34338882
ctla-4 antigen/antagonists & inhibitors	CD8A	0.1527856524723225	34147519
phenotype	CD8A	0.002287805994051705	34338882
phenotype	CD8A	0.002287805994051705	34147519
CD8A	MTOR	0.05319148936170213	34987517
CD8A	NRF1	0.05319148936170213	33462141
ctla-4 antigen/antagonists & inhibitors	CTLA4	0.0016412521261675271	32567084
ctla-4 antigen/antagonists & inhibitors	CTLA4	0.0016412521261675271	32702598
ctla-4 antigen/antagonists & inhibitors	CTLA4	0.0016412521261675271	34147519
phenotype	CTLA4	0.240219629375429	34147519
CD8A	PDCD1	0.01686942661548015	33555016
CD8A	PDCD1	0.01686942661548015	34147519
CD8A	PDCD1	0.01686942661548015	34987517
CD8A	PDCD1	0.01686942661548015	33462141
neutrophils/drug effects	antibodies monoclonal/adverse effects	0.010638297872340427	32567084
ctla-4 antigen/antagonists & inhibitors	PDCD1	0.017158544955387784	32567084
ctla-4 antigen/antagonists & inhibitors	PDCD1	0.017158544955387784	32702598
ctla-4 antigen/antagonists & inhibitors	PDCD1	0.017158544955387784	34147519
phenotype	PDCD1	0.4632807137954702	34147519
neutrophils/drug effects	programmed cell death 1 receptor/antagonists & inhibitors	0.08510638297872342	32567084
neutrophils/drug effects	melanoma/complications	0.031914893617021274	32567084
CHI3L1	CXCL8	0.010638297872340427	36096534
neutrophils/drug effects	ctla-4 antigen/antagonists & inhibitors	0.031914893617021274	32567084
CHI3L1	IL17A	0.02127659574468085	36096534
CHI3L1	IL6	0.02127659574468085	36096534
neutrophils/drug effects	antineoplastic agents immunological/adverse effects	0.07446808510638298	32567084
b7-h1 antigen/metabolism	CD274	0.1595744680851064	32298485
neutrophils/drug effects	CTLA4	0.1276595744680851	32567084
neutrophils/drug effects	PDCD1	0.2659574468085107	32567084
CSF2	HAVCR2	0.010638297872340427	36159840
CSF2	IL15	0.010638297872340427	36159840
CSF2	IL17C	0.010638297872340427	36159840
CSF2	IL21	0.010638297872340427	36159840
CSF2	IL22	0.02127659574468085	36159840
CSF2	IL4	0.010638297872340427	36159840
CSF2	IL6	0.02127659574468085	36159840
CSF2	LIF	0.010638297872340427	36159840
myasthenia gravis/chemically induced	immune checkpoint inhibitors/therapeutic use	0.02127659574468085	32130969
CSF2	PDCD1	0.2659574468085107	36159840
CTLA4	CXCL10	0.1276595744680851	35977003
CTLA4	CXCL9	0.1276595744680851	35977003
myasthenia gravis/chemically induced	ipilimumab/therapeutic use	0.031914893617021274	32130969
CTLA4	PDCD1	6.54938016501819e-07	34992611
CTLA4	PDCD1	6.54938016501819e-07	32702598
CTLA4	PDCD1	6.54938016501819e-07	32603654
CTLA4	PDCD1	6.54938016501819e-07	33555016
CTLA4	PDCD1	6.54938016501819e-07	35977003
CTLA4	PDCD1	6.54938016501819e-07	32567084
CTLA4	PDCD1	6.54938016501819e-07	35917654
CTLA4	PDCD1	6.54938016501819e-07	35191192
CTLA4	PDCD1	6.54938016501819e-07	35432346
CTLA4	PDCD1	6.54938016501819e-07	33314269
CTLA4	PDCD1	6.54938016501819e-07	34147519
CTLA4	SNCA	0.33932141684819905	32934876
CTLA4	TCIM	0.1276595744680851	35977003
CTLA4	TNF	0.33932141684819905	35977003
CXCL10	CXCL9	0.010638297872340427	35977003
CXCL10	PDCD1	0.2659574468085107	35977003
CXCL10	TCIM	0.010638297872340427	35977003
CXCL10	TNF	0.031914893617021274	35977003
CXCL8	IL17A	0.02127659574468085	36096534
antibodies monoclonal/adverse effects	programmed cell death 1 receptor/antagonists & inhibitors	0.08510638297872342	32567084
CXCL8	IL6	0.02127659574468085	36096534
antibodies monoclonal/adverse effects	melanoma/complications	0.031914893617021274	32567084
antibodies monoclonal/adverse effects	ctla-4 antigen/antagonists & inhibitors	0.031914893617021274	32567084
antibodies monoclonal/adverse effects	antineoplastic agents immunological/adverse effects	0.07446808510638298	32567084
CXCL9	PDCD1	0.2659574468085107	35977003
CXCL9	TCIM	0.010638297872340427	35977003
CXCL9	TNF	0.031914893617021274	35977003
HAVCR2	IL15	0.010638297872340427	36159840
HAVCR2	IL17C	0.010638297872340427	36159840
HAVCR2	IL21	0.010638297872340427	36159840
HAVCR2	IL22	0.02127659574468085	36159840
HAVCR2	IL4	0.010638297872340427	36159840
HAVCR2	IL6	0.02127659574468085	36159840
HAVCR2	LIF	0.010638297872340427	36159840
HAVCR2	PDCD1	0.2659574468085107	36159840
IL15	IL17C	0.010638297872340427	36159840
IL15	IL21	0.010638297872340427	36159840
IL15	IL22	0.02127659574468085	36159840
IL15	IL4	0.010638297872340427	36159840
IL15	IL6	0.02127659574468085	36159840
IL15	LIF	0.010638297872340427	36159840
IL15	PDCD1	0.2659574468085107	36159840
IL17A	IL6	0.04232441088995653	36096534
IL17A	MIR15B	0.02127659574468085	33462141
IL17A	NRF1	0.02127659574468085	33462141
IL17A	PDCD1	0.4632807137954702	33462141
IL17C	IL21	0.010638297872340427	36159840
IL17C	IL22	0.02127659574468085	36159840
IL17C	IL4	0.010638297872340427	36159840
IL17C	IL6	0.02127659574468085	36159840
IL17C	LIF	0.010638297872340427	36159840
IL17C	PDCD1	0.2659574468085107	36159840
IL21	IL22	0.02127659574468085	36159840
IL21	IL4	0.010638297872340427	36159840
IL21	IL6	0.02127659574468085	36159840
IL21	LIF	0.010638297872340427	36159840
IL21	PDCD1	0.2659574468085107	36159840
IL22	IL4	0.02127659574468085	36159840
IL22	IL6	0.04232441088995653	36159840
IL22	LIF	0.02127659574468085	36159840
IL22	PDCD1	0.4632807137954702	36159840
IL4	IL6	0.02127659574468085	36159840
IL4	LIF	0.010638297872340427	36159840
IL4	PDCD1	0.2659574468085107	36159840
IL6	LIF	0.02127659574468085	36159840
IL6	PDCD1	0.4632807137954702	36159840
LIF	PDCD1	0.2659574468085107	36159840
MIR15B	NRF1	0.010638297872340427	33462141
MIR15B	PDCD1	0.2659574468085107	33462141
MTOR	PDCD1	0.2659574468085107	34987517
NRF1	PDCD1	0.2659574468085107	33462141
PARP1	PDCD1	0.2659574468085107	33495297
PARP1	TIPARP	0.010638297872340427	33495297
PDCD1	TCIM	0.26595744680851063	35977003
PDCD1	TIPARP	0.26595744680851063	33495297
PDCD1	TNF	0.6091283459162664	35977003
SNCA	TNF	0.09369311569335442	32641348
TCIM	TNF	0.031914893617021274	35977003
antineoplastic agents/adverse effects	intestinal mucosa/chemistry	0.010638297872340427	26448188
antineoplastic agents/adverse effects	leukemia lymphocytic chronic b-cell/drug therapy	0.010638297872340427	26448188
antineoplastic agents/adverse effects	class i phosphatidylinositol 3-kinases/antagonists & inhibitors	0.010638297872340427	26448188
antineoplastic agents/adverse effects	purines/adverse effects	0.010638297872340427	26448188
antineoplastic agents/adverse effects	colon/chemistry	0.010638297872340427	26448188
antineoplastic agents/adverse effects	lymphocytosis/chemically induced	0.010638297872340427	26448188
antineoplastic agents/adverse effects	protein kinase inhibitors/adverse effects	0.010638297872340427	26448188
antineoplastic agents/adverse effects	apoptosis/drug effects	0.010638297872340427	26448188
antineoplastic agents/adverse effects	quinazolinones/adverse effects	0.010638297872340427	26448188
antineoplastic agents/adverse effects	lymphoma non-hodgkin/drug therapy	0.010638297872340427	26448188
antineoplastic agents/adverse effects	PIK3CD	0.010638297872340427	26448188
intestinal mucosa/chemistry	leukemia lymphocytic chronic b-cell/drug therapy	0.010638297872340427	26448188
intestinal mucosa/chemistry	class i phosphatidylinositol 3-kinases/antagonists & inhibitors	0.010638297872340427	26448188
intestinal mucosa/chemistry	purines/adverse effects	0.010638297872340427	26448188
intestinal mucosa/chemistry	colon/chemistry	0.010638297872340427	26448188
intestinal mucosa/chemistry	lymphocytosis/chemically induced	0.010638297872340427	26448188
intestinal mucosa/chemistry	protein kinase inhibitors/adverse effects	0.010638297872340427	26448188
intestinal mucosa/chemistry	apoptosis/drug effects	0.010638297872340427	26448188
intestinal mucosa/chemistry	quinazolinones/adverse effects	0.010638297872340427	26448188
intestinal mucosa/chemistry	lymphoma non-hodgkin/drug therapy	0.010638297872340427	26448188
intestinal mucosa/chemistry	PIK3CD	0.010638297872340427	26448188
leukemia lymphocytic chronic b-cell/drug therapy	class i phosphatidylinositol 3-kinases/antagonists & inhibitors	0.010638297872340427	26448188
leukemia lymphocytic chronic b-cell/drug therapy	purines/adverse effects	0.010638297872340427	26448188
leukemia lymphocytic chronic b-cell/drug therapy	colon/chemistry	0.010638297872340427	26448188
leukemia lymphocytic chronic b-cell/drug therapy	lymphocytosis/chemically induced	0.010638297872340427	26448188
leukemia lymphocytic chronic b-cell/drug therapy	protein kinase inhibitors/adverse effects	0.010638297872340427	26448188
leukemia lymphocytic chronic b-cell/drug therapy	apoptosis/drug effects	0.010638297872340427	26448188
leukemia lymphocytic chronic b-cell/drug therapy	quinazolinones/adverse effects	0.010638297872340427	26448188
leukemia lymphocytic chronic b-cell/drug therapy	lymphoma non-hodgkin/drug therapy	0.010638297872340427	26448188
leukemia lymphocytic chronic b-cell/drug therapy	PIK3CD	0.010638297872340427	26448188
class i phosphatidylinositol 3-kinases/antagonists & inhibitors	purines/adverse effects	0.010638297872340427	26448188
class i phosphatidylinositol 3-kinases/antagonists & inhibitors	colon/chemistry	0.010638297872340427	26448188
class i phosphatidylinositol 3-kinases/antagonists & inhibitors	lymphocytosis/chemically induced	0.010638297872340427	26448188
class i phosphatidylinositol 3-kinases/antagonists & inhibitors	protein kinase inhibitors/adverse effects	0.010638297872340427	26448188
class i phosphatidylinositol 3-kinases/antagonists & inhibitors	apoptosis/drug effects	0.010638297872340427	26448188
class i phosphatidylinositol 3-kinases/antagonists & inhibitors	quinazolinones/adverse effects	0.010638297872340427	26448188
class i phosphatidylinositol 3-kinases/antagonists & inhibitors	lymphoma non-hodgkin/drug therapy	0.010638297872340427	26448188
class i phosphatidylinositol 3-kinases/antagonists & inhibitors	PIK3CD	0.010638297872340427	26448188
purines/adverse effects	colon/chemistry	0.010638297872340427	26448188
purines/adverse effects	lymphocytosis/chemically induced	0.010638297872340427	26448188
purines/adverse effects	protein kinase inhibitors/adverse effects	0.010638297872340427	26448188
purines/adverse effects	apoptosis/drug effects	0.010638297872340427	26448188
purines/adverse effects	quinazolinones/adverse effects	0.010638297872340427	26448188
purines/adverse effects	lymphoma non-hodgkin/drug therapy	0.010638297872340427	26448188
purines/adverse effects	PIK3CD	0.010638297872340427	26448188
colon/chemistry	lymphocytosis/chemically induced	0.010638297872340427	26448188
colon/chemistry	protein kinase inhibitors/adverse effects	0.010638297872340427	26448188
colon/chemistry	apoptosis/drug effects	0.010638297872340427	26448188
colon/chemistry	quinazolinones/adverse effects	0.010638297872340427	26448188
colon/chemistry	lymphoma non-hodgkin/drug therapy	0.010638297872340427	26448188
colon/chemistry	PIK3CD	0.010638297872340427	26448188
lymphocytosis/chemically induced	protein kinase inhibitors/adverse effects	0.010638297872340427	26448188
lymphocytosis/chemically induced	apoptosis/drug effects	0.010638297872340427	26448188
lymphocytosis/chemically induced	quinazolinones/adverse effects	0.010638297872340427	26448188
lymphocytosis/chemically induced	lymphoma non-hodgkin/drug therapy	0.010638297872340427	26448188
lymphocytosis/chemically induced	PIK3CD	0.010638297872340427	26448188
protein kinase inhibitors/adverse effects	apoptosis/drug effects	0.010638297872340427	26448188
protein kinase inhibitors/adverse effects	quinazolinones/adverse effects	0.010638297872340427	26448188
protein kinase inhibitors/adverse effects	lymphoma non-hodgkin/drug therapy	0.010638297872340427	26448188
protein kinase inhibitors/adverse effects	PIK3CD	0.010638297872340427	26448188
apoptosis/drug effects	quinazolinones/adverse effects	0.010638297872340427	26448188
apoptosis/drug effects	lymphoma non-hodgkin/drug therapy	0.010638297872340427	26448188
apoptosis/drug effects	PIK3CD	0.010638297872340427	26448188
quinazolinones/adverse effects	lymphoma non-hodgkin/drug therapy	0.010638297872340427	26448188
quinazolinones/adverse effects	PIK3CD	0.010638297872340427	26448188
lymphoma non-hodgkin/drug therapy	PIK3CD	0.010638297872340427	26448188
